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Foreword 
Finland – Drug Situation 2012 is an annual drug report by the Finnish National Focal Point. The report 
consists of two parts. Part A discusses the latest developments and research data from recent years, mainly 
focusing on 2011 and early 2012.  
The drug situation is described from the perspectives of legislation, policies, use, harm, treatment and 
other interventions, and the drug issue is approached from the health, social and criminal points of view.  
Part B discusses drug-related special themes; this year, institutional treatment for drug users and the 
drug situation in Helsinki.  
Chapter 11 on institutional care for drug users was contributed by research scientist Riikka Perälä from 
the University of Helsinki, and chapter 12 on the drug situation in Helsinki by Senior Planning Officer Vili 
Varjonen from the National Institute for Health and Welfare. 
The report was compiled and the remaining sections written by Senior Planning Officers Vili Varjonen, 
Hannele Tanhua and Martta Forsell at the Finnish National Focal Point, which operates at the National 
Institute for Health and Welfare (THL). Also, researchers Sarianna Petrell from the National Bureau of 
Investigation and Heini Kainulainen from the National Research Institute of Legal Policy contributed 
substantially to the editing of chapters 9 and 10. The assistance of research scientist Marke Jääskeläinen in 
the reporting of morbidity statistics is much appreciated. 
Several experts contributed to and provided helpful comments on the preparation of the report 
(Appendix 1). We extend our warmest thanks to everyone involved in the preparation of the report. The 
report has been approved by the editorial board of Printed Products, Information, THL, as well as the 
working group on international co-operation on drug issues.  
The report is available in Finnish in print and online, and in English online.  
Finland – Drug Situation 2012 is one of the national annual reports compiled by the National Focal 
Points in the European Information Network on Drugs and Drug Addiction (REITOX) which is co-
ordinated by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The national 
reports form the basis for the EMCDDA’s annual report The state of the drugs problem in Europe.  
 
 
 
 
 
 
Helsinki, November 2012  
 
Vili Varjonen    Hannele Tanhua 
Senior Planning Officer  Senior Planning Officer 
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Abstract 
Vili Varjonen, Hannele Tanhua, Martta Forsell, Riikka Perälä. Finland – Drug Situation 2012. National 
Institute for Health and Welfare (THL). Report 76/2012. 131 pages. Helsinki 2012. ISSN 1798-0089 (pdf) 
 
This report is a compilation of the most recent Finnish research on drugs and key indicators of the drug 
situation in Finland. 
Generally, drug use and drug-related problems have remained fairly stable in Finland over the past years. 
The most recent data from 2010 show that cannabis experimentation and home growing of cannabis 
have increased. User percentages were highest in the age group 15 to 34. About 17% of Finns aged 15 to 69 
reported that they had tried cannabis at some point in their lives, 4% within the past year. The percentage 
was slightly higher for men than for women. 
According to the 2011 ESPAD survey of school pupils, 12% of boys and 10% of girls aged 15 to 16 had 
experimented with cannabis at some time in their lives. The 2011 ESPAD survey was the first of its kind in 
Finland to include separate questions on hashish use, marijuana use and home growing of marijuana. 
Hashish use was reported by 7% of the boys and marijuana use by 10%, while the figures for girls were 4% 
and 6%, respectively; 12% of the boys and 10% of the girls reported that they knew someone who had 
grown cannabis at home. Among the pupils themselves, however, home growing was extremely rare: only 
1% of the boys and none of the girls reported having grown cannabis at home at some time. 
In recent years, drug-related treatment has focused on the treatment of problem use of opiates and 
polydrug use. Opiates are far more likely to cause serious problems and lead users to seek treatment than 
cannabis, for instance. Thus, the fact that the percentage of opiate user clients is increasing does not 
directly translate into an increase in drug use overall in Finland. According to the collecting of information 
on drug-related treatment conducted by the National Institute for Health and Welfare each year, opiates 
were the primary problem drug for 59% of clients seeking treatment at drug treatment units in 2011. More 
than half of the clients reported that they had a problem use history with at least three intoxicants. In recent 
years, nearly all of the opiate use recorded in Finland has involved synthetic, pharmaceutical opioids. Two 
of these, buprenorphine and methadone, are used both as intoxicants and as detoxification or substitution 
treatment medication. Substitution treatment medication is typically taken under a physician’s supervision 
and orally, while drug use is typically intravenous and involves the use of other drugs too. 
Among the drug users seeking treatment who were not opiate problem users, cannabis was the most 
common drug leading the clients to seek treatment. The percentage of cannabis as a primary cause for 
seeking treatment was considerably elevated in the youngest age groups. In fact, it was the most common 
problem drug reported as a cause for seeking treatment in the age group of under 20. 
The increased use of designer drugs shows in the statistics on seizures by Customs. The amendment to 
the Narcotics Act that entered into force in June 2011 stipulates that in the future the Finnish government 
may classify designer drugs as narcotic drugs at its own initiative. Under the new Act, any new substance 
entered in the EU early warning system may be nationally classified as a narcotic drug after its health 
hazards have been evaluated. Under the Act as amended, the Finnish government may nationally classify 
not only designer drugs but also pharmaceuticals as narcotic drugs if their pharmacological properties are 
equivalent to those of narcotic drugs. 
A national action plan to reduce substance abuse and its harmful effects for 2012–2015 was adopted in 
August 2012. The measures outlined in the Government Resolution concern prevention and early 
intervention; combating drug-related crime; treatment of drug addiction and reduction of drug-related 
problems; enhancing substance abuse treatment in connection with penal sanctions; EU drug policy and 
international cooperation; collecting of information and research on drug-related problems; and drug policy 
coordination. 
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1 National policies and context 
The purpose of drug policy is to prevent the use and distribution of drugs so as to minimise the economic, 
social and individual harm and costs of their use and prevention. Finland’s drug policy is based on general 
social policy measures, national legislation and international treaties, together aimed at contributing to a 
reduction in the supply of and demand for drugs, and in drug-related harm, enabling early treatment for 
those suffering from drug problems and imposing penal liability on those engaged in illegal activities. 
Drug policy is coordinated by the Ministry of Social Affairs and Health and implemented by the 
various administrative sectors in cooperation. The Drug Policy Coordination Group led by the Ministry has 
the job of developing and coordinating national drug policy and to monitor the drug situation. Finland’s 
drug policy is based on the Government Resolution on an Action Plan to Reduce Drug Use and Related 
Harm 2012–2015 and on the Drug Strategy adopted in 1997. In its drug policy, Finland observes the United 
Nations international drug control conventions and the EU Drugs Strategy for the period 2005–2012.  
The resources allocated have a significant impact on the implementation of drug policy. 
 
1.1 Legal framework 
Legislation concerning drugs that entered into force in 2011 
The amendment (373/2008) to the Narcotics Act that entered into force in June 2011 stipulates that in the 
future the Finnish government may classify designer drugs as narcotic drugs at its own initiative. Under the 
new Act, any new substance entered in the EU early warning system may be nationally classified as a 
narcotic drug after its health hazards have been evaluated.  
Under the Act as amended, the Finnish government may nationally classify not only designer drugs but 
also pharmaceuticals as narcotic drugs if their pharmacological properties are equivalent to those of 
narcotic drugs. 
Following this amendment, the pharmaceutical substance tapentadol was classified as a narcotic drug in 
Finland. Under the Narcotics Act, the manufacture, import, trading, possession and use of the substance are 
prohibited. The relevant Decree (1093/2011) entered into force on 1 November 2011.1  
Amendments pertaining to the prevention of drug use were enacted to the Youth Act (72/2006) in 2010. 
Sections on multisectoral cooperation in guidance and service networks for adolescents and on outreach 
youth work were added to the Act. Multisectoral cooperation involves both local and central government 
authorities. The purpose of outreach youth work is for instance to contact young people who need help 
because of a substance abuse problem and to introduce them to services and other means of support 
conducive to their growth and independence and to their access to education and the labour market. The 
Act entered into force on 1 January 2011 (693/2010). 
The Act on Vocational Education (630/1998), the Act on Vocational Adult Education (631/1998), the 
Polytechnics Act (351/2003), the University Act (558/2009) and the Criminal Records Act (770/1993) were 
amended to revise the criteria for not accepting students and to enable institutions to revoke study rights if 
security concerns so require. Among the amendments were provisions concerning student drug tests. The 
amendments entered into force on 1 January 2012 (HE 164/2010). The University Act was amended 
(954/2011) to include provisions on potential drug testing for students.  
                                                        
 
 
1 Seven designer drugs were classified as narcotic drugs in Finland by a Decree (117/2012) as of 12 March 2012. The synthetic 
cannabinoids JWH-018, JWH-073 and JWH-081 were classified as narcotic drugs, as were the MDPV-like mCPP, the MDPV derivative 
methylon, the central nervous system stimulant 2-DPMP and the LSD-like Bromo-Dragonfly.  
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The Health Care Act (1326/2010), which entered into force at the beginning of May 2011, requires 
preventive substance abuse work in the health care system to be planned and implemented so as to integrate 
with other local preventive substance abuse and mental health care efforts. The purpose of coordinating 
services is to improve the potential for substance abusers to receive effective treatment, as substance abuse 
problems often co-occur with mental health disorders and other health problems. The purpose of mental 
health services for children and adolescents is to provide help at an early stage in emotional and 
behavioural disturbances and other mental health problems in childhood and adolescence, which will 
reduce the probability of them later developing a substance abuse problem. 
The Act on investigating the circumstances of a young person suspected of an offence (633/2010) 
entered into force at the beginning of 2011. The purpose of this Act is to effect a survey of the social 
conditions of the young person in question and the reasons leading to his/her committing an offence, and 
also the potential for supporting that person in leading a crime-free life. 
The Act on electronic monitoring sentences (330/2011) entered into force on 1 November 2011. A 
person with an electronic monitoring sentence must comply with the daily programme and movement 
restrictions imposed on him/her. The sentence may involve work, training, rehabilitation or other activities 
designed to improve functional capacity. The convict is obliged to stay at home at all times when there is 
no predetermined reason for him/her to go outside. Absolute abstinence from intoxicating substances is also 
required, and this is monitored through tests. 
The Community Service Act (1055/1996) was amended (641/2010) to include a requirement not to use 
drugs while performing community service; this amendment entered into force at the beginning of 2011. In 
cases of suspected drug use, the convict is required to submit a urine or saliva sample; a positive sample 
will lead, depending on the situation, to a reprimand, a notification to the prosecutor, or even the 
discontinuation or denial of community service. Moreover, as of the beginning of 2011 the Community 
Service Act tripled the availability of activities other than work in community service. A convict may now 
participate more extensively in rehabilitation and programmes supporting life management skills. 
Definition of drugs 
The Decree on substances, preparations and plants considered as narcotics (543/2008) lists the substances 
and preparations defined as narcotics. This Decree is based on the UN Single Convention on Narcotic 
Drugs (SopS 44/1994) and its Convention on Psychotropic Substances (SopS 23/1967). In addition, the 
Decree lists substances placed under narcotics control at the community level, including 4-MTA, PMMA, 
2C-I, 2C-T-2, 2C-T-7, TMA-2, 1-benzylpiperazine and most recently mephedrone, and also the substances 
nationally classified as narcotic drugs. 
Narcotics Act 
According to the Narcotics Act (373/2008), which entered into force in September 2008,2 the production, 
manufacture, import, export, transit, distribution, processing, possession and use of and trafficking in drugs 
is prohibited, although exemptions are possible for medical, scientific, investigative and control purposes.  
Sanctions prescribed in the Narcotics Act are divided according to the severity of the offence into 
administrative coercive measures and sanctions for offences against the Narcotics Act and for narcotics 
offences. Administrative coercive measures include prohibition of further action and/or a default fine to 
enforce such a prohibition. Offences against the Narcotics Act include for instance intentional neglecting of 
the obligations of the Act. Unless a more severe punishment for the act is provided for elsewhere in the 
legislation in force, a person committing an offence against the Narcotics Act can be sentenced to a fine. 
Provisions concerning the more serious narcotics offences are laid down in Chapter 50 of the Penal Code 
(39/1889). 
                                                        
 
 
2 See the amendments to the Act in section 1.1.  
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Under the Narcotics Act, the Finnish Medicines Agency (Fimea) is the licensing and controlling 
authority for narcotic drugs and drug precursors. A licence is required for the manufacture, import, export 
and handling of drugs unless this is specifically exempt by law, as for instance for many of the actors in the 
health care sector. The Decree on Narcotics Control (548/2008) lays down more specific provisions on the 
license administration, operations subject to authorisation and their supervision under the Narcotics Act. 
The trade in and handling of drug precursors is provided for in more detail by EC Regulations.3 
Legislation on substance abuse prevention 
There are many other legislative provisions intended to prevent, treat and monitor drug use and problem 
use of drugs. Provisions concerning preventive substance abuse work are laid down in the Temperance 
Work Act (828/1982). This Act defines the purpose of temperance work as habituating citizens to healthy 
lifestyles by guiding them in avoidance of the use of substances and tobacco. According to the Act, the 
establishment of general prerequisites for substance abuse prevention is primarily the task of central and 
local government. Practical measures in this area are generally undertaken by local authorities and by 
temperance and public health organisations. Pursuant to the Act, each local authority must have a 
designated body responsible for temperance work. This body must cooperate with the local health care, 
social welfare and education services in particular. The Temperance Work Act is scheduled for revision in 
2013. The purpose of this revision is to develop local measures for prevention of harmful impacts of 
substance abuse. Local aspects of measures aimed at preventing harmful impacts of substance abuse will be 
considered more closely than before in revising the Act. The Temperance Work Decree (233/1983) 
further specifies that this body must cooperate with organisations engaging in temperance work and 
substance abuse prevention and promoting healthy lifestyles. 
Under the Child Welfare Act (417/2007), a child is entitled to a safe growing environment, balanced 
and well-rounded development and special protection. When the parent, guardian or person otherwise 
responsible for the care and upbringing of a child is a client of substance abuse services, mental health 
services or other social welfare or health care services and as a result is judged to be impaired in his/her 
ability to manage the care and upbringing of the child, the child’s need for care and support must be 
investigated, and sufficient care and support must be provided. An amendment to the Child Welfare Act 
entered into force in March 2010 containing a provision on submitting an anticipatory child welfare 
notification. An anticipatory child welfare notification must be submitted when there is reasonable cause to 
suspect that a forthcoming child will need child welfare support measures immediately after the birth. In 
other words, an anticipatory child welfare notification must be submitted by someone who has certain 
knowledge that a mother-to-be or father-to-be has a substance abuse problem or a severe mental health 
disturbance or is subject to a custodial sentence. A suspicion of substance abuse is not in itself enough for 
submitting an anticipatory child welfare report. 
The key principles for pupil and student welfare services and the educational objectives are defined in 
the national curricula for the various educational levels. Legislation related to education (477–479/2003) 
has required educational institutions to apply these principles, together with social welfare and health care 
authorities, in local curricula in order to further the prevention and treatment of substance abuse. 
The Government Decree on welfare clinic services, school and student health services and 
preventive oral health services for children and youth (380/2009) lays down provisions concerning 
health examinations in welfare clinics and carried out by school and student health services. According to 
the Decree, sufficient and regular health examinations and health counselling are aimed at enhancing early 
support and preventing social marginalisation. Another purpose of health counselling is to prevent 
substance abuse and thereby promote psychosocial wellbeing. The Decree specifies that welfare clinics 
must adopt extensive health examinations – as in school health care – involving the entire family. Health 
                                                        
 
 
3 (EC) Regulations Nos. 273/2004 and 111/2005 and Regulations amending them, and the implementing Regulation (EC) No. 1277/2005. 
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examinations in eighth grade in comprehensive school highlight the importance of early detection, 
intervention and further treatment in any substance abuse problems. 
The Occupational Health Care Act (1383/2001) enables drug testing in the workplace. Before 
requiring any individual to take a test, the employer must have a written substance abuse programme, 
which contains the general goals of the workplace and practices to be followed to prevent substance abuse 
and help substance abusers in seeking treatment. The Act on the Protection of Privacy in Working Life 
(759/2004) regulates employers’ rights and their limitations concerning drug tests required from 
employees. Drug control is justified in sectors where special legislative provisions apply. Such provisions 
may be found in the Conscription Act (1438/2007), the Aviation Act (1194/2009) and the Act on traffic 
safety duties in the railway system (1664/2009). The Ministry of Social Affairs and Health has issued 
instructions on drug tests in working life. (Ministry of Social Affairs and Health 2006). 
Legislation on services and harm reduction 
According to the Constitution (731/1999), those who cannot obtain the means necessary for a life of 
dignity have the right to receive indispensable subsistence and care. 
Treatment for drug users is regulated by the Act on Welfare for Substance Abusers (41/1986), requiring 
municipalities to ensure that the provision of substance abuse services meets local needs as regards content 
and scope. These services must be delivered through the development of general social and health care 
services and the provision of services that are intended specifically for substance abusers. Such services 
must be provided primarily through outpatient care and should be easily available, flexible and diversified.  
The Social Welfare Act (710/1982) requires local authorities to provide social welfare services, 
including substance abuse services.  
At the moment, both the Act on Welfare for Substance Abusers (41/1986) and the Mental Health Act 
(1116/1990) allow for commitment to involuntary treatment. Section 11 of the Act on Welfare for 
Substance Abusers allows for involuntary commitment to treatment in case of a health risk, but this 
provision is applied only rarely. However, coercive measures are often exercised on substance problem 
users pursuant to the Mental Health Act (1116/1990).  
The Decree governing detoxification and substitution treatment for opioid addicts (33/2008) 
stresses that unlike under previous legislation only demanding substitution treatment cases should be dealt 
with by specialist health care; other cases should be treated at the primary health care level. 
Pharmaceuticals containing buprenorphine or methadone may only be prescribed for the detoxification or 
substitution treatment of opioid addicts by a physician employed by a health care unit who is responsible 
for this function, or by a physician designated by him/her.4 However, the Decree also allows a combined 
preparation of buprenorphine and naloxone to be issued from a pharmacy under a pharmacy contract signed 
by the patient. A pharmacy contract is an agreement by which the patient commits to collecting the 
pharmaceuticals specified under the contract from only one pharmacy and agrees that this pharmacy may 
transmit treatment-related information to the physician treating the patient and notify other pharmacies of 
the existence of the pharmacy contract. 
The amendment of the Decree on Prescription of Medicines (490/2008) specifies the conditions for 
prescribing a narcotic substance for medicinal use and, if special therapeutic reasons exist, for prescribing 
special preparations outside the special authorisation procedure under the Medicines Act for medicinal use. 
A condition for prescribing a preparation requiring special authorisation is that no other therapies are 
available for treating the patient or that the desired outcome cannot be achieved using other therapies. 
Special authorisation can be granted on a patient-specific basis and, at most, for one year at a time. Based 
                                                        
 
 
4 Medical treatment may be conducted and the medication administered to the patient only under the supervision of the health care unit. If the 
patient’s commitment to treatment is high, the health care unit can give him/her pharmaceuticals equivalent to a maximum of eight daily 
doses (15 in exceptional cases).  
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on the amendment, a cannabis-based analgesic can also be prescribed in certain cases. However, cannabis-
based medicines do not have an actual marketing authorisation. 
The Communicable Disease Decree (786/1986) requires that the municipal body responsible 
combating infectious diseases ensure that work is undertaken for the prevention of infectious diseases, 
including the provision of health counselling for intravenous drug users as well as needle and syringe 
exchange. In addition, as part of the general vaccination programme, Decree 421/2004 recommends free 
hepatitis A and B vaccines for intravenous drug users, their sexual partners and individuals living in the 
same household. 
Penal Code 
Narcotics offences are provided for in chapter 50 of the Penal Code (39/1889), in an amendment to which 
(1304/1993) they were further categorised as narcotics offences, or the preparation or abetting of narcotics 
offences (maximum sentence 2 years’ imprisonment), or aggravated narcotics offences (1 to 10 years’ 
imprisonment). An amendment to the Penal Code enacted in 2001 (654/2001) defined the unlawful use of 
narcotics (maximum sentence six months’ imprisonment). In 2006, a further amendment (928/2006) 
rendered the preparation of and abetting a narcotics offence punishable acts. 
Dealing with the unlawful use of narcotics is possible in summary penal proceedings (692/1993). This 
may be done in cases where the penal provision applicable does not include a punishment more severe than 
a fine or a maximum of six months’ imprisonment. A summary penal order is issued by the police, a 
customs official or another public official performing controls stipulated by law, on their own initiative or 
on behalf of the prosecutor. Through amendment 578/2008 to the Penal Code, it was determined that a fine 
imposed in summary penal proceedings may not be converted into imprisonment. In practice, this means 
that offenders issued a fine in summary penal proceedings by the police or the prosecutor for the unlawful 
use of narcotics may no longer be sent to prison instead. Charges may be waived for unlawful use of 
narcotics if the offender agrees to seek treatment or if, in the case of an offender under the age of 18, a 
reprimand is given. (Kainulainen 2009.)5 
Chapter 23 of the Penal Code (39/1889) concerns driving while intoxicated, including provisions on 
drugs. Since 2002, a zero-tolerance policy has been in effect concerning the use of drugs or 
pharmaceuticals classified as narcotics while driving, unless the driver has a valid prescription for them. 
The control of illegal drugs is also provided for in the Coercive Measures Act (450/1987), which sets 
forth terms and conditions for wiretapping, telecommunications monitoring and technical monitoring, and 
in the Police Act (493/1995), which provides in more detail for undercover action, pseudo purchases and 
other significant intelligence methods in the prevention, uncovering and solving of serious and organised 
crime (including drug crime). 
Legislation on sanctions 
The Act on Imprisonment (686/2005) regulates both drug control and drug prevention and treatment work 
in prisons. The Act stipulates that, in a closed institution, the prison inmate must be provided with the 
opportunity to stay in a contractual ward where the inmates are committed to a supervised intoxicant-free 
life and to the activities arranged in the ward. An inmate with a substance abuse problem can also be placed 
for a fixed term in an institution outside prison, where he/she can participate in rehabilitation or other 
target-oriented activities that reinforce his/her coping skills and where he/she does not use intoxicating 
substances and observes the terms and conditions stipulated for free movement. 
                                                        
 
 
5 See also 9.2 Alternatives to prison. 
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1.2 Drug policy and its coordination 
Finnish drug policy is based on general social policy measures, national legislation and international 
treaties, together aimed at contributing to a reduction in the supply of and demand for drugs, and in drug-
related harm, enabling early treatment for those suffering from drug problems and imposing penal liability 
on those engaged in illegal activities. This policy has not fundamentally changed in recent years. However, 
monitoring has been tightened through enactment of legislation on designer drugs. In its drug policy, 
Finland observes the United Nations international drug control conventions and the EU Drugs Strategy for 
the period 2005–2012. (Finnish Government 2007a.) Anti-drug work will also take account of measures 
contained in other Government action plans (including those adopted by previous Governments and still 
valid) and those under the Internal Security Programme, for instance. 
The Ministry of Social Affairs and Health is responsible for coordinating national measures related to 
drug policy. The principal coordinating body for drug policy is the national Drug Policy Coordination 
Group led by the Ministry of Social Affairs and Health; each administrative sector brings matters under 
preparation with relevance for general drug policy to the group for discussion. The bodies represented in 
this group are the Ministry of the Interior, the National Police Board, the Ministry of Justice, the Office of 
the Prosecutor General, the Ministry of Finance, the Customs authorities, the Ministry of Education and 
Culture, the National Board of Education, the Ministry for Foreign Affairs, the National Institute for Health 
and Welfare and Fimea. The Drug Policy Coordination Group discusses legislative amendments and recent 
research findings and submits initiatives for action. The group regularly reports to the Government about 
the drug situation and new measures.  
Background  
The first Finnish drug strategy was published in 1997, with the aim of arresting the growth of drug use and 
the related crime. Based on this strategy, the Government has issued resolutions in 1998, 2000, 2004 and 
2008.  
According to a dissertation by Tuukka Tammi (2007), two contradictory views on the drug issue were 
held by the first national Drug Policy Committee: the police authorities advocated a drug-free society and 
strict control policies while the social welfare, health and criminal policy alliance was in favour of harm 
reduction. The general objective of harm reduction was not solely based on public health concerns. Indeed, 
the concept’s ideological roots can be traced back to the tradition of a rational and humane criminal policy 
first adopted in the 1960s and 1970s, according to which criminal and social policy primarily aims at 
minimising social harm. (Tammi 2007.) 
According to the study, minimising harm has not presented a threat to the drug prohibition policy; 
rather, it has become part of it. Minimising harm through the establishment of syringe and needle exchange 
points (health counselling centres) and extended substitution treatment has meant new, specialised services 
founded upon medicine and increased efforts by medical professionals to treat drug-related problems. At 
the same time, penal control of drug use has become more effective. Therefore, minimising harm has not 
meant a step towards a more liberal drug policy, nor has it vitiated the traditional policy based on complete 
drug prohibition. Instead, minimising harm combined with punitive prohibition policy forms a two-pronged 
paradigm for Finland's drug policy. (Tammi 2007.) 
Aarne Kinnunen noted in his doctoral dissertation, completed in 2008,6 that despite its social welfare 
and health care elements the Finnish drug policy continues to rely principally on the criminal justice 
                                                        
 
 
6 The study discusses the development of the drug market and drug-related crime since the mid-1990s, the criminal careers and socio-
economic status of narcotics offenders, and efforts to solve the problem of drug-related crime through official enforcement. The study is 
based on statistics, observations of police work, interviews with the authorities and people in the drug market, and official documents. It 
shows that since the mid-1990s drug use has become more common, drug problems have become more serious, and drug control has become 
stricter. Prevention of drug problems became a key issue for the authorities, and more resources were allocated to anti-drug measures. 
Control through the criminal justice system was reinforced, and drug prevention took top priority in the strategies of the Police and the 
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system. Sanctions for drug-related offences in Finland are more severe than for other offences. The 
criminalisation of drug use and the tightening of the practice of issuing fines demonstrate that a stricter 
moralist view of drug use and other high-risk behaviour is now prevalent. Moreover, criminal control tends 
to focus on persons of low socio-economic status. (Kinnunen 2008.) 
Heini Kainulainen came to a similar conclusion in her dissertation. According to her, the criminal 
justice sanction system has in recent years focused increasingly on the offender,7 particularly in the case of 
offenders who are substance abusers. For example, waiving charges remains an extremely rare outcome, 
even though it would be especially needed in narcotics offences. The police have traditionally been 
reluctant to apply this procedure, since intervention in users’ actions has been considered crucial. For a 
long time, prosecutors concurred. (Kainulainen 2009.) 
Traditionally, it has been considered important in Finnish criminal policy to prefer values of humanity 
and social justice and to focus on preventive action. Sanctions have been considered a secondary resort. 
However, in drug policy criminal justice has retained a central role despite the fact that harm-reduction 
policy has made inroads and the welfare society has been able to provide a growing range of care services 
for problem users. (Kinnunen 2008.) 
Current drug policy  
A new Government was appointed in Finland in June 2011. The new Government Programme included the 
following commitments:  
• The efficiency of measures to protect the entire population, but especially children and young 
people, from the adverse effects caused by alcohol, tobacco, other drugs and gambling problems 
will be enhanced. 
• An action plan will be drafted to reduce drug abuse and its effects. 
• Needs for developing drug legislation will be reviewed. 
• Low-threshold services, medical counselling and outreach work for drug users will be increased. 
• The efficiency of treatment referrals carried out by the police will be enhanced. 
• Opportunities for the treatment of drug problems during imprisonment will be increased. 
(Finnish Government 2011a.) 
The Government Resolution on an Action Plan to Reduce Drug Use and Related Harm was adopted in 
August 2012. This Action Plan has five component areas: 1) Preventive work and early intervention; 2) 
Combating drug-related crime; 3) Treatment of drug addiction and reduction of harm from drug use; 4) The 
EU’s drug policy and international co-operation; and 5) Information collection and research regarding drug 
problems. (Ministry of Social Affairs and Health 2012a.) 
1. Preventive work and early intervention 
 
Under the Temperance Work Act (828/1982), preventive substance abuse work is the responsibility of local 
authorities. Preventive substance abuse work is carried out in social and health care, youth work, schools 
and educational institutions, parishes and NGOs. Cooperation between administrative sectors and between 
authorities at the local level is crucial for preventing drug-related harm. The quality and methods of 
                                                                                                                                                                             
 
 
Customs. The prevention and uncovering of drug-related crime was introduced as an objective in police surveillance nationwide. This 
manifested itself as a marked increase in crime statistics. (Kinnunen 2008.) 
7In the drug use offence reform that entered into force in 2001, the police were given the authority to issue summary fines to drug users; at 
the same time, alternative sanctions were heavily recommended. Underage offenders should be given a reprimand instead of imposing a fine, 
and problem drug users should be referred to treatment. However, in practice this reform led in the early 2000s to a substantial increase in 
summary fines issued to drug users. Because there is less scope for waiving charges in this case, the practice also led to a decline in the use 
of waiving of charges, and thereby decreased the use of alternative sanctions and indirectly led to stricter sanctions overall. The effect of 
guiding problem users to treatment that was sought in the ‘unlawful use of narcotics’ reform has not been achieved in practice: it is still 
extremely rare for charges to be waived for drug use offenders who have sought treatment. (Kainulainen 2009.) See also 9.2 Alternatives to 
prison. 
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substance abuse prevention are being developed by the National Institute for Health and Welfare and by 
NGOs and local authorities. The purpose of the forthcoming revision of the Temperance Work Act is to 
reinforce the status of substance abuse prevention in municipalities and to ensure that preventive work is 
taken into account as local government structures change. 
The Youth Act (72/2006) also requires improved planning and implementation of multiprofessional 
cooperation among local authorities. For this purpose, local authorities must have a guidance and service 
network in place for young people, involving representatives of the education, social welfare, health care 
and youth authorities and of the employment administration and the police. This network interacts with 
NGOs that provide services for young people. 
Goals for the current electoral period include: 
• enhancing the participation of young people in decision-making concerning substance abuse prevention 
and its implementation, 
• clarifying the division of duties and structures in preventive work, 
• supporting substance abuse prevention at schools and in pupil and student welfare services, 
• engaging the police and other authorities in closer cooperation at the local level, 
• intervening in crimes committed by young people with substance abuse problems at an early stage, and 
• increasing reprimands issued by prosecutors to underage first-time offenders. 
2. Combating drug-related crime 
 
The purpose of crime prevention is to increase the likelihood of being caught with respect to aggravated 
narcotics offences and those involving distribution carried out in Finland. The aim is to implement criminal 
liability through seamless international co-operation with the offender’s home country or country of 
residence. Drug imports are being combated through cooperation between the police, Customs and the 
Border Guard (PTR cooperation), the aim being to seize drugs at the border, except if a more 
comprehensive investigation of criminal activities calls for controlled delivery or similar measures. Control 
of the distribution of drugs and pharmaceuticals classified as drugs at the street level is part of the basic 
operations of the police. It is also important to uncover secondary drug-related crime such as money 
laundering and to recover criminal proceeds. 
Goals for the current electoral period include: 
• enhancing intelligence-led law enforcement between the law enforcement authorities,  
• combating drug-related crime online, 
• exploring how drug legislation can be revised to prevent the harmful effects of designer drugs, and 
• increasing cooperation between laboratory authorities to prevent the harmful effects of designer drugs. 
3. Prevention and treatment of drug-related harm 
Under the Act on Welfare for Substance Abusers (41/1986), substance abuse services must be offered to 
substance problem users, their families and other people close to them to the extent determined by the 
client’s need for help, support and treatment. The best interests of the problem user and people close to 
him/her must be prioritised. There is solid evidence that providing treatment for a drug abuser is ultimately 
less expensive for society than not providing treatment. What may complicate the handling of drug 
problems in the public service system is that drug use is a criminal offence and clients may not dare report 
their problems even if asked. 
Recovering from a substance abuse problem is a long-term process requiring various kinds of treatment 
and support at various points along the way, and it would thus be important to retain diversity in substance 
abuse services. The Government Programme states the aim of increasing low-threshold services, health 
advisory services and outreach work for substance abusers. The threshold to treatment must be further 
lowered, and obstacles to seeking treatment removed. It is also important to bring the substance abuse 
services of local authorities, NGOs and parishes closer together in terms of development and supply. 
Goals for the current electoral period include: 
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• ensuring the coverage and quality of health advisory services for substance abusers, 
• exploring the current situation in the drug treatment system to improve the coverage of services, 
• enhancing the efficiency of treatment referrals by the police, 
• improving information exchange between the authorities, treatment services and peer group activities, 
• preventing abuse of prescription drugs, and 
• increasing opportunities available for treatment of substance abuse problems while serving a sentence 
for a criminal offence. 
4. EU drug policy and international cooperation 
In accordance with the Government Resolution on Finland’s Policy in International Drug Control, Finland 
is participating actively in the planning and implementation of the forthcoming EU Drugs Strategy and 
Action Plan and in action against drugs in the drug policy contexts of the United Nations, the Council of 
Europe, Baltic regional cooperation and the Nordic Council of Ministers, and also in other established 
forums. 
Finland aims to help dismantle overlaps in the activities of the EU and the Council of Europe. Finland 
also uses development cooperation funds for combating drug use. 
Finland supports the leadership of the UN Office on Drugs and Crime (UNODC) in the planning and 
implementation of international drug control. Finland actively supports the efforts of the EU to enhance the 
drug strategy and actions of the EU in the context of the UN and in other international drug control 
cooperation.  
Goals for the current electoral period include: 
• clarifying Finland’s actions in various forums, and 
• continuing to support the drug control efforts of the UNODC through general funding and theme-based 
funding. 
5. Information collection and research regarding drug problems 
Research into drug use, drug markets, the treatment of drug users and methods of combating drug-related 
problems is being furthered and international co-operation by Finnish researchers promoted. Public opinion 
regarding drugs, their use and their harmful effect is canvassed regularly. National information is also 
submitted to the information-collecting systems of the EU and the UN. Drug-related research is being 
carried out by the National Institute for Health and Welfare, the National Research Institute of Legal Policy 
and universities, among others. 
Goals for the current electoral period include: 
• enhancing research in the sector, and 
• developing drug policy evaluation as a tool for supporting decision-making. 
 
1.3 Government programmes and working groups affecting drug policy 
In 2011–2015, preventing poverty, inequality and social exclusion forms one of the three focus areas in the 
Government Programme. The Government’s cross-sectoral action plan for reducing social exclusion, 
poverty and health problems aims to create a permanent operating model whereby the promoting of 
health and wellbeing and the reduction of inequality are mainstreamed into all public decision-making. The 
action plan includes spearhead projects in various administrative sectors aiming to facilitate participation. 
(Ministry of Social Affairs and Health 2012b). 
Broad-based development of general welfare policy and of social welfare and health care services 
continues. The National Development Plan for Social and Health Care Services (KASTE) is in its 
second four-year period. (Ministry of Social Affairs and Health 2012c.) This plan focuses on primary 
health care, social welfare, first response care, mental health services and substance abuse services. 
The National Plan for Mental Health and Substance Abuse Work, Mieli 2009–2015 (Ministry of 
Social Affairs and Health 2009b) underlines prevention and early intervention as well as shifting the 
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service focus to primary and outpatient services. According to the plan, people with both mental health and 
substance abuse problems must be able to access services flexibly through a one-stop shop and on an equal 
basis in comparison to other people. To enable eventual operating reforms, the National Institute for Health 
and Welfare also published a guide to strategic planning in mental health and substance abuse services at 
the local or regional level. (Laitila et al. 2009.) 
The Ministry of Social Affairs and Health and the National Institute for Health and Welfare are 
responsible for implementing the national plan for mental health and substance abuse work. The National 
Institute for Health and Welfare published a report on the national plan for mental health and substance 
abuse work, its reception8 and its implementation plan in 2010. (Partanen et al. 2010.) 
Key areas of interest in the development of mental health and substance abuse services include 
experiential expertise and peer group support, reforming the legislation on compulsory care, new means for 
reducing coercive measures, and low-threshold basic services, extending far beyond public services to the 
third sector. This involves not only the social welfare and health care sector but also education, culture and 
other leisure functions, businesses and bodies responsible for housing and living environments. (Ministry of 
Social Affairs and Health 2009b). 
The National Action Plan to Reduce Health Inequalities 2008–2011 (Ministry of Social Affairs and 
Health 2008b) laid down practical guidelines for reducing socio-economic health inequalities. The action 
plan also sought to address certain special needs groups, such as families suffering from substance abuse 
and mental health problems. In the context of this action plan, the National Institute for Health and Welfare 
has set up an online service named Kaventaja,9 providing information on welfare and health differentials, 
factors affecting them and means for narrowing them. The National Institute for Health and Welfare and 
the Finnish Institute of Occupational Health are also engaging in a joint project (Teroka)10 for developing 
practices and collating information for attaining the goal in narrowing health differentials. 
The Policy Programme for the Well-being of Children, Youth and Families 2007–2011 (Finnish 
Government 2007c) aimed to create a service system supporting families with children. A key priority was 
support services for children and young people, especially in the case of violence, mental health problems 
or intoxicant problems in families. The final report of this Policy Programme was published in 2011. It 
noted that legislation had been developed, successful efforts had been undertaken to prevent the social 
exclusion of young people, and low-threshold services for families had been increased. (Finnish 
Government 2011b.) 
Under the Youth Act (72/2006), a youth policy development programme shall be prepared every fourth 
year. The first Child and Youth Policy Development Programme 2007-2011 (Ministry of Education 
2007) affirmed that the passing of mental health and substance abuse problems from one generation to the 
next is one of the most common paths to social exclusion. The programme underlined that cooperation 
between child welfare services, substance abuse services and mental health services must be strengthened 
to meet the welfare and rehabilitation needs of children whose parents require adult services. Regarding 
criminal law, mental health or substance abuse services could also be included in juvenile punishments. 
(Advisory Council for Youth Affairs 2011.) The statutory programme for 2012–2015 was completed in 
December 2011; it includes goals for preventing substance abuse among young people. (Ministry of 
Education and Culture 2012.) 
                                                        
 
 
8 In an open online survey targeted at municipal social welfare and health care services, NGOs, educational institutions and other bodies, the 
responses indicated that development of outpatient and basic services and strengthening the status of the client are seen as particularly 
important points. Criticism was voiced particularly regarding the weak presence of social services in the plan. Responses also showed 
concern about the threshold of access to treatment for substance abuse patients rising from its present level. The greatest uncertainty was 
prompted by the transfer of psychiatric hospital care to general hospitals. 
9 Kaventaja service of the National Institute for Health and Welfare: http://kaventaja.thl.fi/fi_FI/web/kaventaja-fi 
10 The Teroka project is at http://www.teroka.fi/teroka/. 
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The Internal Security Programme is a regularly adopted extensive, cross-sectoral programme 
comprising measures in various administrative sectors to maintain and improve security. Previous 
Government Resolutions concerning such a programme were adopted in 2004 and 2008. Interim reports 
have been published annually on the implementation of the 2008 Internal Security Programme (Ministry of 
the Interior 2009; 2010; 2011). The programme for 2012–2015 is the third cross-sectoral programme of its 
kind. Because social exclusion causes security threats, one of the objectives of the programme is to reduce 
social exclusion. Social exclusion generally involves substance abuse, and the programme aims to target 
security threats related to alcohol and other substance abuse. (Ministry of the Interior 2012.) 
A working group appointed by the Ministry of the Interior and the Ministry of Social Affairs and 
Health prepared a report on the taking into custody, transport, treatment and care of intoxicated 
persons. The working group concluded that the involvement of the police in the apprehension, transport 
and taking into custody of intoxicated persons should be reduced and the role of social welfare and health 
care professionals augmented. Sobering-up stations should be located adjacent to a health care emergency 
clinic, a substance abuse service unit or a police custody unit. Key development points included improving 
of substance abuse prevention and services for the homeless in order to reduce the need for taking 
intoxicated persons into custody, clarifying the role of the private security sector with regard to 
assignments involving intoxicated persons, trying out new operating models, and improving information 
exchange between actors and statistics compilation. Regional special features and the long distances in 
sparsely populated areas should be taken into account in the development. (Ministry of the Interior 2011b.) 
 
1.4 Economic analysis  
Public expenditure from drug-related harm 
The expenditure incurred from drug-related harm by the Finnish government is calculated based on a long-
established calculation framework. (Salomaa 1996; Hein & Salomaa 1998.) The calculation framework was 
updated in 2011 and 2012, and the expenditure figures given in this section were derived using the updated 
framework. Harm-related expenditure is published annually in the Yearbook of Alcohol and Drug Statistics 
published by THL. The expenditure incurred by the government given here is consistent with that given in 
the Yearbook of Alcohol and Drug Statistics for 2010. 
In 2010, public expenditure11 caused by drug use totalled approximately EUR 229 million, or about 
0.2% of GDP. Public expenditure incurred from drug-related harm has increased by an average of 8% per 
annum in real terms between 2006 and 2010. The increase in expenditure has been notable in social 
services (22%). By comparison, public funding for substance abuse prevention has decreased by 23%. 
Public expenditure from drug-related harm consists mainly of the costs of treating and correcting problems. 
A large portion of the expenditure goes towards the enforcement of public order and safety. (Jääskeläinen 
2012.) 
The largest part of the public expenditure from drug-related harm, some EUR 77 million (30%), goes 
towards the enforcement of public order and safety, followed by EUR 58–60 million (23%) for court and 
prison costs from drug-related cases. Social services came third at EUR 43–61 million (23%). The majority 
of this expenditure was incurred through child welfare services (about EUR 31 million). (Jääskeläinen 
2012.) 
Expenditure from drug-related harm in health care is considered to include outpatient and inpatient care 
in primary health care and specialist medical care, which amounted to a total of EUR 28–48 million in 
2010. Drug-related pensions and sickness allowances added up to EUR 7–21 million. Substance abuse 
                                                        
 
 
11 The data used were obtained from budget reports and final accounts reports for the year published by ministries, public agencies and other 
public bodies. 
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prevention comprises the appropriations allocated by the Slot Machine Association. Substance abuse 
prevention may also be undertaken in municipalities on local government budget funds, but there is no way 
to include these costs in the calculation of expenditure from drug-related harm. Public funding for 
substance abuse prevention amounted to 4% of all public funding for treating drug-related harm, and has 
decreased by 23% in real terms between 2006 and 2010; mostly funds allocated to drug research and 
substance abuse work. (Jääskeläinen 2012.) 
Table 1. Expenditure from drug-related harm by primary and secondary category in 2010, EUR million 
  Minimum Maximum Average 
Change on 
previous year, 
% 
DIRECT COSTS 324.7 380.1 352.4 0.5 
Health care costs 27.7 48.2 38.0 -1.1 
Specialist medical care 24.0 37.5 30.7 -2.4 
*Somatic specialist medical care 10.9 13.7 12.3 -4.8 
*Psychiatric specialist medical care 13.1 23.8 18.4 -0.7 
Primary health care 3.6 10.7 7.2 5.2 
      
Pensions and sickness allowances 6.8 21.0 13.9 1.4 
Disability pensions 3.0 16.9 9.9 4.1 
Sickness allowances 0.8 1.3 1.1 -5.5 
Family pensions 3.0 3.0 3.0 -2.1 
      
Social services costs 49.4 67.9 58.6 2.0 
Substance abuse services 15.8 32.8 24.3 -0.1 
Income support 2.0 3.4 2.7 3.6 
Child welfare services 31.3 31.3 31.3 3.7 
Home services 0.3 0.4 0.3 4.0 
      
Public order and safety 77.0 77.0 77.0 5.7 
Police 44.0 44.0 44.0 16.1 
Rescue services 22.2 22.2 22.2 -4.8 
Customs 10.8 10.8 10.8 -7.0 
Border Guard - - - - 
      
Judicial system and prison service 57.9 59.9 58.9 1.7 
Courts, prosecutors, legal aid and 
execution 12.2 14.2 13.2 14.9 
Prison service 45.3 45.3 45.3 -1.8 
Other 0.4 0.5 0.4 30.9 
      
Accidents and criminal damage 96.4 96.4 96.4 -2.7 
      
Other expenditure     
General substance abuse prevention 9.6 9.6 9.6 -13.6 
 
*) Classification according to the Classification of the Functions of Government (COFOG).  
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Figure 1.  Breakdown of public expenditure from drug-related harm in 2010. 
 
Source: Expenditure from drug-related harm 2010, National Institute for Health and Welfare. 
Social costs related to drugs 
In 2010, costs related to the abuse of drugs and pharmaceuticals amounted to about EUR 229 to 284 million 
in social costs (Table 2). Social costs include not only public-sector costs but also costs incurred by 
enterprises and households. Social costs include insurance compensation paid as a result of drug-related 
injuries, fires and traffic accidents, and criminal damages. In all, the costs of damage from drug-related 
accidents and crimes in 2010 amounted to EUR 96 million. Between 2006 and 2010, expenditure from 
drug-related harm decreased by an average of 9% per annum in real terms. This, however, was mainly due 
to a decrease in insurance compensation paid on accidents. (Jääskeläinen 2012.) 
Expenditure from drug-related harm amounted to about 0.2% of GDP in 2010, or 0.1 percentage points 
less than in 2009. This decrease was due to the fact that the expenditure itself remained virtually the same 
but GDP went up. Expenditure from drug-related harm accounted for 2.8% of the costs of maintaining 
public order and safety paid by central and local government. (Jääskeläinen 2012.) 
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Table 2.  Expenditure from drug-related harm by main group in 2006–2010 (at market 
 prices), EUR million. 
 Health care 
Pensions and 
sickness 
allowances 
Social 
welfare 
Maintaining 
public 
order and 
safety 
Judicial 
system and 
prison service 
Other 
(substanc
e abuse 
prevention
) 
Accidents 
and 
criminal 
damage 
Expenditure 
total 
  Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max 
2006 24 41 6 19 37 52 67 67 51 52 12 12 98 98 295 341 
2007 25 43 7 20 41 56 69 69 54 56 13 13 95 95 303 352 
2008 28 48 7 19 45 62 73 73 57 59 11 11 96 96 317 368 
2009 28 48 7 20 48 67 73 73 57 59 11 11 99 99 324 377 
2010 28 48 7 21 49 68 77 77 58 60 10 10 96 96 325 380 
 
Source: Expenditure from drug-related harm 2010, National Institute for Health and Welfare. 
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2 Drug use in the population 
In Finland, drug trends have followed international currents. Much like other countries, Finland has 
experienced two major drug waves: one in the 1960s and the other in the 1990s. 
Much like in the 1960s, the new rise in experimentation with and the use of drugs in the 1990s was a 
youth and generational phenomenon. The techno culture landed in Finland at the end of the 1980s, 
beginning as a small underground movement. This phenomenon began to gain in popularity in the mid-
1990s, especially among young adults (aged 15–34). By the end of the 1990s, the phenomenon had 
diversified and was no longer only a marginal way of partying among urban youth. Studies show that the 
trend in drug experimentation of the 1990s was subject to gender-specific variation and was set in motion 
by men, followed by women only in the second half of the decade. The percentage of those having tried 
drugs grew until the end of the 1990s, after which the trend clearly levelled off. Today, drug use is much 
more a part of everyday life for young people and is much more firmly established as a party pastime and 
as a component of substance abuse. 
Nonetheless, drug experimentation and use are still significantly more prevalent now than at the 
beginning of the 1990s. This increase is partly explained by the increasing percentage in the domain of 
population surveys of the generation that began its drug experiments in and after the 1990s, while older 
generations with no drug experiences at all are dropping out. The most recent data show that 
experimentation is on the increase again, now particularly in the 25 to 34 age group. According to data for 
2010, about 17% of Finns aged 15 to 69 reported that they had tried cannabis at some point in their lives, 
4% within the past year. Men accounted for slightly more of those who had tried cannabis than women. 
The highest incidence of use was in the age group of 15 to 34. 
 
2.1 Drug experimentation in Finland 
According to the population study results from 2010, the percentage of the population aged 15 to 69 who 
had at some point in their lives tried cannabis was 17%.12 The percentage was 13% among women and 20% 
among men. There was a heightened incidence of experimentation, 36%, in the young adult age group 
(aged 25–34). The percentage of those who had at some point in their lives tried other drugs was 2.1% for 
amphetamines, 1.7% for ecstasy, 1.5% for cocaine and 1.0% for opiates. In the age group of young adults 
aged 25 to 34, the percentage of those who had at some point in their lives tried other drugs was 6.4% for 
amphetamines, 5.9% for ecstasy, 4.3% for cocaine and just under 3% for opiates. Based on the survey, a 
total of 4% had tried cannabis during the past year, and far less than 1% had experimented with other 
substances. The percentage of those who had tried cannabis during the past month was 1%. Hypnotics, 
sedatives or painkillers had been misused by 6.5% of the general population at some point in their lives, 
misuse being defined as using them for non-medicinal purposes, without a physician’s prescription or in 
larger doses than prescribed, the most common motive for such usage being the ability to sleep soundly. 
The percentage of misuse of pharmaceuticals was 9.9% in the age group of young adults aged 25 to 34. 
(Hakkarainen et al. 2011a; Hakkarainen et al. 2011b.) 
The percentage of those who had tried cannabis within the past year seems to have increased slightly 
throughout the 2000s. This is not a statistically significant increase, however. However, significant changes 
                                                        
 
 
12 The sample space of the study comprised Finns aged 15 to 69, from whom a random sample of 4,250 people was chosen in autumn 2010. 
The basic sample consisted of 3,000 randomly chosen members of the target group, while the additional sample consisted of 1,250 members 
of the age group 15 to 39. The aim of the oversampling was to focus the study on the most active population group in terms of drug use. The 
participants were given the options of responding online or returning a questionnaire by mail. Online responses were protected by personal 
IDs and passwords. To increase the response rate, the participants were sent a reminder form twice. A total of 2,023 responses were received 
(48%), the lowest response rate ever in this series of studies that had begun in 1992. (Hakkarainen et al. 2011b.) 
Drug use in the population 
 
THL - Report 76/2012 27 Finland – Drug Situation 2012 
have occurred particularly within the age group of 15–34: from 2002 to 2010, the percentage of those who 
had tried cannabis remained almost stable in the 15–24 age group, while increasing to the level of the 
younger group in the 25–34 group. In other words, cannabis use almost tripled in the 25–34 group during 
this period. It would thus seem that cannabis is no longer the exclusive province of youth culture; also, the 
cannabis use of the generation that was experimenting around the turn of the 2000s seems to have acquired 
permanence. There are also notable differences in drug use between the genders: in the youngest age group 
men and women are almost on a par, but later the figures for men diverge. Unlike with men, the recent use 
percentage among women decreases sharply in the 25–34 age group. (Hakkarainen et al. 2010b.) 
The percentage of those who had tried cannabis during the past month remained at 3% in the 15–34 
group but was only 1% in the 35–44 age group, demonstrating that long-term, regular use of cannabis has 
not become a widespread phenomenon, at least not yet. An exception to this rule is formed by men who 
began their drug use around the turn of the 2000s; no fewer than 15% of them reported that they had used 
cannabis during the past year, and 5% during the past month. (Hakkarainen et al. 2010b.) 
Table 3. Lifetime and 12-month prevalence of cannabis use by age group, 1992–2010, %. 
 
 
Source: Hakkarainen et al. 2011b. 
 
In Finland, alcohol use and related problems have traditionally been far more common than drug use 
and related problems. However, drug use has increased substantially over the past 15 years. But how are 
alcohol use and drug use linked in Finland? This question was approached by combining data from the 
questionnaires from 1998, 2002 and 2004 referred to above. The material was divided into five categories: 
(1) persons who had never encountered drugs, (2) persons with occasional drug encounters, (3) persons 
who had tried drugs, (4) cannabis users and (5) multi-substance users.13 (Hakkarainen & Metso 2009.) 
                                                        
 
 
13 The categories were more specifically defined as follows: (1) persons who had never been offered drugs and had never tried them; (2) 
persons who had been offered drugs but had never tried them; (3) persons who had at some time tried drugs but had not used or tried them 
within the past 12 months, or who had tried drugs for the first time within the past 12 months; (4) persons who had used cannabis within the  
        
1992 1996 1998 2002 2006 2010
Lifetime All 5 8 10 12 13 17
15-24 12* 14** 19 25 19 21
25-34 10 16 19 19 25 36
33-44 4 8 19 11 16 22
45-69 1 2 8 4 6 6
12 month prevalence All 1 2 3 3 3 4
15-24 6* 9** 10 11 9 12
25-34 2 3 3 4 7 11
33-44 0 1 0 1 2 1
45-69 0 0 0 0 1 0
* = 18–24-ages; ** = 16–24-ages
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Binge drinking (at least 6 units of alcohol at one time) and restaurant visits were the most common by 
far among cannabis users and polydrug users, and the least common among persons who had never 
encountered drugs. This difference remained significant even when the data were controlled for gender and 
age. The intoxicant use of pharmaceuticals was particularly heightened among polydrug users. The study 
suggests a clear correlation between alcohol consumption, particularly binge drinking, and drug use. The 
often-quoted hypothesis that cannabis use tends to replace alcohol use does not seem to hold true, at least 
not in Finland; on the contrary, cannabis use tends to occur alongside heavy drinking. (Hakkarainen & 
Metso 2009.) 
A more recent phenomenon in Finnish drug use, emerging in the late 2000s, is the rapid increase in the 
home growing of cannabis. This phenomenon manifests itself in crime statistics and has also been probed 
by survey.14 Seizure statistics show that while the number of cannabis plants seized annually was only a 
few hundred in the 1990s, this figure had ballooned to several thousand by the 2000s, and in 2010 the 
number of plants seized was 15,000. A similar rapid growth may be seen by comparing the data from the 
2008 and 2010 population studies. In 2008, the lifetime prevalence of hashish was greater than that of 
marijuana (10% vs. 9%), but by 2010 their positions had switched (12% vs. 13%). In terms of 12-month 
prevalence, cannabis overtook hashish in 2008, and according to the 2010 population study, 2% of the adult 
population had used hashish but 4% had used marijuana. Moreover, 10% of the respondents declared that 
they personally knew someone who was growing cannabis, even though only 1% had themselves engaged 
in home growing. Nevertheless, the obvious shift in the relative status of hashish and marijuana 
experiments is probably largely due to increased domestic home growing of cannabis. By comparing the 
responses to questions concerning home growing during the past month, the researchers estimated that 
there must be almost 10,000 active home growers of cannabis in Finland. (Hakkarainen et al. 2011a.) 
The survey shows that the majority (72%) of those practicing home growing of cannabis fall into the 
category of having 1 to 5 cannabis plants. Only slightly over 2% of the respondents reported that they grow 
more than 20 plants at a time. The online survey was weighted towards small-scale home growers, as the 
seizure statistics of the police show that 13% of seizures involved plantings of more than 20 plants. In all, 
about one in five respondents had had dealings with the police because of home growing of cannabis. The 
survey also revealed that the principal sources for information and for acquisition of seeds or seedlings 
were the Internet and other home growers – the percentage of cannabis sellers as sources was almost nil. 
More than two thirds of the respondents reported that they had invested no more than EUR 100 in their 
most recent harvest. (Hakkarainen et al. 2011a.) 
Cannabis is typically grown by male adolescents and young adults who are more likely than other 
members of their age group to live alone and who are less settled in terms of family or children. About half 
of those practicing home growing are daily users of cannabis, whereas the percentage of daily users in 
general population studies is about 6%. Among the home growers 22% were heavy users (more than 1 g 
per day). Principal reasons given for home growing were: for the grower’s own needs; the enjoyment of 
growing the crop; avoiding the illegal drug market; and the better quality of home-grown cannabis. Only 
10% of respondents mentioned selling cannabis as a motive, although one in three did consider that they 
might offer their produce to their friends. The relationship between alcohol and cannabis among home 
growers was dualist: combined use was routine for one in ten, one in three reported that they used both 
together no more than 1 to 3 times per month, and one in three reported that they almost never use both 
together. (Hakkarainen et al. 2011a.) 
                                                                                                                                                                             
 
 
past 12 months and before that and who had tried (no more than two) other drugs; and (5) persons who had been using more than two 
different drugs, also within the past 12 months. In all, the study included data on 7,227 persons. Logistical regression analysis was used. 
14 Finnish home growers of cannabis were recruited for the study via a website dedicated to the subject. The interviews (38) were conducted 
in 2008. There were 36 men and 2 women, most of them (55%) in the 25 to 34 age group. Also, an anonymous online questionnaire was 
targeted at Finnish home growers of cannabis in 2009. There were 1,298 respondents, 80% of whom had grown cannabis during the past year. 
The research material was compared to the results of the 2008 population survey and the preliminary results of the 2010 population survey. 
(Hakkarainen et al. 2011a; Hakkarainen et al. 2011b.) 
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In the Health Behaviour Surveys among the Finnish Adult Population (aged 15 to 64),15 the most 
important annual indicator depicting the development of the drug situation is the percentage of people in 
various age groups who know someone who has experimented with drugs. These percentages increased 
until the early 2000s but then went into a decline until the middle of the decade. The change has been 
clearest among the age group of 15 to 24. For the population as a whole, however, the decrease halted at the 
15% level towards the end of the 2000s due to sharp annual shifts in the trend since 2006, especially in 
younger age groups. (Piispa et al. 2008; Helakorpi et al. 2011.) 
 
 
 
Figure 2. People who know at least one person who has experimented with drugs during 
 the past year, %. 
Source: Helakorpi et al. 2011.  
 
After a plateau period, drug use in Finland began to increase again by the turn of the 2010s. This 
increase owes a great deal to cannabis use among men aged 25 to 34. It also correlates clearly with the 
increased home growing of cannabis. User trends for other substances have been relatively stable, with the 
possible exception that in the group of stimulants ecstasy and cocaine have caught up with amphetamine. In 
the group of opiates, it is noteworthy that the use of buprenorphine and other pharmaceutical opioids 
(tramadole, fentanyl, oxycodone) has increased at the expense of heroin. Misuse of hypnotics and sedatives 
ranks between the use of cannabis and the use of other illegal drugs; these pharmaceuticals are usually used 
for sleep problems but also for intoxication purposes and to alleviate or enhance the effects of other 
intoxicants. The combined use of alcohol and drugs is a characteristic feature of substance abuse in 
Finland, as witness the fact that of those who have used drugs during the past year about half are also high-
risk users of alcohol. Despite the plateau of the early 2000s, by 2010 drugs seem to have strengthened their 
                                                        
 
 
15 Data for the health behaviour surveys have been collected by a postal survey sent to a representative random sample of 5,000 persons 
among those aged 15 to 64 years of age and permanently living in Finland; people living in institutions were excluded from the study. 
Questionnaires were mailed out during the spring (in April) and those who did not respond were sent two (in 1996) or three (in 1997–2009) 
new questionnaires during the following two months. The number of those returning the questionnaire has varied annually between 3,000 
and 3,600. In 2010, there were 2,826 respondents (57%). (Piispa et al. 2008; Helakorpi et al. 2011.) 
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position in the partying habits of young urban adults (men) and recreational use and as a cause of social 
exclusion related to substance abuse. (Hakkarainen et al. 2010b.) 
 
2.2 Drug use in the school and youth population 
According to the 2011 ESPAD survey of school pupils, 12% of boys and 10% of girls aged 15 to 16 had 
experimented with cannabis at some time in their lives, whereas the corresponding figure was 10% in 1999, 
11% in 2003 and 8% in 2007. The 2011 ESPAD survey was the first of its kind in Finland to include 
separate questions on hashish use, marijuana use and home growing of marijuana. Hashish use was 
reported by 7% of the boys and marijuana use by 10%, while the figures for girls were 4% and 6%, 
respectively; 12% of the boys and 10% of the girls reported that they knew someone who had grown 
cannabis at home. Among the pupils themselves, however, home growing was extremely rare: only 1% of 
the boys and none of the girls reported having grown cannabis at home at some time. For other drugs, the 
trend has been rather stable: in 2011, 5% reported that they had tried an illegal drug besides cannabis at 
some time in their lives. (Raitasalo et al. 2012.) 
Drug use among school pupils is also surveyed in the national school health survey, which on a biennial 
cycle covers half of Finland’s municipalities each year and is aimed at 8th and 9th grades in comprehensive 
school and the 1st and 2nd years of upper secondary school.16 
The distribution data are fairly even regionally except for southern Finland, where levels were on 
average one third higher than in the rest of the country. However, there are differences according to 
educational attainment. In 2010–2011, an estimated 14% of students in the 1st and 2nd years of upper 
secondary school had tried illegal drugs at some time in their lives, while the figure for students in the 1st 
and 2nd years of vocational education was 21%. (School health survey 2011.) 
                                                        
 
 
16 The national school health survey is conducted under a teacher’s guidance during one class period. The respondents return their 
anonymous forms to the teacher, who seals all the forms for that class in an envelope in the presence of the pupils. The class envelopes are 
then put together in a package by the school and sent to the research group. Finland has been divided into two geographical areas, each 
surveyed in alternate years. In examining trends and changes, comparable material is used from those schools that have participated in the 
survey every time, whether in odd-numbered or even-numbered years. A total of 535 comprehensive schools and 321 upper secondary 
schools were included. The combined data from odd-numbered and even-numbered years included 81,057 to 83,915 respondents per year in 
comprehensive school and 39,084 to 43,242 in upper secondary school. The change data covered, depending on the years considered, 
between 61% and 65% of all pupils in the 8th and 9th grades of comprehensive school in Finland and between 51% and 58% of all pupils in 
the 1st and 2nd years of upper secondary school. (Luopa et al. 2010.) 
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Figure 3.  School health survey: Students who had tried illegal drugs at least once, % 
Source: School health survey 2011. 
 
The ESPAD study also included questions on the risks of intoxicant use. There was no significant 
difference between boys and girls in the appreciation of the risks involved in trying cannabis. In 2011, just 
under 30% of both boys and girls considered that trying cannabis involved high risk. The percentage of 
those who consider the risks of trying cannabis to be high has decreased steadily except for a slight upward 
bump between 2003 and 2007. The appreciation of the risks involved in trying ecstasy or amphetamines 
has also decreased among young people, more among boys than among girls. (Raitasalo et al. 2012.) 
The questions in the national Adolescent Health and Lifestyle Survey,17 aimed at young people aged 12 
to 18, enable the analysis of their ‘social exposure to drugs’. Respondents are asked whether any of their 
acquaintances has experimented with intoxicants or whether they themselves have been offered such 
substances. The survey indicates that the percentage of young people aged 14 to 18 with at least one 
acquaintance who has experimented with drugs increased between 1987 and 2001 and then started to fall 
before levelling off in 2007. The 2011 survey shows that the majority of drug offers are made by friends 
and acquaintances, which indicates that drugs have become part of young people’s everyday lives and that 
availability is not particularly scarce nor dependent solely on supply from external sources. In 2011, one in 
six boys and girls aged 18 had been offered drugs. (Raisamo et al. 2011.) 
                                                        
 
 
17 The survey takes the form of a postal survey repeated every other year, the first being conducted in 1977. The survey sample is selected 
from among those aged 12, 14, 16 and 18. For those who have not responded, the survey includes two new questionnaires, the final one 
being available in electronic format. The 2011 survey covered a total of 4,566 youth respondents (response rate 47%). (Raisamo S et al. 
2011.) 
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Figure 4.  Social exposure to drugs among 14 to 18-year-olds (percentage, age-adjusted 
 and gender-adjusted). 
Source: Raisamo et al. 2011. 
 
Links between adolescents’ experiences of bullying at school and using drugs were explored in a 
nationwide study where the relevant responses from a survey of 8-year-old schoolchildren (boys) and 
interviews with their parents and teachers were compared with interview responses over a 10-year follow-
up period.18 The results indicate that a boy being a bully at school at the age of 8 is a fairly reliable 
predictor of experimentation in drug use later, at the age of 18. Regular bullying also seemed to predict 
later drug use fairly well independently of the other variables taken into account in the study. Being bullied, 
by contrast, actually seemed to decrease the likelihood of drug use at a later age. As regards regular 
smoking, the correlation was completely reversed. The researchers explain the link between bullying and 
later drug use by referring to the antisocial personality characteristics of bullies. It should be noted, though, 
that the study only concerned boys. (Niemelä et al. 2011.) 
In Finland, data on twins born between 1983 and 1987 have been gathered in the FinnTwin 12–17 
studies. These data have been used to analyse the role of drug use determinants in drug experimentation: 
the role of individual, peer group and family variants in young people’s experiments with cannabis 
(Korhonen et al. 2008) and the effect of early-age depression on later drug experiments (Sihvola et al. 
2008). The purpose was to conduct a two-phase assessment of these interrelationships. First, the twins in 
the study sample were analysed as individuals. Subsequently, controls were introduced to account for any 
family-specific (genetic) sources of error by targeting the analysis at those twins for whom a determinant in 
drug experimentation (and early-age depression) actually distinguished one twin from the other in the same 
family. 
The study examining the effects of individual, peer group and family variants on drug use19 therefore 
found that 13.5% of the twins included in the study had experimented with cannabis by the age of 17.5 
                                                        
 
 
18 The research material was collected in 1988 and 1998. The 1989 material consists of a 10% random sample of the entire age group of 8-
year-olds in that year. There were 2,946 boys. For these children, interviews with their parents and teachers were included in the study. 
Concerning school bullying, the children were asked both about being a victim and being a bully, whereas parents and teachers were only 
asked about being a victim. The follow-up study was conducted in 1999; about 78% of the original research target group responded to 
questions about tobacco, alcohol and drug use. The results are somewhat skewed by the fact that there were more subjects who had reported 
being bullied at school in the loss-to-follow-up group than there were among respondents to the follow-up survey. Logistical regression 
analysis was used. (Niemelä et al. 2011.) 
19 Research data consisted of five full birth cohorts of twins from 1983 to 1987 (n=5,600 twins), baseline surveys targeted at the twins and 
their parents when the twins were aged 11 to 12 (coverage 87%), a follow-up survey when they were aged 14 (coverage 88%) and a second 
follow-up survey when they were aged 17.5 (coverage 92%). The data also included teacher assessments of twins aged 11 to 12 years. The 
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years. These experiments had been significantly influenced by early initiation into smoking, frequent binge 
drinking, the number of smoking friends, the number of friends who had experimented with drugs, weekly 
binge drinking by the family’s father and, for boys, aggressive behaviour in early youth. When the model 
was specified by targeting the analysis at twin pairs of whom only one twin had experimented with drugs, 
the results changed. Ultimately, determinants significantly influencing experimentation with drugs included 
the following: a teacher’s report of hyperactivity or aggressiveness at the age of 12, initiation into smoking 
and binge drinking at 14 or earlier, a high number of smoking friends (more than 5 persons) and, at 14, at 
least one friend who has experimented with drugs. However, the researchers point out that many 
determinants of drug experimentation discovered in other research literature (family attitudes, discipline, 
general environmental factors, availability of drugs) had to be excluded from the study’s original list of 
variants. (Korhonen et al. 2008.) 
In the most recently published twin study, the analysis of a possible connection between smoking and 
drug use was explored on the basis of surveys among subjects aged 17.5 years.20 The study compared 
structural equation models, the first assuming that smoking had a cause-and-effect impact on starting drug 
use and the second assuming that shared genetic and/or environmental factors underlie both. In both 
models, genetics had a lot to do with both starting smoking and starting drug use. The model where early 
smoking was assumed to influence drug use fit the data somewhat better, but shared genes could not be 
completely ruled out. By contrast, starting smoking had no direct impact on continued drug use (using 
drugs more than four times during their lifetime); the impact of smoking was indirect, through starting drug 
use. As a factor in continuing drug use, individual environmental factors emerged as more significant than 
they were for continuing smoking (smoking more than 50 times during their lifetime). (Huizink et al. 
2010.) 
 
2.3 Drug use by university students 
In 2008, a survey was conducted among students at universities and universities of applied sciences to explore 
their health, health behaviour, related factors and use of health care services.21 The average age of respondents 
was 24 at universities of applied sciences and one year more at universities. Women accounted for 63% of the 
respondents. With regard to intoxicant use, it was found that more than 90% of students use alcohol and that 
one in four men and almost one in ten women have more than 6 units at a time each week. 22% of students 
reported that they had tried cannabis at some time in their lives; about one in three of these had tried it during 
the past year. The figure for other drugs was about 3%, of which likewise about one in three during the past 
year. The percentage of cannabis users was higher among men, but there were no significant differences 
relative to educational attainment. (Kunttu & Huttunen 2009.) 
According to Kunttu & Huttunen, the lowest level of alcohol use by faculty was found among students of 
medicine. A voluntary survey on intoxicant use among students was conducted at a general examination 
session at the Faculty of Medicine at the University of Tampere in 2007.22 The average age of respondents was 
                                                                                                                                                                             
 
 
cluster of determinants was selected based on a literature review and assessed using the baseline survey and the first follow-up survey, while 
drug use was gauged through the survey addressed at 17.5-year-olds. After cleaning and inspection, the final data comprised information on 
3,118 persons (twins). These data were analysed using logistic and conditional logistic regression analyses by using the odds ratio as a 
measure of association. (Korhonen et al. 2008.) A comprehensive description of the twin study can be found here: 
http://wiki.helsinki.fi/display/twineng/Finntwin12. 
20 The material was obtained from the twin study referred to in the previous footnote. This time, tobacco and drug use was studied among 
17.5-year-olds, and finally the material consisting of data on 3,744 twins was analysed. The material was analysed using a model with two 
alternative multiple variable methods and standard statistical tests. (Huizink et al. 2010.) 
21 The sample space of the study in 2008 consisted of Finnish students aged under 35 studying for a bachelor’s degree at a university of 
applied sciences (sample 4,984, 46% men) or a university (sample 4,983, 45% men). The total response rate, after three reminders, was 51% 
for students at universities of applied sciences and somewhat higher, 55%, for university students. A similar study was conducted among 
university students only in 2000 and 2004. (Kunttu & Huttunen 2009.) 
22 The sample space of the study consisted of 1st to 5th year students at the Faculty of Medicine at the University of Tampere. The 
questionnaire was distributed at a compulsory examination session. There were 497 students at the examination, and 468 acceptable forms 
were returned (response rate 94%). 
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24, and 62% of them were women. The survey indicated that while more than 90% of students used alcohol, 
the percentage of those who drank more than 6 units at one time at least once a week was more than 25% 
among men but only about 2% among women. 23% of the students had tried cannabis, but fewer than 2% had 
tried other drugs. The incidence of cannabis experimentation was the same among men and women. 
(Meriläinen et al. 2010.) 
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3 Prevention 
3.1 General remarks on substance abuse prevention in Finland  
Substance abuse prevention affects awareness of, attitudes to and rights pertaining to intoxicants; factors 
protecting from harm from substance abuse and risk factors; and the usages, availability, offering and 
harmful effects of intoxicants. 
Substance abuse prevention is principally governed by the Temperance Work Act (828/1982), the 
Temperance Work Decree (822/1976) and the Act on Welfare for Substance Abusers (41/1986). Provisions 
concerning preventive substance abuse work are laid down in the Temperance Work Act (828/1982). This 
Act defines the purpose of temperance work as habituating citizens to healthy lifestyles by guiding them in 
avoidance of the use of substances and tobacco. According to the Act, the establishment of general 
prerequisites for substance abuse prevention is primarily the task of central and local government. Practical 
measures in this area are generally undertaken by local authorities and by temperance and public health 
organisations. Pursuant to the Act, each local authority must have a designated body responsible for 
temperance work. This body must cooperate with the local health care, social welfare and education 
services in particular. The Temperance Work Act is scheduled for revision in 2013. The purpose of this 
revision is to develop local measures for prevention of harmful impacts of substance abuse. The 
Temperance Work Decree (233/1983) further specifies that this body must cooperate with organisations 
engaging in temperance work and substance abuse prevention and promoting healthy lifestyles. Section 17 
of the Local Government Act states that a ‘municipal body’ is the municipal council, the municipal board, a 
committee or another body appointed by the council with decision-making powers. When the Temperance 
Work Act entered into force in 1984, temperance committees in municipalities were disbanded and the 
duties specified in the Act were to be assigned to another municipal body, generally the social services 
committee, the health care committee or the education committee. (Strand 2011.) The purpose of the Act on 
Welfare for Substance Abusers (41/1986) is to prevent and reduce problem drug use and related harmful 
social and health impacts, and also to enhance the functional capacity and safety of substance abusers and 
persons close to them. 
Preventive substance abuse work forms part of the wider concept of promotion of well-being and health. 
In Finland, municipalities and joint municipal boards are principally responsible for arranging and 
providing social and health care services. Substance abuse prevention is highlighted through inclusion in 
legislation in addition to the Temperance Work Act and the Act on Welfare for Substance Abusers (Public 
Health Act, Child Welfare Act, Youth Act, etc.), in ongoing policy programmes (the Health 2015 public 
health programme, Kaste) and the service quality recommendations which guide policies 
(recommendations concerning the quality of services for substance abusers, quality criteria for substance 
abuse prevention, etc.). 
In municipal substance abuse strategies, substance abuse prevention is usually seen as part of a 
continuum including prevention, early intervention and treatment. According to a new concept definition, 
substance abuse work is divided into preventive and corrective substance abuse work. Municipal substance 
abuse strategies usually address intoxicating substances as a whole, without making a distinction between 
drugs and alcohol. Substance abuse prevention also includes the prevention of smoking and functional 
addictions. 
Local authorities are recommended to have a mental health and substance abuse service strategy in 
place, defining the responsibilities of substance abuse services at health centres. (Ministry of Social Affairs 
Prevention 
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and Health 2009b.) However, a study23 shows that only 69% of health centres have an approved strategy 
for substance abuse services. Moreover, only 65% of health centres have a plan approved by management 
for reducing harm caused by substance abuse. In the study, 73% of health centres stated that they undertake 
mini-interventions aimed at reducing alcohol use. Health counselling for drug users was only provided by 
one in three health centres (35%), and 40% had agreed on shared practices for identifying drug users. 
(Rimpelä et al. 2009a.) 
In order to improve substance abuse work, a network of municipal contact persons for substance abuse 
prevention was established in 2000. The duties of a contact person include the promotion of substance 
abuse prevention through multi-professional co-operation in the municipality, information dissemination 
between the actors involved in prevention and co-ordination of the municipal or regional substance abuse 
strategy. 
Development of the municipal and regional networks for substance abuse prevention is carried out 
within the framework of the National Alcohol Programme, whose principal coordinator is the National 
Institute for Health and Welfare. All six Regional State Administrative Agencies have a regional 
coordinator for the National Alcohol Programme responsible for implementation of the Programme goals in 
their respective regions and for coordinating actions to prevent harm from substance abuse. In addition, 
THL is developing the regional developer network for substance abuse. It also collects and disseminates 
best practices in the field. Substance abuse prevention involves not only municipalities: NGOs and other 
third-sector actors play a central role in the practical work of substance abuse prevention both as individual 
actors and as service providers for municipalities. The NGOs aim to promote discussion and provide 
information on drugs, drug use and the related causes and consequences. In addition, NGOs attempt to 
influence public attitudes, organise peer support activities and provide post-care for substance abuse 
patients. 
Quality criteria have been determined for substance abuse prevention. The criteria are qualitative and 
suited to the prevention and reduction of harm related to substance abuse.24 The practical implementation 
of the quality criteria is considered a central tool in improving the quality of substance abuse prevention. 
These quality criteria do not separate drug prevention from other substance abuse prevention. (STAKES 
2006.) 
The Ministry of Education and Culture supports preventive drug and substance abuse work by providing 
funding for improving the potential for prevention, for training employees and volunteers, and for running 
long-term projects. Drug use prevention also forms a component of other youth activities such as youth 
workshops and afternoon clubs. Education and information projects concerning young people’s lifestyle 
choices are also supported as and when possible. 
Drug prevention measures include electronic drug information services, discussion forums and self-
testing services for evaluating one’s own substance abuse. The dissemination of information and training of 
professionals has been developed by creating web-based expert forums in support of training. 
The Neuvoa-antavat themed service (http:/www.thl.fi/fi_FI/web/neuvoa-antavat-fi) is the national 
substance abuse online service maintained by the National Institute for Health and Welfare. The website 
includes a database of substance abuse treatment facilities and of strategies. 
                                                        
 
 
23 Directors of health centres (n=231) were sent an online survey in October 2008, requesting a joint response from the management group. 
In addition to aspects of actively promoting health among the population, the questionnaire included questions on how the management 
viewed health promotion and key public health programmes. Responses were received from 190 health centres (82%), including all of the 
largest ones (50,000+ residents) and 89% of the medium-size ones (20,000 to 49,999 residents). 
24 Criteria: focus of the work, target group, degree of effectiveness, knowledge base, values, realistic objectives, compatibility of the 
objectives with other strategies, operational models, resources, monitoring and evaluation, balance in the different subsections and 
relationship to the original situation. 
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3.2 Environmental prevention 
Regulation of taxes on alcoholic beverages is one of the principal tools of alcohol policy. The taxation of 
alcoholic beverages has been amended several times in the 2000s. The tax rates were lowered when Estonia 
joined the EU in 2004. This was motivated by an increase in passenger imports of alcohol. Since then, taxes 
have again been raised, four times in all (in 2008, twice in 2009, and in 2012).25 
The blood alcohol limit for drunk driving in Finland is 0.05%, and 0.12% for aggravated drunk driving. 
Offenders who have active substances of narcotics or their metabolic products in their blood may also be 
sentenced for drunk driving or aggravated drunk driving. 
The sale and delivery of mild alcoholic beverages (up to 22%) to persons under 18 years of age is 
prohibited, and the sale and delivery of strong alcoholic beverages (over 22%) to persons under 20 years of 
age is prohibited. Possession of alcoholic beverages by persons under 18 years of age is prohibited, and 
possession of strong alcoholic beverages by persons under 20 years of age is prohibited. Alcoholic 
beverages with an alcohol content of no more than 4.7% may be sold in food shops; Alko has a monopoly 
on the retail sale of all products with a higher alcohol content. Retail outlets are only allowed to sell 
alcoholic beverages between 09.00 and 21.00. Advertising mild alcoholic beverages is basically allowed. 
However, advertising for alcoholic beverages must be restrained and conservative and must not be designed 
to attract ‘weak consumer groups’ such as heavy drinkers or young people. It is inappropriate to depict the 
intoxicating properties or plentiful consumption of alcoholic beverages in a positive light, or to give a 
misleading impression of the properties or effects of alcohol. (National Supervisory Authority for Welfare 
and Health 2010.) 
There are a number of legislative provisions governing the marketing and sale of alcoholic beverages in 
licensed restaurants and also smoking in such premises. The Regional State Administrative Agencies 
supervise retail sales of alcoholic beverages, licensed restaurants and advertising and promotion for 
alcoholic beverages in their regions. The National Supervisory Authority for Welfare and Health (Valvira) 
is authorised to carry out supervision nationwide. (National Supervisory Authority for Welfare and Health 
2010.) The sale and delivery of tobacco products to persons under 18 years of age is prohibited. The 
advertising of tobacco products in Finland is prohibited. As of the beginning of 2012, tobacco brands may 
                                                        
 
 
 
25 ALCOHOLIC BEVERAGES 
Ethyl alcohol content, % by volume  Product group  Tax  
Beer 
 – over 0.5 but no more than 2.8  11.  EUR 0.04 per centilitre of ethyl alcohol  
– over 2.8   12.  EUR 0.299 per centilitre of ethyl alcohol  
Wine and other alcoholic beverages produced by fermentation  
– over 1.2 but no more than 2.8  21.  EUR 0.11 per litre of alcoholic beverage 
 – over 2.8 but no more than 5.5  22.  EUR 1.59 per litre of alcoholic beverage 
 – over 5.5 but no more than 8  23.  EUR 2.24 per litre of alcoholic beverage  
– over 8 but no more than 15  24.  EUR 3.12 per litre of alcoholic beverage  
Wine  
– over 15 but no more than 18  25.  EUR 3.12 per litre of alcoholic beverage  
Intermediate products  
– over 1.2 but no more than 15  31.  EUR 3.79 per litre of alcoholic beverage  
– over 15 but no more than 22  32.  EUR 6.25 per litre of alcoholic beverage  
Ethyl alcohol 
 Products under CN code 2208: 
 – over 1.2 but no more than 2.8  41.  EUR 0.04 per centilitre of ethyl alcohol  
– over 2.8   45.  EUR 0.434 per centilitre of ethyl alcohol 
 Others   46.  EUR 0.434 per centilitre of ethyl alcohol 
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not be displayed to retail customers even at point of sale. Smoking is banned in all public indoor spaces. 
Many workplaces have declared themselves non-smoking workplaces.26 
 
3.3 General substance abuse prevention 
Youth work and policy  
Substance abuse prevention components of the Youth Policy Development Programme 2007–2011, 
implemented pursuant to the Youth Act, have been run under the coordination of the Ministry of Education 
and Culture, in co-operation with the Ministry of Social Affairs and Health and the Ministry of the Interior, 
and youth work methods have been developed from the substance abuse prevention perspective. 
Preventiimi, a national knowledge centre for youth substance abuse prevention, has published support 
materials for high-quality substance abuse education. In its guide, preventive substance abuse work with 
young people is considered to include social empowering, general prevention and risk prevention. The 
purpose of general prevention is to provide young people with current information on various intoxicants 
and the risks caused by their use. In addition to health risks, these include problems that substance abuse 
may cause in relationships with friends, in school work and in families. How these matters are discussed 
and from what perspectives, and which examples are used, should be as closely related to the young 
people’s own experiences as possible. Simply dishing out information is not necessarily enough. Efforts 
should also be made to ensure that the young people can process the information given to them and that the 
understanding they gain is relevant for their world. (Pylkkänen et al. 2009.) 
Whereas prevention aimed at adults usually focuses on adverse health effects and risk factors, substance 
abuse prevention aimed at young people may avoid mentioning intoxicants at all and instead focus on 
building up life management skills overall. The general prevention aspect of youth work is based on giving 
young people guidance, help and support in growing up and in becoming a member of society, assisting 
them in coping with issues that they cannot necessarily handle on their own. What is essential is that the 
young people concerned feel that they are themselves participating in making decisions that affect their 
lives. (Pylkkänen et al. 2009.) 
Preventiimi, which is administered by HUMAK University of Applied Sciences, also provides 
professionals with continuing education in substance abuse prevention for young people. Preventiimi is one 
of the national youth service and development centres designated by the Ministry of Education and Culture 
in a resolution adopted in 2010. Preventiimi provides training in substance abuse prevention for youth work 
professionals and others involved with young people, networking with local authorities and NGOs. The 
Preventiimi centre has developed and provided training in substance abuse prevention aimed at young 
people. Its projects also support prevention at schools, and it has produced a variety of materials. Support 
for projects aimed at young immigrants has been increased. Several hundred young people have 
participated in the international youth education programme Avartti, which is intended for all young 
                                                        
 
 
26 TOBACCO PRODUCTS 
Product    Product group EUR/unit  %  
of retail price  
Cigarettes      1.  22.50/1,000 pcs  52,0  
– – Minimum tax on cigarettes      1A.  146.00/1,000 pcs  –  
Cigars and cigarillos      2.  –  27,0  
Pipe and cigarette tobacco      3.   13.50/kg  48,0  
Fine-cut tobacco for self-rolled cigarettes    4.   16.50/kg  52,0 
 – – Minimum tax on fine-cut tobacco for  
self-rolled cigarettes      4A.    87.50/kg  –  
Cigarette paper       5.  –  60,0 
 Other product containing tobacco    6.  –  60,0 
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people. The website of Preventiimi, a knowledge centre for youth substance abuse prevention, is at 
www.preventiimi.fi. 
General substance abuse prevention at school 
Finland applies what is known as an environmental strategy in substance abuse prevention in schools, the 
aim being to make schools into a safe and risk-reducing environment for pupils. Schools also constitute part 
of local substance abuse prevention networks. 
 
Substance abuse prevention at schools consists of: 
• intoxicant education in normal classroom teaching, e.g. integrated into the compulsory health education 
subject, 
• support for healthy growth and development, 
• promotion of a safe and healthy learning environment, 
• school health care support and extensive health examinations, 
• availability of guidance and assistance in confidence, 
• support for learning, helping pupils stay at school and cope, 
• leisure activities, 
• a school curriculum to prevent substance abuse and ground rules outlining what to do in a case of 
substance abuse at the school, 
• planned and learned correct and timely intervention in substance abuse, 
• co-operation with homes, 
• co-operation with substance abuse services, and 
•  co-operation with other professionals and active citizens in the local substance abuse prevention 
network. 
 
According to a recent evaluation study, both teachers and pupils in Finland are highly motivated to 
engage in the health education subject: teachers and pupils alike feel that there is much discussion in health 
education classes, and a notable percentage of pupils discuss the topics with their friends and parents after 
the classes. A qualification in health education is being required from teachers after a transition period, as 
of the beginning of 2012. (Aira 2010.) 
Because substance abuse education is integrated into the school curriculum, school-based drug 
prevention programmes play a secondary role in Finland’s drug strategy. Schools may decide for 
themselves whether to implement such programmes, and they are not systematically monitored. In 2008, 
two thirds of all upper-level comprehensive schools held health theme days, and more than one in ten held 
health theme weeks. (Aira 2010.) The police have cooperated closely with schools in anti-drug efforts and 
have appointed a liaison officer for each school. School resource officers and community policing have 
enabled the police to establish a close co-operation. The police have published information locally and 
nationwide on drug-related crime, designer drugs, drug offences under investigation and their backgrounds. 
The information published is preventive in nature and specifically targeted at adolescents who are 
susceptible to experimenting with drugs. 
 
3.4 Selective substance abuse prevention 
Grants awarded from appropriations for youth work in 2010 have been used to support prevention projects 
aimed at risk groups among young people. Such projects have been organised by local authorities, NGOs, 
young people’s workshops and national youth centres. Outreach youth work in particular has been 
improved, and at the moment there are 230 two-person teams in outreach youth work around Finland. The 
youth research network, working for instance with the National Institute for Health and Welfare, has been 
conducting research on substance abuse prevention. 
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Related to this issue, a guidebook for parents and people working with young people has been produced 
on how to approach anxiety and substance abuse and identify problems. (Fröjd et al. 2009). 
In surveys for the promotion of health and wellbeing at upper secondary schools and vocational 
education institutions,27 respondents were asked what the procedure was when drug use was suspected. In 
all, the number of cases of drug use reported was very low, though notably higher at vocational education 
institutions (n=29) than at upper secondary schools (n=13). Generally, the procedure was for a teacher, 
group leader or headmaster to talk to the student in question. Vocational education institutions are 
markedly more active in referring students to student health care in these cases and also in contacting the 
parents in the case of a student aged under 18 and/or child welfare services and/or the police. (Rimpelä et 
al. 2009b; Väyrynen et al. 2009.) 
In working life, drug tests are conducted to prevent drug-related harm and for referring individuals with 
drug problems for treatment as early as possible. In order to implement this, employers and employees have 
to co-operate in drafting a written substance abuse programme for the workplace. 
As of 1 January 2012, the Association for Healthy Lifestyles, the Terveys-Hälsan association and the 
Life is the Best Drug association merged into the EHYT association for substance abuse prevention. The 
creation of EHYT as an umbrella organisation established a single solid platform for a broad-based 
approach to substance abuse prevention. In the field of drug prevention work, this led to the setting up of a 
joint drug prevention working group organised by the coordination unit of EHYT. The working group 
began its work in 2011. Improving cooperation in the field of drug prevention work is the key task of the 
working group, which is an open network whose members currently include an expert member from the 
National Institute for Health and Welfare, the Elämäni Sankari association, Free from Drugs, YAD Youth 
Against Drugs, Music Against Drugs, the Omaiset huumetyön tukena [Families supporting drug prevention 
work] association, the Stop Huumeille [Stop drugs] association, the A Clinic Foundation, the Finnish Red 
Cross, the Nykterhetsförbundet Hälsa och Trafik temperance league and the Finnish Blue Ribbon, in 
addition to an expert member from the National Institute for Health and Welfare. 
Free from Drugs is a national volunteer organisation for preventive and corrective substance abuse 
work founded in 1984. The Avaa silmäsi [Open your eyes] campaign co-organised with the Finnish Parents’ 
League reached thousands of parents and guardians nationwide, warning them against the proliferation of 
cannabis. In 2011, the avaasilmasi website recorded 16,000 visitors. The professional unit of the 
association, the Family Support Centre, engages in family-oriented drug prevention work and serves as a 
low-threshold service centre in the Greater Helsinki area and nationwide. 
YAD Youth Against Drugs is a national substance abuse prevention association. Founded in 1988, it 
relies on volunteer action by adolescents and young adults. Up-to-date drug use prevention and supporting 
materials with informative and emotive content are key elements in the operations of the association, which 
are based on peer influence. A new departure in recent years is the Street Team, a low-threshold volunteer 
task force with online guidance, offering opportunities for participating in substance abuse prevention 
regardless of time or place. In 2011, the association offered activities and employment for drug use 
rehabilitees, and there are plans for recruiting recovering drug users as experiential experts in substance 
abuse prevention. 
Music Against Drugs is a substance abuse prevention association that promotes the health and social 
wellbeing of children and adolescents. In 2011, the association organised Music Against Drugs events at 
four locations in Finland, featuring a variety of substance abuse prevention methods. 
In 2011, the A Clinic Foundation continued to provide health and social guidance related to drug use, 
outreach work, peer support services, substitution treatment, detoxification treatment, therapeutic work at A 
Clinics and youth stations, institutional rehabilitation with both non-medical and medication-supported 
                                                        
 
 
27 A largely coherent survey was conducted in 2008 among all upper secondary schools (n=416) and institutions with vocational upper 
secondary qualification programmes (n=192). The response rate was 90% for upper secondary schools and 84% for the other institutions. 
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approaches, and community therapy. Drugs were featured in a large number of studies, student theses and 
development project, such as the Huuko project, which has been running since 2001. In 2011, the project 
involved networking actors involved in substance abuse and mental health services, enhancing their 
expertise and disseminating good practices. Drugs were also prominently featured in the publicity and 
online services of the A Clinic Foundation. The Päihdelinkki online service, launched in 1996, reaches an 
average of 82,000 individual visitors each month. Discussing all types of intoxicants and addictions, this is 
a service that provides both citizens and professionals with information, tests, peer support and advisory 
services. The services of the A Clinic Foundation are being developed in cooperation with clients and 
partners. 
 
3.5 Targeted substance abuse prevention 
Targeted substance abuse prevention aimed at young people often takes place in sheltered youth homes, 
rehabilitation units for young people and workshops. Substance abuse treatment and rehabilitation for 
young people is also a form of risk prevention, being aimed at discouraging them from returning to an 
intoxicant-favouring lifestyle. (Pylkkänen et al. 2009.) 
In 2009, the National Institute for Health and Welfare published a guide on early identification of 
mental health and substance abuse problems. This guide is intended for social welfare and health care 
professionals involved with clients to help them identify and screen for mental health problems and 
substance abuse problems among young people and adults. It provides indicators for risk assessment and 
practical advice for prevention. Regarding drugs, the guide stresses the importance of a confidential client 
relationship and of having sufficient basic information on drugs. The guide does not recommend routine 
drug testing as a screening procedure. Drug testing is feasible as a component of a treatment relationship 
encouraging a lifestyle change. (National Institute for Health and Welfare 2009a.) 
Early intervention in offences committed by young offenders has been effected in co-operation with 
various authorities. The purpose of the police engaging in early intervention is to prevent the development 
of a vicious circle of crime and substance abuse. Co-operation between the police and the health care and 
social welfare authorities is particularly important in improving the conditions of children and adolescents 
in problem families where the parents have a history of substance abuse. 
According to the prosecutor guidelines on unlawful use of drugs, a first offender under the age of 18 
must by default be given a reprimand; instead of being fined, their charges should be waived and a verbal 
warning given instead. The reprimand session is attended by the young offender himself/herself and his/her 
parent or guardian, and also representatives of the police, the prosecutor and the social welfare authorities. 
Reprimands were issued and charges waived thereafter in 40 cases in 2008, in 66 cases in 2009 and in 161 
cases in 2010. The increase in the number of reprimands can be considered a positive trend, as it means that 
the procedure is being increasingly applied and that prosecutors are increasingly willing to do so. In 2008, 
five of Finland’s prosecution units gave no reprimands at all, whereas in 2010 all but one prosecution unit 
gave reprimands. 
Health counselling centres28 engage in risk group prevention. Local authorities and NGOs also perform 
outreach work to find individuals not covered by services, such as school dropouts or drug users who do 
not use the services of the health counselling centres. Targeted information about the risks of drug use is 
also provided by NGOs in various relevant environments such as rock festivals or techno music events. 
(See e.g. Finnish Red Cross 2010; YAD 2011.) 
 
 
                                                        
 
 
28 See chapter 7. Responses to health correlates and consequences. 
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3.6 National and local media campaigns  
 
Traffic and waterway safety campaigns are organised annually, focusing on all substance abuse. A general 
intoxicant education campaign is also conducted during the annual substance abuse prevention week (week 
45). Each year during the week, two regional radio stations (Radio Auran Aallot and Radio Melodia) 
conduct an anti-drug campaign in co-operation with the education authorities, the Turku Customs, the Free 
from Drugs NGO and corporate sponsors. 
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4 Problem drug use 
The number of problem drug users in Finland is estimated based on the number of problem users of 
amphetamines and opiates, which was 14,500 to 19,100 in 2005; this accounts for 0.6% to 0.7% of the 
population aged 15 to 55. Nearly four fifths of problem drug users used amphetamines. The percentage of men 
was almost 80%, the majority of problem drug users being in the age group 25 to 34. 
According to the 2010 data from the Drug Treatment Information System, opiates were the major 
primary problem substance of clients entering drug treatment (representing 59% of all drug treatment 
clients of the substance abuse services), followed by stimulants (13%), cannabis (10%), alcohol (11%) and 
pharmaceuticals (6%). These results reflect the provision of treatment, since substitution treatment is so far 
available only to opiate users. Buprenorphine was the primary problem substance for as much as one third 
of the clientele. Although among the drug users with the most severe problems there are persons who use 
both amphetamines and opioids, the hard core of Finnish drug use consists of combined use featuring both 
polydrug use of opioid-based painkillers and sedatives (benzodiazepines) on the one hand and alcohol and 
cannabis on the other. 
According to studies, alcohol is the primary problem substance in Finland. In fact, problem drug use is a 
very recent social problem in Finland. Typical factors in problem drug use in Finland are the relatively young 
age of users and, consequently, a relatively short history of drug use, albeit the average age of drug users has 
risen substantially over the past ten years. A particular feature is the central role of buprenorphine in 
intravenous use. Many drug users are socially marginalised in many ways and, in addition to substance abuse 
problems, have several other social and health-related disorders. 
 
4.1 Prevalence and incidence estimates of problem drug use  
Estimates on the prevalence of problem drug use based on administrative statistics have been made since 
1997.29 According to these estimates, out of the population aged 15 to 54, there were some 14,500 to 19,100 
amphetamine and opiate problem users in the entire country in 2005. (Partanen et al. 2007.) 
The number of problem users of amphetamines and opiates30 increased noticeably between 1999 and 2002. 
Since then, the proportion of problem users of amphetamines and opiates seems to have stabilised. The 
majority of problem users, 75% to 80%, consisted of amphetamine users, and they accounted for 0.4% to 0.7% 
of the population aged 15 to 54 in Finland in 2005. The estimated proportion of problem users of opiates was 
0.13% to 0.18% of the population. The percentage of women was 20% to 30% in both substance groups. While 
the proportion of young people aged 15 to 24 was about 25% to 35%, they were no longer the largest user 
group, the age group 25 to 34 having already exceeded the younger age group’s percentage. (Partanen et al. 
2007.)  
                                                        
 
 
29 The estimates of problem drug users are based on the statistical capture-recapture method in which the samples from the same group are 
used to assess statistically the size of the entire target population. The samples were defined based on the interventions directed by society at 
the target population (amphetamine and opiate users). The interventions employed in the system included amphetamine or opiate diagnoses 
recorded in hospitals, penal action for drug offences involving the use or possession of amphetamines or opiates, arrest for driving under the 
influence of amphetamines or opiates and hepatitis C cases recorded in the infectious diseases register due to intravenous drug use. The 
estimate intervals are based on 95% confidence intervals of the estimates. Different log-linear models were applied to different subgroups, so 
the sum of the subgroups differs from the overall estimate. (Partanen et al. 2004; 2007.) 
30 According to the national definition used in the study, ‘problem use’ refers to the use of amphetamines and opiates which is so extensive 
that it causes social or health problems for the user. Furthermore, the authorities have had to intervene in one way or another, and this has 
been recorded in administrative registers. The intention was to produce a new estimate in 2010 using the 2008 data, but in analysing the 
register data it was found that because of a change in the register systems, the results were no longer compatible with earlier studies. New 
estimates of the number of problem users were therefore postponed by two years while the basis for retrieving data is re-evaluated. 
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Table 4.  Development of the percentage in the population (%) of amphetamine and opiate 
 problem users in Finland in 1998–2005. 
 
 
1998 1999 2001 2002 2005 
Overall estimate 0.4–0.55 0.4–0.5 0.5–0.6 0.55–0.75 0.52–0.69 
Amphetamine users 0.26–0.45 0.29–0.43 0.35–0.54 0.38–0.65 0.43–0.74 
Opiate users 0.06–0.09 0.09–0.11 0.14–0.17 0.15–0.21 0.13–0.18 
Men 0.54–0.70 0.54–0.66 0.58–0.71 0.77–1.03 0.74–0.98 
Women 0.20–0.58 0.14–0.24 0.20–0.31 0.29–0.57 0.20–0.31 
Ages 15 to 25 0.67–1.12 0.73–1.02 0.81–1.04 0.93–1.30 0.63–0.95 
Ages 26 to 35 0.51–0.71 0.46–0.59 0.64–0.82 0.74–1.13 0.68–0.94 
Ages 36 to 55 0.14–0.25 0.19–0.46 0.22–0.36 0.25–0.50 0.30–0.54 
Source: Partanen et al. 2004; 2007. 
 
Some 50% to 60% of all problem users were from Southern Finland and more than half of them from the 
Greater Helsinki area. The proportion of women among problem users seems to be on the constant decline 
everywhere in Finland, possibly excluding the Greater Helsinki area. The aging trend among users is most 
evident in the Greater Helsinki area. In the light of data from 2005, it seems possible that the drug problem 
as well as specialised treatment services (substitution treatment, health counselling) will be concentrated in 
the Greater Helsinki area and possibly some other large cities. (Partanen et al. 2007.) 
 
4.2 Problem drug use in a wider context  
Finland’s second wave of drug use, at the turn of the 2000s, manifested itself for instance in deaths from 
heroin overdose. In the statistics on drug-related deaths, which indirectly reflect the incidence of problem 
drug use, buprenorphine has been more common than heroin since 2002. The number of buprenorphine 
findings in forensic post-mortem examinations rose year on year throughout the 2000s, from fewer than 10 
in 2000 to 156 in 2010. On the other hand, the number of cannabis and amphetamine findings increased by 
50% over the same period, to more than 100 findings per year. By contrast, the number of deaths caused by 
either heroin or cocaine were restricted to a few cases every year during the same period. (Vuori et al. 2006; 
Vuori et al. 2011.) 31 
The increase in the percentage of treatment periods related to pharmaceutical opioids can be clearly seen 
in medical care statistics. In the information collected from drug-related treatment, 74% of the clients 
reported problem use of pharmaceutical opioids. 
                                                        
 
 
31 See chapter 6.2. Drug-related deaths and mortality of drug users.  
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In the 2000s, the average number of treatment days related to drug use32 has slightly decreased, but the 
percentage of those treatment days related to opiate use has doubled. The number of treatment days 
classified as substitution treatment is showing a clear upward trend; the number of treatment periods related 
to other opioid use varies considerably year on year but is not showing a clear upward trend. 
The absolute number of hospital days per year related to other drugs has decreased, but their percentage 
has remained fairly stable. An exception to this may be found in the percentage of treatment days related to 
stimulants (amphetamine and cocaine); this figure has slightly decreased over the past decade.33 
 
 
 
Figure 5.  Treatment days at hospital, 2000–2010 analysed by the drug indicated in the 
 primary diagnosis 
Sources: Institutional health care. SVT, THL. 
 
According to a study of morbidity statistics,34 the incidence of behavioural disorders and organic brain 
syndrome caused by drug use, controlled for age, was 16.5 in 10,000 among men and 8.1 in 10,000 among 
women in 2009. The incidence was thus about twice as high among men as among women. The absolute 
numbers were 4,141 men and 2,071 women. The age-controlled incidence of behavioural disorders and 
                                                        
 
 
32 This includes all cases where 24-hour treatment is given in the health care system and the principal diagnosis is F11–F16, F18 or F19 
(ICD-10). Poisonings are excluded. However, it should be noted that hospital treatment constitutes only part of all drug-related treatment 
given. Other types of treatment, such as outpatient care or institutional care provided by the social services, is more rehabilitative in nature 
and does not rely on medication as heavily. It is therefore only natural that a higher percentage of opiate use may be found in clients of drug-
related treatment provided by health care than in that provided by the social services. 
33 Stimulants accounted for 14% of treatment days per year on average between 2000 and 2011, and 6% between 2009 and 2010. 
34 In this study, data from the care registers for health care and social welfare and from the statistics on disability benefits provided by the 
Social Insurance Institution (Kela) were combined. The study covered all drug treatment diagnoses – F11 through F16, F18 and F19. The 
focus was on hospitals in the health care system, because social welfare institutions seldom use ICD-10 codes, and outpatient substance 
abuse services were not included in the study.    
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organic brain syndrome caused by drug use increased by almost 25% among both men and women between 
2005 and 2009 (Gissler et al. 2012). 
The above findings notwithstanding, it is unclear by how much problem drug use actually increased in 
the 2000s, if at all. It is also unclear whether the percentage of opiate use out of all drug use has increased. 
The number of clients in substitution treatment has multiplied many times over, and both problem users and 
health care professionals are very well aware of the treatment available for opiate addiction. On the other 
hand, opiate problem users are more likely to seek out substance abuse services than users of other drugs. 
Opiate use is often an indicator of a clear need for treatment: users have typically used several kinds of 
drugs for years, often intravenously. Also, opiate withdrawal symptoms are easier to treat medically than 
withdrawal symptoms from other drugs. Indeed, it is a good thing that more treatment for opiate use is now 
available. What is not clear is whether drug users’ access to treatment has become more difficult at the 
same time. (Forsell 2012a.) 
 
Information collecting from drug-related treatment 
In the annual survey for collecting information from drug-related treatment conducted by the National 
Institute for Health and Welfare,35 the drug user clients were mainly men (67%) and mainly aged 20 to 35 
(67%). Their educational attainment was low, and most of them were unemployed (61%). One out of ten 
clients (10%) was homeless, and 77% of the clients had used intravenous drugs at some point in their life. 
(Forsell 2012a.) 
Opiates were the primary problem drug for 59% of the clients covered by the information collection. 
Overall, 74% of drug user clients had a history of opiate problem use. In recent years, nearly all of the 
opiate use recorded in Finland has involved synthetic, pharmaceutical opioids. Two of these, buprenorphine 
and methadone, are used both as intoxicants and as detoxification or substitution treatment medication. 
Substitution treatment medication is typically taken under a physician’s supervision and orally, while drug 
use is typically intravenous and involves the use of other drugs too. (Forsell 2012a.) 
Buprenorphine is by far the most common single opiate also in drug use (accounting for at least 74% of 
all opiate use). Other substances were occasionally reported as being used:36 heroin and other poppy 
derivatives (9%), tramadol (4%), oxycodone (4%), codein preparations (3%) and phentanyl (1%). There 
was less intoxicant use of methadone (1%) than of a combined preparation of buprenorphine and naloxone 
(5%). (Forsell 2012a.) 
Of those who reported that buprenorphine was their primary problem drug, no fewer than 86% used this 
substance mainly intravenously; 69% of them had used it intravenously in the previous month, and 44% 
used it on a daily basis. (Forsell 2012a.) 
The percentage of clients whose primary problem drugs are opiates has been increasing since 2002 
(Figure 5). However, as noted above, it is not clear whether opiate use has actually increased in the past 
decade. Opiate problem users are more likely to seek out substance abuse services than users of other 
drugs, and the number of clients in substitution treatment has multiplied many times over in the past ten 
years. (Forsell 2012a.) 
                                                        
 
 
35The statistical report on drug user clients of substance abuse services is based on data from a separate round of information collection on 
drug-related treatment. In 2011, 74 units providing drug-related treatment participated in the information collecting, submitting data on 2,527 
clients. Information collecting is not compulsory for the units involved, and no client identification data are submitted. The data collected 
cover an estimated one third of the drug-related treatment provided in Finland. The figures reported here include clients who continue in 
treatment, which means that the material has a broader coverage than specified in the treatment demand indicator (TDI) protocol of the 
EMCDDA. Finland’s TDI figures may be found at http://www.emcdda.europa.eu/themes/key-indicators/tdi.  
36 In the information-collecting process, clients are asked which drugs led them to seek treatment. A treatment relationship may last several 
years (especially with substitution treatment clients), and thus at the time of the inquiry the client may no longer be using the drug that 
initially caused him/her to seek treatment. For instance, 7% of substitution treatment clients reported that their primary problem drug was 
heroin, yet 69% of these clients had not used heroin during the previous month and indeed may not have done so for years. Regular, 
continuous use of heroin was practically non-existent in Finland in 2011. 
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Figure 6.  Primary substances used by clients entering treatment for the use of narcotics 
 and pharmaceuticals (% of clientele) in 2000–2011. 
Sources: Drug Treatment Information System, THL. 
 
Polydrug use was very common. More than half (57%) of the clients seeking substance abuse treatment 
reported that they had a problem use history with at least three intoxicants. The average number of problem 
drugs reported was 3.2 for those clients who used opiates but were not in substitution treatment, 2.8 for 
those undergoing opiate substitution treatment, and 2.3 for those who did not report opiate abuse. 
Tranquilisers were reported as secondary drugs far more often than as primary drugs. Pharmaceutical 
abuse comprised benzodiazepine abuse in 90% of the cases, with barbiturates (sleeping medicines) 
accounting for 9% and pregabalin for less than 2%. (Forsell 2012a.) 
Stimulant use mainly comprised amphetamine use; there were some reports of secondary drug use of 
cocaine (7% of all stimulants) and ecstasy (6% of all stimulants). Although methamphetamine and MDPV 
had become more common on the drug market, they were not significant problem drugs, both having an 
incidence of 2%. (Forsell 2012a.) 
Of the clients who sought treatment primarily for stimulant problem use, only one out of ten (10%) used 
a stimulant on a daily basis; 45% had not used stimulants in the previous month. By contrast, of the clients 
who sought treatment primarily for tranquiliser problem use, the majority used such drugs on a daily basis 
(57%), and only one out of five (16%) had not used them in the previous month. The principal mode of use 
was intravenous for stimulants (76%) and oral for tranquilisers (91%). (Forsell 2012a.) 
Among the drug users seeking treatment who were not opiate problem users, cannabis was the most 
common drug leading the clients to seek treatment (31%). The percentage of cannabis as a primary cause 
for seeking treatment was considerably elevated in the youngest age groups. In fact, it was the most 
common problem drug reported as a cause for seeking treatment in the age group of under 20 (41%). Out of 
all clients who named cannabis as their primary drug, nearly half (42%) also had an alcohol problem. On 
the other hand, one out of three (31%) reported no other problem intoxicants. (Forsell 2012a.) 
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4.3 Data on problem drug use from non-treatment sources  
In late 2009, a study was conducted on the substances used by drug users in Helsinki, how they used them 
and where they obtained them.37 The criterion for inclusion in the study was that the interviewees had to be 
active users; however, persons who had not been actively using drugs for up to a month were also accepted. 
Out of the 100 people interviewed, 71 were men and 29 women; 23 of the interviewees were in substitution 
treatment, 20 of them men. The average age of the interviewees was about 29 years. However, more than 
two thirds of the women were under 28 years of age, as compared with less than a third of the men. The 
substitution treatment patients included in the study were on average older than the other interviewees 
(average age about 32 years). More than half of the interviewees were not in a steady relationship at the 
time of the interview. (Tammi et al. 2011.) 
The interviewees were seriously disadvantaged. The majority (79%) of them were unemployed at the 
time of the interview, three fourths of them had only completed comprehensive school, and the highest 
educational attainment among them was vocational education or upper secondary school. More than half of 
the interviewees had a place to live, whether own or rented, but one in four lived in a shelter or were 
completely homeless. Three out of four respondents named social security as their principal source of 
income, and nearly one in six named drug trading or other illegal activities; by comparison, no one’s 
principal source of income was begging or prostitution. Two out of every three interviewees had had 
trouble with the police more than once in the preceding year. (Tammi et al. 2011.) 
For all interviewees, the average period of drug use was 13 years, the shortest being 3 and the longest 
35 years. Interviewees in substitution treatment had been drug users for longer than the average, the 
average among them being 17 years. Most of the users had begun using drugs during the ‘second wave’ of 
drug use increase in Finland after the mid-1990s. The most commonly used substances during the previous 
month were opioids (88 respondents), followed by benzodiazepines (81), alcohol and cannabis (73) and 
amphetamines (66). The most frequently used opioid was buprenorphine as Subutex (60), followed by 
buprenorphine-naloxone combination (Suboxone) (39) and methadone (14). More than 90% of the 
interviewees used Subutex intravenously, and a similar percentage may be obtained for Suboxone and 
methadone when the interviewees in substitution treatment are excluded. Injecting Suboxone was 
particularly popular with users under the age of 28. Amphetamine, metamphetamine and MDPV were also 
used intravenously by more than 90% of users; 26 respondents said they had used MDPV during the 
previous month. (Tammi et al. 2011.) 
Nearly half of those who had used benzodiazepines during the previous month (39 out of 81) had used 
them on a daily basis. Half of them had obtained the benzodiazepine from a physician, and about one fourth 
of them had used the illegal market. Four out of five of those who had used opioids during the previous 
month (74 out of 88) had used them on a daily basis; 23 of these were in substitution treatment. Nearly half 
of those who had used Subutex during the previous month (29 out of 60) had used it on a daily basis, and 
more than 80% had used it at least every other day. Four out of five Subutex users had obtained the 
substance on the illegal market. More than half of Suboxone users had obtained the substance on the illegal 
market. Amphetamine use is more occasional: out of the 56 respondents who said they had used 
amphetamine during the previous month, only 8 had used it on a daily basis, and 17 at least every other 
day. (Tammi et al. 2011.) 
                                                        
 
 
37 The study was a structured interview study whose participants (100) were recruited at the end of 2009 through anonymous health 
counselling centres intended for drug users (needle and syringe exchange points) (67), through peer support interviews in user networks (20) 
and through two outpatient clinics providing harm-reducing substitution treatment (15). The interviewees were instructed to approach women 
and immigrants in particular to gain a representative sample. The interviews lasted between 30 and 60 minutes. Two of the interviews were 
eventually discarded because of reliability issues. Only statistically significant differences were analysed; the tests used were the Fisher exact 
test, Chi test, and t-test in variance analysis. This study forms part of the European Quaf2 project. (Tammi et al. 2011.) 
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Certain statistically significant differences were observed in substance profiles with regard to user age: 
benzodiazepines were more common among those under 30 than in older age groups, whereas in the older 
group there were more amphetamine users who had not used the substance at all in the previous month. 
Gender analysis showed that men more frequently than women had used drugs in the previous month in all 
substance groups except for amphetamine. The substitution treatment patients interviewed used alcohol, 
benzodiazepines and cannabis just as commonly as the rest of the respondents, but amphetamines more 
rarely. All except one of the substitution treatment patients had used self-procured opiates during their 
treatment. (Tammi et al. 2011.) 
Assessing forms of polydrug use was one of the key findings of the study. Although the study does not 
allow for broad generalisation, it may be concluded that among the drug users with the most severe 
problems there are persons who use both amphetamines and opioids; the most common pattern, however, is 
combined use featuring both polydrug use of opioid-based painkillers and sedatives (benzodiazepines) on 
the one hand and alcohol and cannabis on the other. (Tammi et al. 2011.) 
A register study38 showed that the most common substances found in the blood and urine samples of 
intoxicated drivers were benzodiazepines and amphetamines. The study also showed that polydrug use was 
common in cases of suspected driving while intoxicated. It was considered important for intoxicated drivers 
to be referred to treatment and rehabilitation as an alternative to being convicted and sentenced, because 
being caught for driving while intoxicated would be a good opportunity for reaching out to substance 
abusers and referring them to treatment. (Karjalainen 2010.) 
How the problem use of drugs is addressed is influenced by conceptions of problem use in society at 
large. Shifts in the discussion and scope of substance abuse and of addiction in general in the press between 
1968 and 2006 has been analysed on the basis of articles published in Finland’s leading daily newspaper.39 
The findings show that four trends may be identified over the 40-year period: an increasing number of 
articles on the topic, the expansion of discussion of the phenomenon from alcohol use to various other 
kinds of divergent behaviour, the mainstreaming of a previously marginal phenomenon, and a shift from 
social models explaining the phenomenon to personal histories. Over the period examined, the number of 
articles in this area per year would seem to have doubled. As recently as in the 1970s and 1980s, the 
phenomenon was identified with a specific group of people who had problems with a specific behavioural 
pattern, usually related to a specific substance (alcohol or drugs). The problems were seen as functions of 
the social status of these groups and not discussed as wider phenomena. From the 1990s onwards, however, 
addiction has been identified in highly diverse areas (work, gaming, TV, Internet use, eating disorders, 
etc.), and today a large percentage of the population could be described as being addicted to something. As 
the problem is seen to affect an increasing percentage of the population, it is becoming less of an anomaly 
and more of a mainstream phenomenon. At the same time, the identification of problems with a specific 
social status has decreased, and addiction is now seen largely as a personal problem; this is also reflected in 
the treatment of addiction, particularly in the medicalisation of treatment. (Hellman 2009; Hellman 2010.) 
In a joint Nordic study, the harm caused by illegal drug use to family members and friends was studied 
in the Nordic countries by asking respondents about personal experiences of drug users among their family 
and friends, the harm caused by them and the willingness of the respondents to help drug users close to 
them.40 The study showed that respondents in Helsinki differed from those in the other Nordic capitals in 
                                                        
 
 
38 The study concerned cases between 1977 and 2007 of drivers apprehended by the police and suspected of driving while intoxicated (total 
number of suspects during the period: 31,963). 
39 The study examines articles published in the Helsingin Sanomat newspaper, the concept of ‘addiction’ referring to any discussion of a 
problematic or repeated behaviour over which the individual has little or no control, or to specific concepts such as ‘alcoholism’, ‘problem 
use’, ‘bulimia’, etc., and the treatment of same. The articles were selected from the same period of three weeks in even-numbered years. In 
all, 200 articles were found between the years 1968 and 2006. Analysed by decade, the number of articles varied as follows: 49 articles in 
1968–1978, 26 in 1980–1988, 63 in 1990–1998, and 62 in 2000–2006. The material was analysed using the content analysis method. The 
daily circulation of Helsingin Sanomat has been between 400,000 and 500,000 since the 1990s. (Hellman 2009.) 
40 The study was conducted using a representative sample of 3,092 persons in the capital cities of the Nordic countries. The persons selected 
were over the age of 18 and were contacted by e-mail and asked to respond anonymously to an online questionnaire with 34 questions. The 
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that they had fewer personal experiences of drug users in their proximity than the other respondents. In 
Helsinki, 45% of respondents had had concerns about the drug use of someone personally known to them 
(12% within the previous year), whereas the figure in the other Nordic capitals was 56% to 67% (22% to 
28%). The researchers explained this difference by referring to Finland’s relatively brief history of drug use 
(compared to Denmark in particular), lower number of users of hard drugs (compared to Denmark and 
Norway) and shorter history of hard drug use (compared to all other Nordic countries). Similarly, fewer 
respondents in Helsinki had been personally acquainted with someone receiving treatment for substance 
abuse, but the difference between Helsinki and the other Nordic capitals was no longer significant in 
responses concerning personal acquaintance with someone receiving treatment within the previous year. 
(Melberg et al. 2011.) 
There were also clear differences between Helsinki and the other Nordic capitals as to how serious the 
drug problem overall was considered by people who knew problem drug users personally. In Helsinki, 30% 
of respondents had experienced a fear of violence because of drug use by a person close to them in their 
lifetime (9% during the previous year), whereas the figures in the other Nordic countries were 20% to 23% 
(5% to 7%). Correspondingly, in Helsinki 11% of respondents had had to call in the police because of drug 
use (3% during the previous year), whereas the figures in the other Nordic countries were 4% to 6% (1% 
during the previous year). The researchers explain this difference too by the fact that this problem set is 
unfamiliar in Helsinki and that, on the other hand, Finland’s drug policy is traditionally control-oriented, 
which is reflected in how citizens act. However, there were no great differences between the countries as 
regards how large a percentage of those personally acquainted with problem users had attempted to get 
those problem users to seek treatment. (Melberg et al. 2011.) 
With regard to drug-related harm, the views of respondents personally acquainted with drug users 
differed from one another in that the perceived harm sometimes proved to be greatest in the countries with 
the longest history of drug-related problems. By contrast, there were only minor differences between 
countries in conceptions of drug-related harm in the previous year among respondents personally 
acquainted with drug users. In all the cities, the most experiences of drug-related harm were cited by 
women and by respondents who had experience of a drug problem in a person close to them, for instance in 
their own family. When comparing the drug problem with a variety of common diseases (e.g. diabetes, 
asthma, cancer), the seriousness of the drug problem was assessed in much the same way in all the 
countries. In all, the incidence of personal experiences of drug-related harm proved to be slightly lower in 
Helsinki than in the other Nordic countries. (Melberg et al. 2011.) 
                                                                                                                                                                             
 
 
response rate was slightly over 50%. The group of participants did not significantly differ from the general population in terms of gender, age 
or educational attainment, at least not in the case of Helsinki. Cross-referencing and logistical regression analysis were used. (Melberg et al. 
2011.)  
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5 Drug-related treatment services 
According to the Act on Welfare for Substance Abusers, municipalities must provide substance abuse services 
that are in accordance with the needs of the municipalities both in their content and coverage. All substances 
that are used for intoxication are considered intoxicants: alcohol, substitutes, pharmaceuticals and drugs. Units 
providing specialised services for substance abusers include outpatient care (A-Clinics, youth centres), short-
term inpatient care (detoxification units), longer-term rehabilitative care and support services (day centres, 
sheltered housing and supported housing) and peer support activities. 
In addition to the units providing specialised services for substance abusers, increasing numbers of 
substance abusers are treated within primary social and health care services, including social welfare offices 
and child welfare services, mental health clinics, health centre clinics and wards, hospitals and psychiatric 
hospitals. The Finnish system emphasises that drug treatment as such is often insufficient and the substance 
abuser should be assisted in solving problems related to income, living and employment. 
In Finland, municipalities are in charge of organising social and health services, but local government 
lacks monitoring systems that would help identify client group specific welfare deficits and service needs. 
In particular, the most socially marginalised substance abuse clients face an increased risk of exclusion 
from the service network. 
A quality framework for substance abuse services (Ministry of Social Affairs and Health 2002) and Current 
Care guidelines (Duodecim 2006) for the treatment of drug abusers have been created in order to develop 
substance abuse work. The development policy for drug treatment services emphasises developing low-
threshold services and related training. 
It is alleged that, due to the fact that more and more drug users are receiving medical treatment, 
substance abuse problems, which were previously considered social problems, are now regarded as medical 
problems and are increasingly being handled by the health care services. Substitution treatment for opiate 
addicts is increasingly being transferred to health centres and, in part, also to pharmacies. This phenomenon 
reflects the differences in focus between psychosocially and medically oriented substance abuse treatment 
services. Another reason would be that municipalities are attempting to transfer these services from the 
specialist level to the primary level in order to generate savings. 
It is also a challenge for the substance abuse service system to see substance abuse problems as a part of 
broader problem spectra that include mental health problems, needs for new treatment and a vicious circle 
of social exclusion. 
 
5.1 Strategy and treatment systems 
According to the Government Resolution concerning the drug policy for 2008–2011, treatment services 
will be developed and their provision increased, in order to ensure equal access to services for all citizens. 
Drug users will be offered a range of treatment options, appropriate for the type of addiction in question 
and, for instance, access to treatment will be facilitated for opioid addicts. In addition, the objective is to 
increase the types of treatment, health counselling and support directed at reducing drug-related harm such 
as diseases, mental health problems and crime. (Finnish Government 2007a.) 
Treatment services 
In Finland, services for substance abusers are provided within both social welfare and health care. 
Specialised services for substance abusers are mainly provided under social welfare. Outpatient treatment 
within these specialised services is free of charge for the client, whereas inpatient treatment generally 
requires a payment guarantee from the social welfare office of the client’s home municipality. 
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The practical difficulty in substance abuse treatment is that the clients’ problems and the availability of 
services do not necessarily meet. Some of the largest obstacles to receiving treatment are waiting times, the 
lack of knowledge and skills and negative attitudes towards substance abusers within the primary services 
and the physical distance of the treatment units within specialised services. One possible solution 
particularly for drug users is service guidance, a more personal counselling service for drug problem users 
(see also section 8.2 Social rehabilitation). 
Outpatient substance abuse services 
Drug users are offered specialist outpatient care services at A Clinics and youth centres. The services 
offered may include a survey of mental and somatic state, counselling, individual therapy, family therapy, 
group therapy, networking, outpatient detoxification or substitution treatment, depending on the client’s 
needs. The care is undertaken according to a treatment plan drawn up together with the client and his/her 
support network. (Korteniemi 2011.) 
Institutional detoxification or withdrawal treatment 
Detoxification or withdrawal treatment is 24h institutional care. The length of the treatment period is 
determined according to the care needs of the client. The purpose of this treatment is to break the vicious 
circle of substance abuse, to treat withdrawal symptoms and to plan for further treatment. Once the client’s 
physical health has improved, rehabilitative discussions are begun. (Korteniemi 2011.) 
Rehabilitative institutional care 
Rehabilitative institutional care in substance abuse services is long-term 24h institutional care. 
Rehabilitative institutional care forms part of a client’s overall rehabilitation programme and is part of the 
treatment plan. Institutional care is intended as a treatment period to support outpatient care in the case of 
clients for whom outpatient care or institutional detoxification are not sufficient or feasible, or whose 
rehabilitation requires them to be removed from their normal living environment for a while. The length of 
the treatment period is individually determined. The content of the rehabilitation is also determined 
individually, according to the treatment ideology of the facility in question and the methods used. 
(Korteniemi 2011.) 
Rehabilitative housing services 
The purpose of housing services is to provide safe accommodation for the client, to support him/her in 
leading an intoxicant-free life and to guide him/her to the use of services. Rehabilitative housing services 
include sheltered housing with 24h assistance, sheltered housing, supported housing (near a sheltered home 
where help is available) and assisted housing (hour-based guidance). Forms of assistance may include 
guidance and counselling in everyday matters, setting limits, charting and strengthening the client’s social 
networks, and providing health care services. Housing services are covered in the service and rehabilitation 
plan drawn up for the client. (Korteniemi 2011.) 
Specialist medical care for drug users 
Drug use treatment, which aims at ending or reducing drug use or abuse of pharmaceuticals or their 
harmful effects, is also provided at hospitals. 
Somatic illnesses whose underlying causes include drug use are treated both at emergency clinics and in 
inpatient care. Drug-related poisoning, for instance, may be treated at an emergency clinic, or the client 
may need to be admitted for a few days of observation in an inpatient ward. Primary and secondary 
diagnoses are recorded for patients in health care, and a given patient may have a primary diagnosis of 
poisoning and a secondary diagnosis of polydrug use. 
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Drug use treatment proper is given at psychiatry outpatient clinics and wards. Clients may seek 
treatment at a specialist medical care substance abuse clinic through an A Clinic or a psychiatric emergency 
clinic, for instance. Substance abuse clinics conduct assessments of substitution treatment needs, among 
other things, if the client also has a psychiatric illness. 
General social welfare and health care services 
Drug use treatment given at health centres include discussions with a substance abuse nurse, substitution 
treatment, withdrawal treatment and treatment of somatic illnesses. Social welfare services and child 
welfare services offer discussion therapy and referral to treatment. 
Low-threshold services 
The point in low-threshold services is to explain to clients that they may easily seek out services intended 
for them without fear of consequences. The concept has broadened from syringe and needle exchange 
points to a wider range of services intended for the disadvantaged, such as shelters, day centres and night 
cafés. (Törmä 2009. See also the chapter Clinical research, Study on low-threshold operations.) 
 
Treatment methods  
A quality framework for substance abuse services (Ministry of Social Affairs and Health 2002) and Current 
Care guidelines (Duodecim 2006) for the treatment of drug abusers have been created in order to develop 
substance abuse work. A new Current Care guideline will be published in autumn 2012. The recommendations 
have been augmented with anthology articles updating clinical studies published in professional journals: 
on the treatment of clients suspected of using designer drugs (Lapatto-Reiniluoto et al. 2011), on 
encountering substance abusers at an emergency clinic (Salaspuro 2009), on encountering cannabis users in 
primary health care (Tacke et al. 2011), on developing treatment for pregnant women with substance abuse 
problems (Pajulo 2011), on opioid substitution treatment for young people (Mikkonen et al. 2010), and on 
ADHD and intoxicants (Niemelä et al. 2010). The Guide for Nurses was revised for teaching purposes in 
2010 with updated articles on how to identify substance abusers, how to treat drug poisonings and 
withdrawal, how to refer intravenous drug users to treatment, and the co-occurrence of substance abuse and 
mental health problems (Mustajoki et al. eds. 2010). 
Treatment of opioid addicts 
The opiate addiction treatment with the best proven track record is medical substitution treatment. 
(Duodecim 2006.) 
Substitution treatment may be given to opioid addict clients who have not been able to quit through 
other types of detoxification treatment. The aim of medical substitution treatment for opioid addicts is 
rehabilitation and abstinence or the reduction of harmful impacts, and in any case improving the client’s 
quality of life. 
There are nearly 2,000 substitution treatment clients in Finland. Subuxone, a combination preparation 
containing buprenorphine and naloxone, accounts for about 60% of the treatment and methadone for the 
remaining 40%. The use of buprenorphine only, i.e. Subutex, in substitution treatment is limited to a 
number of isolated cases according to the surveys. (MSD 2010.) A new study on the volume of substitution 
treatment will be published near the end of 2012. 
Substitution treatment is preceded by a treatment needs assessment, which may be conducted in either 
outpatient or institutional care. In most cases, the treatment needs assessment is conducted or the treatment 
begun at a specialist unit such as an addiction psychiatry ward at a hospital, after which the actual course of 
treatment is provided by substance abuse outpatient services (e.g. an A Clinic) or a health centre. The time 
limits imposed by the treatment guarantee apply to medical substitution treatment (for non-urgent cases, 
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assessment of treatment needs within 3 days and access to treatment within 3 months and, for specialist 
medical care, assessment of treatment needs within 3 weeks and access to treatment within 6 months). 
In order to improve the availability of medical treatment, a new Decree on substitution treatment was 
issued at the beginning of 2008. The aim in amending the Decree was the appropriate scaling of treatment 
(demanding patients being allocated to specialist medical care, others to the primary level; long-term care 
at a level which enables a normal life for the patient and is cost-efficient for the system). The Decree also 
enabled pharmacies to distribute substitution treatment medication containing buprenorphine and naloxone. 
(Ministry of Social Affairs and Health 2009e.) However, pharmacy contracts proved to be problematic 
from the viewpoint of the customer’s personal data protection, as the contracts were deemed to constitute a 
sensitive personal data file, the use of which was not approved by the Data Protection Board until autumn 
2010, and even then only in conjunction with a patient’s individual treatment and detoxification plans. 
(Laine 2010.) 
The pharmaceutical preparation containing buprenorphine and naloxone is subject to limited basic 
reimbursement, and the client must apply for a Kela refund entitlement. The Kela reimbursement is 42% of 
the cost of the medication. Even after the reimbursement, the client is paying nearly EUR 5,000 per year. 
However, if the client receives the medication at the place of treatment, it is free of charge. 
Of the substitution treatment clients in the largest municipalities (n = 1,010), 20% were health centre 
clients and 5% were pharmacy distribution clients (Korteniemi 2011.) 
Treatments for other drug users 
The Current Care guideline includes care for the use of other drugs. (Duodecim 2006.) 
Non-medical treatment and short-term detoxification are available for amphetamine problem users. 
Some amphetamine problem users undergo occasional treatment periods for amphetamine psychoses at 
hospital psychiatric wards. 
There are scarcely any specialised treatment programmes for those who seek treatment because of 
cannabis use. 
Organisation of services 
The provision of services for substance abusers currently takes multiple forms: it can form part of a 
municipality's own operations or co-operation with the major provider of services for substance abusers. 
Moreover, it can also be arranged within a federation of municipalities or foundation for treating substance 
abusers or through purchase agreements with other organisations or private companies. For instance, 
according to 2008 data among A Clinics (n=75) providing outpatient substance abuser services for adults, 
61 were municipal and 14 were maintained by the A Clinic Foundation. In all, the A Clinic Foundation has 
concluded agreements with approximately a hundred municipalities for the provision of substance abuser 
services. There are three federations of municipalities providing substance abuser services, each with from 
24 to 71 member municipalities. Providers of institutional, detoxification and rehabilitation units most often 
include foundations, NGOs or private service providers. (Kekki & Partanen 2008.) 
Riikka Perälä has studied the ways in which local authorities organise their social welfare and health 
care services through a case study involving co-operation between local authorities and Christian substance 
abuse service NGOs.41 Co-operation is based on business models rather than partnership. In the customer-
provider model used in competitive tendering, the actual clients cannot influence the content of the service, 
and cost consciousness often trumps quality in developing services. Although the new service culture is 
hoped to increase networking, to strengthen the civic society and to shape services to match citizens’ needs 
                                                        
 
 
41 The material for the study consists of themed interviews with 20 local government officials and representatives of Christian substance 
abuse service organisations collaborating with the local authorities, conducted in autumn 2008. There were 8 local authorities involved, 5 
large (population more than 100,000) and 3 medium-sized; civil servants responsible for liaison with NGOs were interviewed, as were 12 
persons responsible for the operations of various service points run by the NGOs involved. (Perälä 2010.) 
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better, the reality as outlined in the study is very different – albeit there are in fact some examples of 
successful cooperation. (Perälä 2010.) 
Development of treatment services  
In a study evaluating the treatment of drug addiction in Finland and its backgrounds, it was noted that five 
fundamental changes have taken place in forms of treatment and their underlying assumptions over the past 
50 years.42 The study shows that drug addiction treatment can be divided into five phases: the psychiatric 
phase in the late 1960s; the social therapy phase in the early 1970s; the decline of drug treatment between 
1975 and 1986; the drug treatment derived from the social therapy outpatient care tradition after 1986; and 
the expansion of specialist drug treatment since the late 1990s. The shifts in treatment methods were above 
all about changes in therapeutic reasoning: as drug addiction came to be regarded not as a personality 
aberration but as a problem manifesting itself in interaction, thinking and actions, the focus shifted from 
searching for the causes of drug addiction to seeking successful solutions. The technologies geared towards 
discipline and the patient’s acknowledgement of his/her (alcohol) addiction were replaced by communal 
technologies and self-control techniques. Obedience and social conformity were joined by an emphasis on 
active client participation as the scope of drug addiction broadened from considering only the personality of 
the individual to an understanding of the client’s family and its internal interaction and from there to 
considering entire population groups (e.g. youth rebellion). The author of the study notes that a solution-
oriented approach gradually took centre stage in family therapy and therapeutic communities. In all, 
treatment in the 1970s, 1980s and 1990s was characterised by a trend towards voluntary and active 
participation by clients. Nevertheless, the problems of dropping out of treatment persisted; entering the 
1990s, drug users could not identify with the forms of treatment available. (Selin 2010a; 2011a; 2011b.) 
Psychodynamics was joined in the 1990s by two new disciplines, behavioural and cognitive 
psychology, according to the former of which addiction is more of a learned behaviour than an identity 
trait. The latter focuses on an individual’s capacity for influencing the factors exposing him/her to addictive 
behaviour. The breakthrough of substitution treatment, supported by brain research, had the medical impact 
of shifting the focus from curing drug addiction to managing the risks of drug use. The earlier 
psychodynamic theory of addiction combined with an epidemiological viewpoint did not allow for 
interventions of any specific kind. However, as more knowledge was gained about the neurochemistry of 
the brain and the communicable diseases caused by drugs, the door was opened for specific risk-reducing 
measures. This change enabled the monitoring of the social effectiveness of treatment, which boosted the 
position of evidence-based medicine. (Selin 2010a; 2011a; 2011b.) 
By 2002, as substitution treatment and maintenance treatment became generally accepted, medical 
treatment of opioid addicts had completely changed in its approaches, highlighting the medical side. The 
causes of addiction were eventually sidelined, and the emphasis was now on promoting a self-image 
conducive to self-control techniques and abstinence. Instead of eliminating the client’s own thoughts and 
mental problems, cognitive and behavioural therapy seeks to replace harmful habits and skills with new, 
better skills that prevent the client from relapsing. The purpose of such a change is to highlight the match 
between drug treatments and the hopes and desires of potential clients with drug problems. At the same 
time, opiate addiction as a specifically defined somatic illness has become easier to control, and clients are 
more likely to stick with the treatment. However, substitution treatment does not in and of itself forfeit the 
control inherent in treatment or a transition towards an ethically sustainable way of providing treatment: 
substitution treatment too makes use of social control techniques to control and normalise the body. At the 
                                                        
 
 
42  The study was based on articles collected from five periodicals (Tiimi, Suomen lääkärilehti, Aikakauskirja Duodecim, 
Alkoholipolitiikka/Yhteiskuntapolitiikka, Sosiaalilääketieteellinen aikakauskirja), all of which except Tiimi also publish refereed articles. 
The articles span five decades, from 1965 to 2005. Detailed analysis involved articles on treatment methods, treatment problems and 
proposed measures. The texts were analysed in the light of the research framework of the analytics of power developed by Michel Foucault. 
(Selin 2010a; 2011a; 2011b.) 
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same time, the treatment system requires clients to conform to its logic and to behave more predictably and 
to be more patient – which may require a drug addict to display precisely the kind of active initiative the 
lack of which led him/her to need treatment in the first place. (Selin 2010a; 2011a; 2011b.) 
 
Institutional control of drug-related harm 
In a study on institutional substance abuse treatment and substance abuse control, data on substance abuse 
clients of the social welfare and health care services, the police and the prison administration from between 
1985 and 2006 were compared.43 Up until the recession of the early 1990s, the volume of rehabilitative 
social welfare and the number of treatment days in institutional care increased year on year as the welfare 
state and the social sector were built up. The focus was on softer values in treatment, not so much on 
coercive measures. However, following the recession the number of beds in institutional substance abuse 
treatment was drastically cut, the number of treatment days reduced and control increased; this was also 
partly due to the general increase in the use of drugs. By the mid-2000s, the number of related prison 
sentences issued has grown particularly because of extended sentences for drug-related crimes, drunk 
driving and violent crime. In 1985, prison inmates with a substance abuse background accounted for 45% 
of the prison population, but this figure had risen to 84% by 2006. It would thus appear that institutional 
control of drug-related harm has increased the most in prisons, where control and rehabilitation are strictest 
and days stayed are the most expensive. This would seem to dovetail with Finland’s two-track 
interpretation of drug policy, whereby drug users are subjected to increasingly strict control while a low-
threshold service network (excluded from the study referred to here) is being set up for drug users. 
(Obstbaum et al. 2011.) 
 
Clinical research 
Several studies on rehabilitation have been published in recent years: on community rehabilitation (Prättö et al. 
2009), on peer group support in Narcotics Anonymous (Kotovirta 2009), on the involvement of the rehabilitee 
(Mattila-Aalto 2009) and on the results of substitution treatment (Vorma et al. 2009). 
 
Study on low-threshold operations 
In her dissertation, Riikka Perälä explored what kind of help is available to drug users at health counselling 
centres and how effective these are in controlling drug-related problems.44 Users considered the operations 
of health counselling centres to be client-oriented. They treated their clients with respect and saw the 
person beyond the stereotypes associated with drug use and drug users. The employees were motivated and 
willing to help drug users with a wide variety of problems. The client-oriented approach had a clearly 
positive impact on the everyday lives and life management skills of drug users. This, in turn, helped the 
users commit to the work done at the centre and to be more receptive to the suggestions made by the 
employees. (Perälä 2012.) 
                                                        
 
 
43 The study was based on inpatient treatment days for drug-related illnesses in the case of health care; on detoxification, rehabilitation and 
housing services treatment days in substance abuse special services in the case of social services; on statistics on taking into custody in the 
case of the police; and on health studies and interviews conducted in prisons in 1985 (n=1,099), 1992 (n=325) and 2006 (n=711). (Obstbaum 
et al. 2011; Joukamaa et al. 2010; see also sections 5.3 and 9.4.) 
44 The material for the study was collected at one health counselling centre in southern Finland between 2003 and 2007 using an 
ethnographic research method. The bulk of the material consists of observation notes made at and around the centre (about 200 pages in all) 
and themed interviews with clients (n = 19 and n = 20).   
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Drug users felt that they received the help and support they needed at health counselling centres. By 
contrast, the clients of health counselling centres felt that the majority of the mainstream service and 
treatment practices were controlling rather than supportive in nature. 
The author felt that “the care dimension focusing on human contact and interaction has been sidelined in 
the discussion on substance abuse service policy. Many users turn to public services for something to 
balance their harsh life experiences and are discouraged – yet again – when they are met with a cool 
detachment.” (Perälä 2012.) 
A more social approach should be highlighted in planning and developing policy to reduce the harmful 
impacts of drug use. Even though drug use involves serious addiction and sometimes criminal activities, 
drug use is also often just a symptom of much broader psychological, social and societal problems. 
Employees at health counselling centres felt that clients came to them or ended up with them because they 
could not get help for their problems anywhere else. As a result, health counselling centres are overworked 
with trying to explore and solve complex problems with multiple underlying causes. (Perälä 2012.) 
Role of substance abuse counsellors in treatment 
The effectiveness of substance abuse treatment has been studied from the perspective of what are known as 
common factors.45 
In this study, the impact of common factors in treatment on the effectiveness of outpatient substance 
abuse treatment was examined. The aim was to explore how the relationship between client and therapist, 
the therapist’s actions and the expectations and conceptions of the client affect the outcome of the 
treatment. (Kuusisto & Saarnio 2012.) 
A follow-up study showed that the relationship between client and therapist, the work of the therapist 
and the client’s expectations are all significant factors for the effectiveness of treatment as measured by 
continuity of treatment, the number of sober days after the treatment, and satisfaction with the treatment 
received. The project demonstrated that common factors are interlinked and have combined impacts in 
addition to their individual impacts. (Kuusisto & Saarnio 2012.) 
The principal findings emerging were that a well-functioning relationship between client and therapist 
and positive expectations on the part of the client were highly significant contributing factors in the 
effectiveness of treatment. The study also showed that there are differences between therapists that have a 
bearing on the effectiveness of the treatment they provide. Contextual factors combine with the treatment 
methods used to create the treatment environment perceived by the client. (Kuusisto & Saarnio 2012.) 
 
5.2 Characteristics of treated clients 
In the annual survey for collecting information from drug-related treatment conducted by the National 
Institute for Health and Welfare,46 the findings on the backgrounds and life situations of drug user clients 
were found to be much similar to findings in earlier years. The percentage of women out of all drug user 
clients was 33%, but this figure was 40% in the age group of under 29. By contrast, women accounted for a 
smaller percentage of older age groups of clients and of clients in opiate substitution treatment. 
 
                                                        
 
 
45 The follow-up study involved outpatient substance abuse treatment units (n = 7) in southern and western Finland. The clients (n = 327; 111 
women and 216 men) comprised an unselected comprehensive sample of the new clients entering the clinics during the period in question. 
The study was conducted in the course of the clinics’ normal activities. The material was analysed using independent sample means testing 
and various regression analysis models. The therapist impact factor was analysed using intraclass correlation. 
46The statistical report on drug user clients of substance abuse services is based on data from a separate round of information collection on 
drug-related treatment. In 2011, 74 units providing drug-related treatment participated in the information collecting, submitting data on 2,527 
clients. Information collecting is not compulsory for the units involved, and no client identification data are submitted. The data collected 
cover an estimated one third of the drug-related treatment provided in Finland. The figures reported here include clients who continue in 
treatment, which means that the material has a broader coverage than specified in the treatment demand indicator (TDI) protocol of the 
EMCDDA. Finland’s TDI figures may be found at http://www.emcdda.europa.eu/themes/key-indicators/tdi.  
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Life situation 
The average age of the drug user clients was about 31 years, median 29 years. The men were on average 
more than two years older than the women. Clients from Uusimaa were the oldest, and those from more 
predominantly rural regions were the youngest. Clients in 24h institutional care were younger (median age 
28 years) than those in outpatient care (median age 30 years). The clients in substitution treatment for 
opioid addiction were by far the oldest (median age 33 years; age range 20 to 62 years). (Forsell 2012.) 
Of the clients, 22% of the men and 39% of the women were married or cohabiting. Of those who were 
married or cohabiting, 69% had another problem substance user in the same household, women more 
commonly (79%) than men (41%). Children under the age of 18 were reported by 39% of the clients. Only 
29% of the parents lived in the same household with their child or children, and 25% had had their children 
placed in care by child welfare services. Of the clients under the age of 20, half (52%) were still living with 
their parents. (Forsell 2012a.) 
The clients’ educational attainment was low, and most of them were unemployed (61%). One out of ten 
clients (10%) was homeless, although only 5% of substitution treatment clients were homeless, while the 
figure among other opiate problem users was 13%. This is probably due to two causes: the effectiveness of 
substitution treatment and the ‘apartment first’ principle. (Forsell 2012a.) 
 
Intoxicants used 
Polydrug use was very common. Use of at least three problem drugs was reported for 57% of the clients. 
Opiates were among the top three problem drugs with 78% of the clients, followed by stimulants at 47%, 
cannabis at 44%, tranquillisers at 40% and alcohol at 30%. (Figure 7.) The percentage of opiate users 
among drug users seeking treatment increased significantly in the 2000s. Opiate problem users are more 
likely to seek out substance abuse services than users of other drugs. (Forsell 2012a.) 
Intravenous drugs had been used at some point in their life by 77% of the clients. Intravenous drug use 
during the previous month was reported by 69% of those whose primary problem drug was buprenorphine 
(35% of all treatment periods). (Forsell 2012a.) 
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Opiates Stimulants 
     
Tranquillisers Alcohol Cannabis 
(2011 n = 1,965) (2011 n = 1,179) (2011 n = 1,002) (2011 n = 766) (2011 n = 1,123) 
     
Figure 7.  Problem drugs (primary, secondary and tertiary) leading drug users to seek 
 treatment in 2005–2011, % of clients (n = 2,527). 
Source: Forsell 2012a. 
 
Treatment 
Among the clients, 12% were seeking treatment because of drug use for the first time. About half of the clients 
(49%) had previously received treatment for drug use but began a new treatment period in 2011. The treatment 
relationship had lasted more than one year for 34% of the clients and more than two years for 19% of the 
clients. Opiate substitution treatment had lasted less than a year for 44% of substitution treatment clients, more 
than five years for 15% of them and more than 10 years for 1% of them. (Forsell 2012a.) 
Out of all clients, 67% were in outpatient care and 33% in institutional care. Out of substitution 
treatment clients, 79% were in outpatient care and 21% were undergoing a period of institutional care. 
Institutional care, particularly rehabilitative institutional care, was more common among those clients who 
were not opiate users. The percentages of problem users of tranquillisers and alcohol were somewhat 
higher in institutional care than in outpatient care. (Forsell 2012a.) 
At least 22% of the clients were undergoing opiate substitution treatment: out of these 52% were 
receiving a buprenorphine-naloxine combination (Suboxone), 38% were receiving methadone and 10% 
were receiving buprenorphine (Subutex or Temgesic). (Forsell 2012a.) 
Intravenous drugs had been used at some point in their life by 77% of the clients. Intravenous drug use 
during the previous month was reported by 69% of those whose primary problem drug was buprenorphine 
(35% of all treatment periods). (Forsell 2012a.) 
 
5.3 Client trends in substance and drug treatment 
As discussed above, the Finnish substance abuse service system is heterogeneous; both social welfare and 
health care services must be taken into account. The numbers of cases of drug-related treatment have been 
estimated using general care statistics and three separate studies conducted by the National Institute for 
Health and Welfare. The substance abuse census is conducted during one day and collects information 
concerning clients who used the services of social welfare or health care units due to an injury caused by 
substance abuse or while intoxicated. This census, implemented at four-year intervals, enables an estimate 
to be made as to how large a percentage of all clients of social welfare and health care services are 
substance abusers. Collecting of information on drug-related treatment is a voluntary, continuous system of 
information collecting at treatment units for compiling anonymous, individual information on clients 
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undergoing drug-related treatment (see section 5.2 for clientele). A coverage survey was used to estimate 
the overall volume of drug-related treatment by treatment unit and by region for 2003 and 2008.  
Substance abuse census 
The most recent published results of the substance abuse census date from 2007. The results of the most 
recent census, conducted in 2011, will be published late in 2012. The census is conducted during one day 
and collects information concerning clients who used the services of social welfare or health care units due 
to an injury caused by substance abuse or while intoxicated. This census is carried out every four years and, 
since 1995, in a format allowing comparison. The percentage of drug users among all clients included in 
the census of intoxicant-related cases was 11% in 1995, 16% in 1999, 27% in 2003 and 24% in 2007. 
(Nuorvala et al. 2008a.)47 
The causes behind the rapid growth in 1999 and 2003 include not only increased demand for treatment 
services but also changes in the service structure. The first health counselling centres for intravenous drug 
users were established in the late 1990s, and this manifested itself as an increase in the use of outpatient 
substance abuse services. Substitution treatment was not initiated on a wider scale until 2002, which is 
reflected in the number of drug treatment clients using substance abuser services or outpatient health care 
in 2003 and 2007. 
While the range of substances abused included drugs with 20% of the outpatients in substance abuse 
services in 1999, this figure had risen to 35% in 2003 and 40% in 2007. On the other hand, a cut in alcohol 
tax in Finland in 2004 increased the consumption of alcohol, and its delayed impact may be seen in the 
increased relative proportion of alcohol abusers in the 2007 census of intoxicant-related cases. This impact 
is particularly visible in the group of those over 50 years old. In the 2007 census of intoxicant-related cases, 
relatively little information was obtained from health counselling centres for intravenous drug users and, 
consequently, the proportion of drug users may have been underestimated in the 2007 census. (Huhtanen 
2008; Nuorvala et al. 2008b.) 
Based on the findings, drug-related problem use manifests itself in approximately 40% of the users of 
outpatient or inpatient substance abuse services, 25% of the users of outpatient health care and 20% of the 
users of inpatient health care. Among the clients included in the census, female drug users accounted for 
some 30% of those in outpatient care and 20% of those in inpatient care. In comparison to problem users of 
other substances, drug-using clients were relatively young. Among patients in substance abuse treatment, 
two thirds of those aged under 35 used drugs in addition to other substances, while among clients aged 35 
to 44 drugs were used by only one third, and the figure for clients older than that was less than 10%. 
(Huhtanen 2008.) In addition to their age structure, drug-using clients differed from other users of 
substance abuse services in terms of marginalisation and mental health problems. Homelessness was 
significantly more common among drug users than other client groups, and over half of clients with a 
history of drug abuse suffered from depression or other mental disorders. (Nuorvala et al. 2008b.) 
The overall trend suggested by long-term client monitoring in substance abuse service systems is in 
accordance with the census findings. The greatest changes include the increased number of low-threshold 
health counselling centres and their higher number of clients since 2000 and the more frequent use of 
outpatient substance abuse services (including substitution treatment). Towards the end of the decade, 
client numbers in both outpatient and inpatient care decreased while increasing in housing services. 
(Yearbook of Alcohol and Drug Statistics 2011.) 
                                                        
 
 
47 Intoxicant-related visits refer to visits which either directly or indirectly involve intoxicants. The data were based on reports made by 
service unit personnel. The most recent census was carried out on 9 October 2007, when intoxicant-related cases reached a record high of 
12,045. 
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Figure 8.  Intoxicant-related clients in social welfare and health care services 1996–2010. 
Source: Yearbook of Alcohol and Drug Statistics 2011.  
Coverage survey 
In 2009, about 60% of the substance abuse service units that received the drug treatment coverage survey 
responded.48 The reported number of clients in drug-related treatment was 12,807, or 18% of all substance 
abuse service clients. In considering this figure, we should note that the survey was not targeted accurately, 
nor were responses comprehensive. On the other hand, there was no provision for eliminating overlapping 
client relationships in the survey. A similar survey was conducted regarding clientele for 2004. At that time, 
324 units responded, reporting 75,018 substance abuse service clients and 17,825 (24%) drug user clients. 
The coverage of the Drug Treatment Information System compared to the domain of clients in drug-related 
treatment was the same in both surveys (32%). This would seem to indicate that the decrease in client 
numbers observed is an actual trend and not due to the decreased number of units returning information. 
(Väänänen 2011.) 
The majority of the units that responded (78%) reported that they provided substance abuse services for 
drug user clients. The percentage of drug users out of all substance abuse service clients was the highest at 
outpatient and inpatient units specialising in drug-related treatment (58% and 89%, respectively), at the 
inpatient unit conducting medical treatment needs assessments for opiate addicts (78%) and in addiction 
psychiatry outpatient treatment at hospitals (75%). Drug users also accounted for a high percentage of 
substance abuse service clients in prisons (52%). By contrast, the percentages were considerably lower in 
outpatient substance abuse services at A-Clinics (10%), health centres (17%), detoxification stations (11%) 
and rehabilitation units (23%). 
The data in the Drug Treatment Information System cover the different types of treatment unit fairly 
representatively, although the clientele in prisons and in outpatient treatment at health centres is under-
represented. Specialised drug-related treatment was widely provided. The most common criteria for 
                                                        
 
 
48 The survey was relatively comprehensive with regard to specialised substance abuse services, but not so much with regard to health care 
outpatient services, for instance at municipal health centres. There was no provision for eliminating overlapping client relationships in the 
survey. Nevertheless, nearly two out of three treatment units responded, and the overall number of clients corresponds quite well to the 
annual number of substance abuse service clients obtained by combining data from other separate registers (cf. Figure 5). 
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specialised drug-related treatment were the unit’s right to provide medical treatment for opiate addicts 
(43%) and a treatment programme dedicated to drug users (38%). Just under 20% of the units had a 
specialised ward for drug-related treatment. (Väänänen 2011.) 
Based on the survey data for 2008, drug user clients were concentrated in the Province of Southern 
Finland (43%) and the Province of Western Finland (36%), with 16% of them in Helsinki alone. The 
coverage survey for 2004, on the other hand, showed that no fewer than 70% of clients were located in the 
Province of Southern Finland and 17% in the Province of Western Finland, the figure for Helsinki being 
43%. This indicates that, compared with the data for 2003, the drug user clientele had spread out more 
widely in southern and western Finland. Also, the coverage of the Drug Treatment Information System 
would seem to have improved for southern Finland but weakened for the rest of the country. (Väänänen 
2011.) 
 
  
THL - Report 76/2012 63 Finland – Drug Situation 2012 
6 Health correlates and consequences 
The number of HIV infections caused by intravenous drug use and hepatitis C, B and A cases recorded in 
the National Infectious Diseases Register has clearly declined over the past decade. Hepatitis A and B 
vaccinations for intravenous drug users have played an important role in reducing the spread of drug-
related infectious diseases. Under the national vaccination programme, intravenous drug users and their 
sexual partners and people living in the same household are given vaccinations for both hepatitis A and B 
free of charge. 
Health counselling centres have proved to be a cost-effective way of reducing adverse health impacts of 
drug use. The health and social welfare counselling centres provide health advisory services and a variety 
of support measures to help clients manage their own wellbeing. In addition to receiving advice, clients 
may exchange their needles and syringes for clean, disposable ones; receive vaccinations for hepatitis A 
and B; be tested for HIV and hepatitis; be treated for cuts and mild skin infections; and receive guidance 
and support for seeking other treatment or for managing everyday affairs. 49 
The number of drug-related deaths grew along with other detriments at the turn of the millennium as a 
consequence of increased drug use in the 1990s. In the early 2000s, the number of deaths remained at this 
higher level. Drug findings in forensic toxicology investigations continue to increase, and new designer 
drugs are already beginning to be seen here too. 
The increase in drug-related deaths have to do with polydrug use becoming common, with the fact that 
young drug users are risk-prone and inexperienced, with pharmaceuticals being used for intoxication and 
with mental health problems. It would be particularly important for users to be aware of the dangers of 
combined use, particularly with opioids, benzodiazepines and alcohol. In deaths related to combined use, 
victims typically die in their sleep, especially if buprenorphine, benzodiazepine and alcohol are involved. 
 
6.1 Drug-related infectious diseases  
More than 64% of the drug user clients of substance abuse service units submitting information to the drug 
use treatment information system had at some time in their lives taken all three tests: HIV, hepatitis B and 
hepatitis C: 70% had taken an HIV test, 66% a hepatitis B test and 75% a hepatitis C test. Of those who had 
at some time used intravenous drugs and who had taken an HIV test and received a test result (n = 1,551), 
about 2% came up HIV-positive, while of those who had at some time used intravenous drugs and who had 
taken a hepatitis C test and received a test result (n = 1,688), 73% tested positive for hepatitis C. The 
similar figures for hepatitis A and B were about 3% and about 5%, respectively. 
The percentage of users positive for hepatitis C correlated with the length of intravenous drug use, 
calculated as the difference between the user’s current age and the age at which he/she began using 
intravenous drugs. The percentage of users who had taken a hepatitis C test also correlated with the 
calculated length of intravenous drug use. These figures include both tests reported by the clients 
themselves and confirmed test results (test taken at the unit itself or confirmed for instance in the referral 
document). There were no significant differences between the positive HIV and hepatitis C test results 
reported by clients themselves and confirmed test results. 
Of those who had used intravenous drugs at some time in their lives, more than half (52%) had received 
at least one dose of hepatitis B vaccine, and 39% had received all three doses. 
 
                                                        
 
 
49 For more on the health counselling centres, see chapter 7.  
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HIV 
According to the HIV infection statistics maintained by the National Institute for Welfare and Health, 176 new 
HIV infections were reported in 2011 (187 in 2010). Between 2001 and 2011, the annual number of HIV 
infections has increased by about 50, due to the rise in sexually transmitted HIV infections. The number of 
intravenous infections, by contrast, has remained low: in 2011, only 9 infections caused by intravenous drug 
use were reported, which is only 5% of the reported total (4% in 2010).50 (Jaakkola et al. 2012.) 
In addition to the passive monitoring enabled by the National Infectious Diseases Register, the National 
Institute for Health and Welfare has been co-ordinating prevalence surveys conducted approximately once a 
year.51 These surveys have aimed to assess the prevalence of infections also among those intravenous drug 
users who do not seek diagnostic testing. According to the survey results, the prevalence of HIV among 
intravenous drug users has remained, in spite of the epidemic of the early 2000s, at some 1% to 2%, which by 
international standards is very low. (Arponen et al. 2008.) 
Hepatitis C 
In 2011, the number of new hepatitis C infections reported was 1,160. This was 28 more than in 2010. 
However, because it is difficult to distinguish acute HCV infections from those contracted years ago, trends in 
case numbers must be viewed with caution. The mode of transmission reported was intravenous drug use in 
about half of the cases (600). The incidence of HCV among intravenous drug users is so high (80%) that 
bringing it down is a slow process that will take a decade at least even in the best case where risks are brought 
under immediate control. The number of unclear cases has decreased slightly but remains high (35% in 2011). 
(Jaakkola et al. 2012.) 
The number of annual cases in the age groups 15 to 19 and 20−24 has remained fairly stable. This may be a 
sign that health counselling for intravenous drug users and the related preventive work has decreased the risk of 
infection most effectively in younger age groups and that hepatitis C is now more typically contracted at a later 
age, after prolonged intravenous drug use. The highest number of infections per capita were reported in the 
hospital districts of South Karelia, North Ostrobothnia and Helsinki and Uusimaa. (Jaakkola et al. 2012.)  
                                                        
 
 
50 HIV and AIDS statistics reports compiled by the National Institute for Health and Welfare: http://www.ktl.fi/ttr/gen/rpt/hivsuo.html. 
51 The survey has been conducted on a total of eight occasions between 1998 and 2009. The survey is usually arranged at several health 
counselling centres over a period of about two weeks. The respondents were clients of health counselling centres, numbering between 150 
and 700. The respondents fill in an anonymous risk questionnaire and give a saliva sample, which is analysed for hepatitis C and HIV 
antibodies. Both the form and the sample bear the same anonymous participant number, enabling the comparison of individual risk factors 
against the antibody result. The test is not a diagnosis and, due to the anonymity observed, the results cannot be returned to participants. This 
fact is emphasised to the participants and it is also essential in terms of the survey's representativeness, since it enables participation by those 
who do not necessarily wish to learn of their infection. All clients of the health counselling centres are encouraged to participate in the study 
regardless of their HIV or HCV status. 
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Table 5.  Hepatitis C according to physicians’ reports, arranged by means of transmission, 
 2001–2011. 
? 2001 2003 2005 2007 2008 2009 2010 2011 
???????????????? 822 627 621 416 508 433 596 600 
???????????????? 42 46 61 63 68 65 73 86 
?????????? 3 1 5 4 9 9 10 11 
???????????????? 19 22 24 17 15 1 9 7 
?????? 31 34 35 23 31 26 38 39 
??????????????? 574 533 497 634 513 527 406 417 
?????? 1492 1264 1244 1157 1144 1061 1132 1160 
Source: Jaakkola et al. 2012. 
*) Since 2000, no HCV infections transmitted via the transfusion of Finnish blood components have been reported. 
Hepatitis B 
The number of acute hepatitis B cases recorded in the National Infectious Diseases Register has shown a 
significant decline over the past decade, Altogether there were 24 new infections in 2011, and the means of 
transmission was identified in 14 cases; in all of these, the infection had been contracted through sexual 
intercourse. (Jaakkola et al. 2012.) 
Hepatitis A 
In 2011, the number of new hepatitis A cases reported totalled 14. In 7 of the cases, the infection was 
reported as having been acquired through food or water. One infection was acquired in Finland and 9 
abroad; in 4 cases, the country of acquisition was not specified. During the past few years, the number of 
infections has remained low. The prevalence has remained low owing to the vaccination of risk groups. 
Intravenous drug users, their sexual partners and persons living in the same household have had access to 
hepatitis A vaccination free of charge under the national vaccination programme since 2005. Seeking a 
hepatitis A vaccination is also common among those who are planning to travel abroad. (Jaakkola 2012.) 
Follow-up study of HIV strains among intravenous drug users  
Skar et al. conducted a detailed study52 of HIV epidemics among intravenous drug users in Stockholm and 
Helsinki, using both molecular epidemiology and epidemiology data. In summer 2006, the number of HIV 
infections among intravenous drug users in Stockholm began to spike, and the epidemic persisted until the 
end of 2007 with a total of more than 70 new cases. Prior to this, some 20 cases of HIV infection through 
intravenous drug use had been recorded in the Stockholm area annually since the early 1990s. In western 
Europe, HIV epidemics among intravenous drug users are principally caused by the HIV-1 B subtype. Of 
the infections among intravenous drug users in Sweden in 2001–2002, 85% were of the B subtype, and the 
majority of these had been contracted in Sweden; however, a handful of cases were reported as having been 
contracted in Finland. Finland experienced an HIV epidemic among intravenous drug users beginning in 
                                                        
 
 
52 Materials and methods: The material for the study consisted of 74 cases of HIV infection associated with intravenous drug use, diagnosed 
in the Stockholm area between 2004 and 2007.  The following data were obtained from patient records: year of diagnosis, age, gender, 
principal drug, housing conditions, CD cell count and virus burden. A blood sample was also taken from patients for a HIV-1 V3 loop 
sequence. The V3 sequences were analysed using phylogenetic and phylodynamic methods. Also, 83 V3 sequences obtained from HIV-
positive intravenous drug users in Helsinki between 1998 and 2007 were added to the analysis. Statistical analyses were used to compare 
virus counts and CD4 counts among the infected patients. (Skar et al. 2011.) 
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1998. This epidemic was caused by the HIV-1 recombinant subtype CRF01-AE, which is common in 
Southeast Asia. (Skar et al. 2011.) 
It was shown using phylogenetic analysis that the strain which caused the epidemic in Stockholm was 
CRF01-AE and came from Helsinki. Although several transmissions of CRF01-AE from Finland to 
Sweden were detected, the epidemic had a single source. While the CRF01-AE variant spread rapidly in 
Stockholm, the spread of the B subtype continued at a moderate pace. No biological factor could be 
isolated that would have explained the rapid spread of CRF01-AE: no difference in virus levels in the blood 
could be observed between patients infected by the B subtype and patients infected by the CRF01-AE 
subtype. However, a number of socio-demographic differences were noted; for instance, nearly all heroin 
users contracting the disease had CRF01-AE, whereas both B and CRF01-AE were common among 
amphetamine users. The CRF01-AE epidemics in both Stockholm and Helsinki are probably best explained 
by the appearance of HIV in networks of previously HIV-negative intravenous drug users, with risk 
behaviour related to drug injection and/or sex. (Skar et al. 2011.) 
Studying local epidemics among intravenous drug users in Stockholm and Helsinki produced data on 
key factors in the spreading of HIV (number of virus strains, temporal and spatial distribution patterns, time 
from infection to diagnosis). These data may be used to enhance monitoring and to prevent infections. 
Combining phylogenetic and epidemiology data results in an effective tool for studying epidemics caused 
not only by HIV but by other infectious diseases too. (Skar et al. 2011.) 
 
6.2 Drug-related deaths and mortality of drug users 
Drug-related death cases in Finland can be analysed using three different types of statistics: chemical 
findings, causes of death and poisoning. Since the number of chemical findings is based on positive drug 
findings in forensic autopsies, the drug itself is not necessarily always the direct cause or a major indirect 
cause of death. In Finland, all cases involving an unclear or doubtful cause of death are examined for drugs. 
Statistics by cause of death are kept based on the EMCDDA protocol,53 under which drug-related deaths 
include cases of intentional and unintentional poisoning (i.e. overdosing) and mental health disturbances 
due to drug use. In Finland, the causes of death statistics are produced by Statistics Finland. A separate 
report was compiled for cases of accidental poisoning in 2007. Table 9 shows a summary of the three 
different ways of analysing drug-related deaths for 2007. The table shows that analysing the deaths by 
cause of death produces a bias towards the older age groups. 
In Figure 8, the trend in drug-related deaths is illustrated on the basis of causes of death and drug 
findings. In these drug-related death statistics, changes occurring since 2000 are highly consistent. An 
exception to this rule arises in the sharp increase in the number of findings in 2007 and in the number of 
entries in the National Cause of Death Register in the following year. 
                                                        
 
 
53 Data are extracted from the national cause of death statistics on the basis of WHO ICD-10 codes. The protocol is available as a PDF 
document at: http://www.emcdda.europa.eu/?nnodeid=1419. 
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Figure 9.  The number of drug-related deaths based on causes of death and drug findings 
 in 2000–2010. 
Source: Hjelt Institute and Statistics Finland 2012. 
Drug findings in forensic toxicology investigations continue to increase, the number of chemical findings 
increasing by 14 on the previous year in 2008, by 8 in 2009 and by 48 in 2010. Growth has been strongest 
in findings of buprenorphine and the amphetamine group (Table 6). (Vuori et al. 2012.) 
Intoxicant use of buprenorphine caused 46 deaths by poisoning in 2010. In deaths from poisoning 
caused by buprenorphine abuse, the substance was generally either injected or inhaled. In a typical case, the 
victim was also under the influence of alcohol and benzodiazepine and died in his/her sleep. After 
buprenorphine, the highest numbers of drug-related deaths were attributed to tramadol (26 cases), fentanyl 
(16), methadone (15), codeine (7) and oxycodone (5). Heroin and morphine were found in one case each. 
(Vuori et al. 2012.) 
The statistics for the amphetamine group include MDPV, which is used like and as a substitute for 
amphetamine; this was the most commonly found designer drug in forensic investigations. Between 2008 
and 2010, there were fewer than ten findings of ecstasy per year. By contrast, methamphetamine was a 
clearly more common finding between 2008 and 2010, being found in 11, 17 and 18 fatalities in those 
years, respectively. The finding of several amphetamine groups present at the same time is typical of 
amphetamine findings. (Vuori et al. 2012.) 
In 2010, new designer drugs detected in samples from deceased persons included one case each of 
methylone, mCPP, 4-fluoromethamphetamine, 3-fluoromethamphetamine and desoxypipradrol (2-DPMP) 
and two cases of mephedrone.54 (Vuori et al. 2012.) 
                                                        
 
 
54 Among designer drugs, MDPV was classified as a narcotic drug in Finland in 2011, and methylone, mCPP and 2-DPMP in 2012.  
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The year 2009 produced a spike in the number of GHB findings, the drug being found in 11 subjects as 
opposed to only one finding in the previous year and three in the following year. (Vuori et al. 2012.) 
In 2010, cannabis findings were accompanied by findings of amphetamine in 38% of the cases and 
buprenorphine in 45% of the cases. Alcohol was also found in one third of the cases, and simultaneous 
finding of benzodiazepines was also common. Findings of pregabalin have become common since 2007, 
and in 2010 pregabalin was found in 65 drug user fatalities. The findings indicate that intoxicant use of 
pregabalin is often linked with opioid abuse. (Vuori et al. 2012.) 
Of those who die of pharmaceutical poisoning (including drugs), a little over 60% are men. Suicide 
accounted for 43% to 47% of deaths from pharmaceutical poisoning between 2008 and 2011, the 
percentage varying by pharmaceutical substance group. In cases where the finding was a beta blocker, an 
anti-depressant, an anti-psychotic medication or a sleeping medication, the percentage of suicides was 
higher. Only one out of four deaths from opioid poisoning was a suicide, and these tended to involve 
codein and tramadol. Buprenorphin is commonly abused, but deaths from buprenorphin poisoning are 
rarely suicides; in 2008 and 2009, none of them were. 
Table 6.  Drug findings in forensic toxicology investigations of cause of death, 2006–2010.* 
  2006 2007 2008 2009 2010 
Heroin  2 (2) 1 (1) 3 (3) 3 (3) 2 (1) 
Buprenorphine  88 (28) 97 (35) 104 (34) 111 (34) 156 (46) 
Cannabinoids  99 94 93 119 116 
Amphetamines  64 (10) 94 (9) 73 (9) 94 (12) 113 (10) 
Methadone  21 (3) 26 (16) 33 (16) 34 (18) 34 (15) 
Cocaine  1 (0) 3 (0) 3 (0) 4 (0) 4 (1) 
Gamma  6 (5) 2 (1) 1 (1) 11 (6) 3 (2) 
Total  191 234 248 256 304 
* The number in parentheses is the number of cases where the substance was the principal finding in a case of 
death from poisoning. The data on intoxicant use of pharmaceuticals are derived from background information 
provided by a forensic physician or from the death certificate.  
** Gammahydroxybutyrate or similar lactone.  
*** Includes other pharmaceuticals used as intoxicants besides the ones listed. 
Source: Vuori et al. 2012.  
Nordic study on drug-related deaths in 2007, Finnish component 
A Nordic research team reviewed all of the positive drug findings for 2007 in attempting to describe what 
Nordic drug-related deaths are like and what the substances are that cause them and in what proportion.55 In 
the case of Finland, the findings showed that the number of drug-related deaths per 100,000 inhabitants in 
2007 was 4.02. In the Nordic countries in general, the place of death was in the capital city area in 29% to 
35% of the cases in 2007, while the corresponding figure in 1991 had been between 53% and 75%. In 
Finland, about 15% of those who died from drugs in 2007 were women. The largest number of fatalities 
                                                        
 
 
55This was the fifth study of this kind conducted in the Nordic countries over the past 23 years. The material for the study was obtained from 
forensic autopsies and toxicology analyses in the five Nordic countries (Finland, Sweden, Norway, Denmark, Iceland). These data were 
compared to similar data from 1991, 1997 and 2002. For the purposes of the study, a ‘drug user’ was someone who, according to police 
records or an autopsy report, had been using substances listed in Schedule I or Schedule II of the UN Single Convention on Narcotic Drugs 
(1961) or in Schedule III or Schedule IV of the UN Convention on Psychotropic Substances (1971). The causes of death determined the 
principal toxic agent and, in cases involving polydrug use, the substance with the highest levels, being most probably the substance that 
caused death.  
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was found in the 25 to 29 age group. The average age of persons dying from drugs in Finland increased 
from 2002 to 2007. The number of fatalities in the 20 to 29 and the 25 to 34 age groups also increased. 
(Simonsen et al. 2011.) 
Considered by drug classification, class I substances such as cocaine, fentanyl, heroin/morphine, 
ketobemidone, methadone, oxycodone, etc., caused 40% of all drug-related deaths. Of class II substances 
(amphetamine, methamphetamine, MDMA, etc.), amphetamine in particular caused a number of deaths 
(7%). The number of fatalities from heroin and morphine had dropped to almost nil by 2007. On the other 
hand, Finland had higher percentages than any other Nordic country of fatalities caused by class III 
substances (benzodiazepine, buprenorphine, meprobamate, zolpidem, etc.) (35%) and by class IV 
substances (other drugs and poisons, including ethanol and carbon monoxide) (17%). The drug most 
commonly found was buprenorphine, and drug-related deaths ascribed to buprenorphine increased from 16 
cases in 2002 to 32 cases in 2007, accounting at that point for 25% of all drug-related deaths. Methadone 
fatalities were not previously analysed in the statistics, but in 2007 methadone was listed as the cause of 
death in 16 cases. This indicates that the methadone used in opioid substitution treatment is finding its way 
onto the illegal market. Tramadol fatalities increased from 9 cases in 2002 to 14 cases in 2007. Combined 
use was common in all the Nordic countries; in Finland, a typical scenario was using ethanol and several (5 
on average) other substances simultaneously. (Simonsen et al. 2011.) 
Study on drug-related deaths  
Mikko Piispa categorised the causes of drug-related death as drug addiction, going crazy and self-
medication. Piispa considered that in about half of the cases of drug-related death the deceased can be 
considered to have been actual drug addicts, characterised by compulsive use and diagnosed with intoxicant 
addiction, for instance. The subjects in these cases were over 20 years of age. In the ‘going crazy’ category 
were subjects aged 15 to 30 whose drug use had not (yet) become compulsive. Self-medication involved 
people who use drugs to alleviate their mental health problems (subjects over the age of 20) or somatic 
illnesses (subjects over the age of 30). Several of these actually had prescribed medication but used other 
drugs too. (Piispa 2010.) 
In 2007, one in six (17%) of all deaths of young adults (aged 15 to 34) were drug-related. Accidental 
poisoning from drug use or polydrug use accounted for about one in ten (8% to 11%)56 of all deaths of 
persons aged 15 to 34. The most significant causes of death in this age group in 2007 were disease (29%), 
suicide (27%) and road traffic accidents (17%). By contrast, alcohol poisoning accounted for only 3% of 
deaths in this age group. In examining the larger age group of 15 to 44, we find that drugs were involved in 
11% of all deaths, accidental drug poisoning being the cause of death in 5% to 7% of cases.57 
A study by Piispa58 on drug-related deaths in 2007 explored the backgrounds of and events leading to 
these deaths, the contributing substances and how they were used. The study clearly shows how common 
polydrug use is, how risk-prone and inexperienced young drug users are, how pharmaceuticals are used for 
intoxication and how mental health problems are relevant in this context. Ignorance of the dangers of 
combined use was particularly apparent in cases of opioid, benzodiazepine and alcohol use among young 
people. (Piispa 2010.) 
                                                        
 
 
56 The figure is 8% according to the National Cause of Death Register maintained by Statistics Finland (2008) and 11% according to Salasuo 
et al. (2009). 
57 The figure is 5% according to the National Cause of Death Register maintained by Statistics Finland (2008) and 7% according to Salasuo 
et al. (2009). 
58 The study material consisted of the cause of death documents for 2007 where traces of drugs were found in the deceased in a forensic 
autopsy. The research approach was material-oriented qualitative research as per Glaser & Strauss 1967 and Charmaz 2006. 
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Driving while intoxicated in Finland 1977–2007 
According to a register study,59 driving while intoxicated seems to have become more common, as over the 
past three decades the number of cases of driving while intoxicated reported to the police has multiplied by 
a factor of 18. The most common substances found in the blood and urine samples of intoxicated drivers 
were benzodiazepines and amphetamines. Polydrug use was also very common. (Karjalainen 2011.) 
An exploration of the social background of intoxicated drivers showed that being socially disadvantaged 
correlated with driving while intoxicated.60 Because being socially disadvantaged correlates with substance 
abuse more generally, narrowing the gaps between socio-economic groups would be beneficial both in 
reducing and preventing drug use in general and in curbing driving while intoxicated in particular. 
Intoxicant use is often begun at an early age, and the majority of intoxicated drivers are young; therefore 
substance abuse prevention and early intervention with young people are crucially important. (Karjalainen 
2011.) 
A study61 shows that over a five-year monitoring period mortality among persons suspected of driving 
while intoxicated was almost ten times higher than among sober drivers. A particularly high risk – 15 to 25 
times that of the general population – was noted among those suspected of driving while intoxicated who 
were found to have been using two or more intoxicants simultaneously on the occasion of their first offence 
(drugs / pharmaceuticals impairing driving ability / alcohol). The most common causes of death among 
those suspected of driving while intoxicated were suicide, accidental overdose of drugs or pharmaceuticals 
and alcohol-related diseases or accidental alcohol poisoning. Two thirds of those who were killed driving 
while intoxicated were intoxicated at the time of their death, as opposed to one fifth of the control 
population. The significance of intoxication as a contributing cause of death was elevated in cases where 
the primary cause of death was a traffic accident or homicide. (Karjalainen 2011.) 
The widespread use of benzodiazepines among those suspected of driving while intoxicated was one of 
the key findings of the study. The study showed that benzodiazepine users had a higher risk of premature 
death than amphetamine users and that combined use of benzodiazepines and other drugs or alcohol was 
very common. Although it was not recorded why the drivers had taken benzodiazepines, it seems likely that 
most cases involved substance abuse; therefore more attention should be paid to the intoxicant use of legal 
pharmaceuticals. (Karjalainen 2011.) 
The study also showed that polydrug use was common in cases of suspected driving while intoxicated. 
It was considered important for intoxicated drivers to be referred to treatment and rehabilitation as an 
alternative to being convicted and sentenced, because being caught for driving while intoxicated would be a 
good opportunity for reaching out to substance abusers and referring them to treatment. (Karjalainen 2011.) 
                                                        
 
 
59 The study concerned cases between 1977 and 2007 of drivers apprehended by the police and suspected of driving while intoxicated (total 
number of suspects during the period: 31,963). 
60 The social backgrounds of persons suspected by the police of drinking while intoxicated, between 1993 and 2006 (n=5,859), were 
compared to those of a control group representing a balanced sample of the population (n=74,809). The relevance of social background 
factors as predictors of driving while intoxicated was evaluated using logistical regression.  
61 The study included drivers apprehended by the police and suspected of driving while intoxicated, between 1993 and 2006 (n=5,832); their 
mortality was compared against the mortality of the Finnish population in general. The mortality was assessed using the Kaplan-Meier 
method and Cox regression. 
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7 Responses to health correlates and 
consequences 
The best-known ways of reducing drug-related harm are health counselling, medical substitution treatment 
programmes and needle and syringe exchange programmes for intravenous drug users. Distributing 
information about safe use and providing peer support are also at the core of substance abuse work for 
harm reduction. Users are informed about correct dosages to avoid overdoses, and the importance of calling 
the rescue services immediately in an emergency is highlighted. The issue is also dealt with in drug 
treatment units with users, when necessary. The prevention of drug-related deaths is carried out as part of 
health counselling related to infectious diseases and in problem user peer group activities. Some training 
concerning the prevention of drug-related deaths is provided as part of basic training in social welfare and 
health care. 
Low-threshold services in particular have been essential in preventing and reducing infectious diseases 
spread by intravenous drug use. There are separate health and social security counselling centres for drug 
users at about 35 locations in Finland. 
According to the quality recommendations for substance abuse services, substance abusers with serious 
mental health problems tend to fall through the cracks between substance abuse services and mental health 
services in the present service system. The quality recommendations stipulate that a client should primarily 
be provided with help at that social welfare or health care unit at which he/she seeks help. Municipalities 
must also have a clearly agreed division of duties in substance abuse services. In particular, the principal 
responsibility for treatment of substance abusers with mental health problems must be defined. 
The health counselling centre concept has proved to be a good way to make contact with drug users. 
The guidance and advice provided at health counselling centres is driven by clients’ needs. Goals are set 
according to clients’ wishes and abilities. The primary goal is to prevent the transmission of infectious 
diseases through intravenous drug use by encouraging users to employ practices as hygienic as possible. If 
a client expresses a desire to cut down or quit drug use, various alternatives for attaining this goal will be 
discussed. Information collected anonymously indicates that the health counselling centres had some 
11,500 clients in 2011. There were about 85,000 visits recorded, and 309 syringes and needles per client 
were exchanged on average. The most visits were to the health counselling centres in Helsinki (about 
8,350), Vantaa (about 900), Turku (about 890), Espoo (about 825) and Tampere (about 568). 
The treatment and prevention of infectious diseases related to drug use is provided within primary 
health care services, specialised services within health care and substance abuse services, health 
counselling centres and pharmacies that sell syringes and needles. HIV infected patients are treated at 
university hospitals and at central, regional and psychiatric hospitals in the area. Under the Communicable 
Disease Decree of 2003, municipalities must, within their health centres’ operating areas, conduct 
prevention work against infectious diseases, including the dissemination of information on infectious 
diseases and health counselling. The scope of the Act encompasses health counselling for intravenous drug 
users, and exchanging syringes and needles where necessary. Free hepatitis A and B vaccinations have 
been included in the vaccination programme for intravenous drug users. Pharmacies play an important role 
in exchanging syringes and needles in areas where there are no health counselling centres. 
In 2011, 3.5 million items of injection equipment were exchanged at health counselling centres.62 The 
most recent survey on needles and syringes sold at pharmacies was conducted in 2003. At that time, 
pharmacies sold 600,000 needles/syringes per year. 
                                                        
 
 
62 Needles and syringes.  
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The websites of the health and social security counselling centres63 provide information on their 
location, on harm reduction, on field work and on peer support activities. The websites also give access to a 
materials databank with information for instance on infectious diseases, various drugs, health counselling, 
sexual health and first aid in an overdose emergency. (A Clinic Foundation 2012.) 
 
7.1 Prevention of drug-related emergencies and reduction of drug-
 related deaths 
Information for drug users on what to do in an emergency situation and how to prevent death from 
overdoses is provided in connection with all health counselling. However, the increase of drug-related 
deaths has also been taken into account by the authorities,64 and there is concern about the combined use of 
opioids, benzodiazepines and alcohol, which was evident in the findings of a study65 published in spring 
2011. Combined use seemed to be a central part of the drug culture of the disadvantaged in Helsinki. 
Combined use of opioids, benzodiazepines and/or alcohol is the cause of a significant percentage of drug-
related deaths in Finland. The study concluded that users should be informed of the risks of combined use 
to prevent drug-related deaths. Also, attention should be paid to intoxicant use of pharmaceuticals and the 
development of prescription practices to curb such use should be explored. (Tammi et al. 2011.) 
Information on drugs is available on a 24/7 basis from third-sector helplines, for instance. Helplines are 
anonymous and free of charge for the caller. Information on drugs and the risks related to drug use is also 
distributed by the A Clinic Foundation, the Life is the Best Drug association and the rapid drug 
communications ring NOPSA maintained by the Deaconess Institute in Helsinki. NOPSA communicates 
with various target groups as needed. NOSA publishes information on the Päihdelinkki and Vinkki websites 
(www.paihdelinkki.fi, www.vinkki.info), uses the Mobiilivinkki® SMS service (free number 18182) and 
drafts press bulletins. (A Clinic Foundation 2012.) 
Janne Liisanantti studied the prognosis of a patient with acute pharmaceutical poisoning and factors 
affecting the prognosis in his doctoral dissertation. His specific focus was on risk factors for prolonged 
treatment periods and repeated treatment periods and on long-term prognoses for patients with poisoning. 66 
(Liisanantti 2012.) 
For acute pharmaceutical poisoning treated in hospital, the prognosis was good; even patients requiring 
intensive care only required a short treatment period in hospital. Mortality during the treatment period was 
1.6% to 2.3% for patients requiring intensive care. In complicated cases of poisoning requiring intensive 
care, aspiration pneumonia caused by the inhalation of stomach contents was found to be a common 
complication, leading to an extended period of intensive care. Securing the airways by intubation prior to 
admission to hospital reduced the risk of aspiration pneumonia. Other risk factors for prolonging intensive 
care included respiratory failure, kidney failure and low blood platelet count on admission. (Liisanantti 
2012.) 
Both young and adult patients were found to have quite a lot of repeat visits because of poisonings (7% 
to 21%). Young people in particular logged repeat visits, as occurrences of poisoning are associated with 
impulsive behaviour in their case. In a long-term follow-up covering 14 years on average, 30.4% of patients 
hospitalised for poisoning died. The percentage in the control group, controlled for age and gender, was 
                                                        
 
 
63 Website (in Finnish): http://toimipaikka.a-klinikka.fi/vinkki/. 
64 Measures include publications on drug-related deaths; a seminar on drug deaths organised by the Ministry of Social Affairs and Health in 
2008; and a seminar on work to reduce drug-related harm, organised by the Deaconess Institute of Helsinki in May 2011.  
65 In this study, 100 drug users in Helsinki were interviewed concerning which drugs they use, how they use them and how they obtain them; 
a European structured interview was used, translated into Finnish. This study formed part of the Second Multi-City Study on Quantities and 
Financing of Illicit Drug Consumption, or Quaf2. (Tammi et al. 2011.)  
66 The study domain consisted of patients with pharmaceutical poisoning treated at Oulu University Hospital between 1985 and 2006, and 
patients with pharmaceutical poisoning treated at Finnish intensive care units between 1998 and 2004. 
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13.6%. Patients with poisoning commonly died from cardiovascular disease. Injuries, poisonings and 
suicides were also more common in the study domain than in the control group. (Liisanantti 2012.) 
The study indicated that patients with acute poisoning have a good prognosis while they are in hospital 
but that their long-term mortality rate is more than twice that of the control group. Respiratory disorders in 
particular are risk factors for prolonging treatment periods. Mortality from preventable causes such as 
suicide and cardiovascular disease was notably high in the long-term follow-up. (Liisanantti 2012.) 
 
7.2 Prevention and treatment of drug-related infectious diseases 
Almost two out of three (64%) of the drug user clients of substance abuse services had at some time in their 
lives taken all three tests: HIV, hepatitis B and hepatitis C. About 2% of the drug user clients of substance 
abuse services67 who had at some time used drugs intravenously were HIV positive, while 75% tested 
positive for hepatitis C, 3% for hepatitis A and about 5% for hepatitis B. Based on the data available in the 
drug treatment information system, of those drug treatment clients who had used drugs intravenously at 
some point in their lives, more than half (52%) had received at least one of the vaccine doses for hepatitis B. 
A total of 39% had received all three vaccine doses.68 (Forsell 2012a.) 
Health counselling centres offer exchange of syringes and needles and also provide counselling on 
health issues, small-scale health care, testing and vaccination services and case management. Health 
counselling centre services are provided in all municipalities with more than 100,000 inhabitants and, 
overall, at more than 35 locations. Many counselling centres offer anonymous instant HIV tests free of 
charge. The user’s family members and acquaintances may visit the counselling centre too if they wish. 
Some health counselling centres undertake field work. The purpose of field work is to reach substance 
abusers not normally reached by the service system and to make services available to them. 
 
Table 7. Activities of health counselling centres 2001–2011. ? ? ?
  2001 2003 2005 2007 2009 2010 2011 
Health counselling centres 18 24 ~26 <30 <30 <30 <30 
Clients 8,400 9,300 11,800 12,600 13,291 14,193 11,432 
Visits 44,500 70,600 80,500 90,000 79,735 83,450 84,586 
Needles and syringes per client 113 150 161 190 233 242 309 
Exchanged syringes or needles 950,500 
1.4 
million 
1.8 
million 
2.4 
million 
3.1 
million 
3.4 
million 
3.5 
million  
Source: THL 2012.  ? ? ? ? ? ? ?
 
According to an evaluation study, the services of health counselling centres have played a central role in 
the prevention of HIV, hepatitis A and B and, to some extent, hepatitis C, as well as in combating 
epidemics among intravenous drug users and therefore indirectly in the population at large. The ambitious 
objectives set for the HIV infection situation have been attained, namely stopping the epidemic and 
bringing the annual number of new cases below 30. The health counselling centre model has proven to be a 
very cost-effective health intervention, and safeguarding its continuation and further development is very 
important. (Arponen et al. 2008.) 
                                                        
 
 
67 Self-notified testing and result (n=1,583). 
68 These percentages are lower than in the previous year’s report, because they have been calculated from figures that include the missing 
data (18%–30%). 
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7.3 Study on the social management of the drug problem in Finland 
In her doctoral dissertation, Riikka Perälä studied policy and practices for reducing drug-related harm. 69 
The study points out that when working with drug users, better attention should be paid in the future to the 
concrete consequences of the multiple problems associated with drug use, such as a compulsive pace of life 
resulting from attempts to control problems and the emotional stress caused by drug use. (Perälä 2012.) 
The study showed that drug users try to put their life back on track in a number of ways: by seeking 
training, by trying to find accommodation or a place to stay the night, to enter treatment or to gain various 
benefits. Obtaining drugs involves routines of its own, and drug users describe these as very similar to 
work. Many drug users would like to have help in life management. (Perälä 2012.) 
Drug users considered that the ways in which the service systems try to help them are problematic. 
Many users had tried to seek help for their problems through services and treatment but had been 
discouraged by the bureaucracy and chilly attitudes they had encountered. Perälä notes that the human 
interaction dimension of treatment has been neglected in the discussion on how to develop substance abuse 
services, and during the period examined only the practices of the harm-reduction policy seemed to have 
succeeded in achieving a client-oriented approach in providing services. Drug users felt that they were 
treated like human beings at the health counselling centres, which they said was in itself a remarkable 
improvement over other services. (Perälä 2012.) 
According to Perälä, the Finnish harm-reduction policy has successfully incorporated prevention of the 
harmful social and health impacts related to drug use, and efforts should be made to retain this feature of 
the policy. In Finland, harm reduction and treatment are not considered separate disciplines. Referral to 
services is a key component of harm reduction in Finland, and service professionals also emphasised the 
importance of treatment as the principal means for controlling drug problems. (Perälä 2012.) 
 
                                                        
 
 
69 The material for the study was collected at one health counselling centre in southern Finland between 2003 
and 2007 using an ethnographic research method. The material mostly consisted of observation notes and 
themed interviews with employees and clients.  
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8 Social correlates and social 
reintegration 
The results of the drug treatment information system revealed the same facts as many other studies on the risk 
behaviours, substitution treatment and HIV infections of problem drug users: they have more social problems 
than the general population. About two thirds of drug treatment clients are unemployed and approximately one 
tenth are homeless, and clients have a low level of education. 
Multi-professional co-operation between authorities has been emphasised in after-care adjustment 
activities. Drug problem users are often socially excluded and disadvantaged, and their social support 
network is oriented in drug user culture. Treatment and rehabilitation are required to take a comprehensive, 
long-term approach with concrete help. This includes social rehabilitation, employment and supported 
housing services. The education authorities are also involved; the planning of education and vocational 
guidance are automatically included in the treatment of young people. 
The Finnish Constitution guarantees citizens universal rights to basic services. The Social Welfare Act 
is binding upon Finnish local authorities, stipulating the statutory duties that must be carried out at the 
municipal level. The Social Welfare Act provides for social services, income support, granting social 
credit, social security benefits and guidance and advisory services for their use, development of social 
conditions and elimination of social problems. (Ministry of Social Affairs and Health 2011c.) Universal 
basic services are complemented by special services for specific groups, such as substance abuse services 
and child welfare services. Preventive child welfare work is undertaken in family services, but also in 
substance abuse services for adult users, by investigating whether children involved have a need for care 
and support. 
 
8.1 Social exclusion and drug use  
The drug information system provides information annually on the socio-demographic situation of drug 
treatment clients and reveals that the situation has remained surprisingly unchanged for years. The clients’ 
educational attainment was low, and most of them were unemployed (61%). One out of ten clients (10%) 
was homeless, although only 5% of substitution treatment clients were homeless, while the figure among 
other opiate problem users was 13%. This is probably due to two causes: the effectiveness of substitution 
treatment and the ‘apartment first’ principle. Of the clients, 22% of the men and 39% of the women were 
married or cohabiting. Of those who were married or cohabiting, 69% had another problem substance user 
in the same household, women more commonly (79%) than men (41%). Children under the age of 18 were 
reported by 39% of the clients. Only 29% of the parents lived in the same household with their child or 
children, and 25% had had their children placed in care by child welfare services. Of the clients under the 
age of 20, half (52%) were still living with their parents. (Forsell 2012a.) 
 
8.2 Social rehabilitation 
The purpose of social rehabilitation is to support the re-entry into society of persons severely affected by 
social exclusion through enhancement of their social functional capacity and their ability for social 
interaction. According to the Act on rehabilitative employment activities (189/2001), such activities are 
meant for the long-term unemployed, in order to improve their possibilities of finding employment. The 
Act obliges municipalities and employment offices to co-operate in providing client-specific service 
packages. However, it is not expedient to start rehabilitative employment activities if the client has an acute 
substance abuse problem; instead, the client should be directed primarily to substance abuse services. 
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Social work is aimed at strengthening the resources of citizens who need help and to support the self-
reliance and coping of individuals, families and communities. The goal is to prevent social exclusion and to 
resolve social problems, thereby maintaining and promoting the wellbeing and social safety of citizens and 
communities. 
In individual social work, social workers guide and counsel their clients, work through their problems 
with them and organise other support measures through official networks to maintain and improve the 
safety and coping of the individual and the family. 
Community work is for preventing the emergence of social problems in communities and for 
reinforcing potential for involvement and participation of residents in the development of their 
communities. In community work, social workers and other social welfare professionals help individuals 
and groups contribute to the wellbeing of their communities and to network with community members, 
officials in various administrative sectors, NGOs and other parties. (Ministry of Social Affairs and Health 
2011d.) 
Homelessness and the programme to reduce long-term homelessness 
In 2011, there were about 7,400 homeless people in Finland, about 7,000 of them single. Some 4,000 of 
them live in the Greater Helsinki area. There are some 350 homeless families, more than half of them in 
Helsinki. Substance problem users are a risk group for homelessness. 
In Finland, financially supported housing for substance abusers can be arranged within municipal social 
services. Housing service units for substance abusers form part of the Finnish substance abuse services. 
They are intended for substance abusers who need daily support for independent living. 
The Ministry of the Environment’s programme to reduce long-term homelessness 2008–2011 will be 
continued in the period 2012–2015 as outlined in the Government Programme. The purpose of the 
programme is to eliminate long-term homelessness by 2015, to reduce the risk of long-term homelessness 
by boosting the use of social rented housing for reducing homelessness and by enhancing measures to 
prevent people from becoming homeless in the first place. By 2015, some 1,000 apartments, supported 
housing apartments or treatment beds for the long-term homeless will be assigned in the Greater Helsinki 
area – 750 in Helsinki and 250 in Espoo and Vantaa combined. The aim is similarly to create at least 250 
apartments, supported housing apartments or treatment beds in Tampere, Turku, Lahti, Kuopio, Joensuu, 
Oulu and Jyväskylä by 2015. 
Social guarantee for young people 
Under the Government Programme 2012–2015, the aim is to provide everyone under the age of 25 and all 
new graduates under the age of 30 with a job or traineeship or a placement in studies, workshops or 
rehabilitation within three months of becoming unemployed. To this end, a working group was appointed in 
autumn 2011 to prepare a proposal for what is known as the social guarantee for young people. 
Implementation will begin in 2012, and the policy will be fully in place at the beginning of 2013. Exclusion 
of young people from working life will be prevented through a variety of measures by the employment and 
economic development authorities. Despite previous such measures, youth unemployment remains high. 
According to employment exchange statistics, there were 54,600 unemployed jobseekers under the age of 
29 in August 2011, of whom 30,300 were under the age of 25. About one third of them have only 
completed comprehensive school. Nearly half of these unemployed persons have a vocational qualification 
or a bachelor’s degree yet cannot find a job. 
The training guarantee will form part of the social guarantee for young people. Everyone completing 
comprehensive school will be guaranteed a further placement at an upper secondary school, in vocational 
education, in apprenticeship training, at a workshop, in rehabilitation or elsewhere. Comprehensive 
education lays the groundwork for the employment of young people. However, just completing 
comprehensive school is not enough; a secondary-level qualification is in practice a necessity for finding 
employment or for entering further studies. Some young people drop out at every stage of the education 
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and training system. Some do not study further at all after comprehensive school, and some of those who 
do never complete a qualification. The result is that there are some 100,000 young adults (aged 25 to 34) in 
Finland who have no post-comprehensive qualification or degree of any kind. 
Outreach youth work is intended for helping young adults under the age of 29 who are beyond the reach 
of training or the labour market. They need support in order to make use of the public-sector services 
available to them. In 2011, 223 local authorities are receiving a government grant for hiring 270 outreach 
youth workers. This covers 70% of Finland’s municipalities. In 2010, outreach youth work contacted nearly 
11,000 young people; 22% of them said they were unemployed even though they had not registered as 
jobseekers. 
Implementing the social guarantee for young people requires broad-based cooperation between public 
actors. The Ministry of Social Affairs and Health stresses the importance of proactive prevention of social 
exclusion, early detection of problems and support for solving them. When a child’s growth process is 
secured, he/she can grow up into a young person with a firm hold on training and on working life. During 
the current term of government, the Ministry of Social Affairs and Health is coordinating a programme to 
reduce poverty and social exclusion; this is also closely connected with the implementation of the social 
guarantee for young people. 
The Government has set aside an annual appropriation of EUR 60 million for implementing the social 
guarantee. The first report of the working group presents solutions for allocating these funds and other 
proposals for implementing the social guarantee. With these solutions, implementation of the social 
guarantee for young people may begin in 2013. 
The working group divided the task into two parts. Firstly, it must be ensured that the service network 
works as it should with regard to young people entering the sphere of the social guarantee. The aim is to 
create a system where all young people have a realistic chance of finding employment, training or other 
activities. These measures will create a situation where the number of young people who are socially 
excluded or at risk of social exclusion will no longer be increased by younger age groups. 
Another focus area is to take care of the 110,000 young people who have no post-comprehensive 
education and who are thus at risk of social exclusion. Bringing them onto a stable employment path will 
be effected by increasing the supply of training so that by 2016 a ‘normal situation’ will have been attained: 
the youth service network is working and there is no longer an extensive number of young adults 
marginalised from society. This, however, cannot be achieved with the EUR 60 million per year reserved 
for implementing the social guarantee. 
Cultural added value to preventing drug use  
In August 2011, Finland organised a Nordic drug forum in Helsinki with topics including the prevention of 
drug use and social exclusion through cultural efforts. It was proposed at the meeting that cross-sectoral 
efforts between the cultural, health care and wellbeing services must be supported and that culture must be 
incorporated into the routines of the social welfare and health care services. 
In 2008, the Finnish Cultural Foundation launched the Myrsky (Storm) project to strengthen the 
wellbeing and the social and mental growth of young people by bringing art and culture into their lives. 
Another aim was to introduce young people to new forms of arts activities. Myrsky was principally aimed 
at adolescents aged 13 to 17, who are difficult to reach with traditional means. In the project, adolescents 
engaged in a variety of arts events under the guidance of professional artists. All adolescents were eligible, 
but particular attention was paid to those threatened by social exclusion. Some of the arts events were 
aimed at immigrants, mental health rehabilitees and institutionalised young people. Over a period of three 
years, more than 14,000 young people have had the opportunity to create art on their own terms. The 
Myrsky evaluation study shows that such activities strengthen the wellbeing of young people: arts activities 
make young people more content and happier with their lives while improving their social skills and 
capabilities. Art also boosts social participation among young people. 
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Social disadvantage as described in research 
Being socially disadvantaged and being likely to turn to crime show a positive correlation: the weaker a 
family’s financial standing is, the more likely it is that an adolescent in that family has committed criminal 
offences and been subject to violence. A survey among Finnish-speaking pupils in the 9th grade of 
comprehensive school (aged 15–16)70 showed that the probability of experimenting with cannabis is the 
higher the worse off the family is. Of the young people who described the financial situation of their family 
as very good, only 5% reported that they had used cannabis during the current year. Similarly, of the young 
people who described the financial situation of their family as extremely poor, 14% reported that they had 
used cannabis during the current year. Cannabis use was also the more probable the less support and 
control the young person’s parents provided (4% of young people under strong control, 9% of those under 
weak control). (Kivivuori et al. 2009.) 
Finnish studies have shown that the majority of young people who commit homicide have similar 
family backgrounds (instability, lack of care, intoxicant abuse, domestic violence), an early history of 
disruptive behaviour (learning problems and behavioural problems at school, petty crimes) and problem use 
of intoxicants begun at a young age. Half of all young offenders who have committed a homicide have been 
diagnosed as drug users in the psychological evaluation following the offence. For a significant percentage 
of them, the parents or at least one of them had a history of problem use of alcohol. (Kivivuori et al. 2009.) 
Young people who receive a suspended sentence for a narcotics offence have a high risk of recidivism. 
The study showed that the social ties, use of time and cognition of young probationers influenced the risk 
of recidivism the more the poorer their education, housing situation and work or study situation was. 
Obvious or worrying drug use was found in 11% of probationers, and slight or occasional use in 14%. 
Problem users of drugs were subjected to somewhat more effective surveillance during their suspended 
sentence than other probationers. The more severe the probationer’s drug problem was considered, the 
more the probation focused on that particular problem. (Harrikari 2010.) 
In a study of short-term prisoners, the most unfortunate were those young prisoners who had begun their 
criminal careers in their childhood or youth. They were the most active as criminals in adulthood too, and 
they used more alcohol and drugs and began earlier than others. They were also the least confident of 
finding legal paid employment after their release. (Kivivuori & Linderborg 2009.) 
 
                                                        
 
 
70 In 2008, 5,826 young people responded to a questionnaire about self-declared crime. The sample space consisted of all pupils in the ninth 
grade (aged 15 to 16) in Finnish-language schools in Finland. The National Research Institute of Legal Policy conducts a survey on youth 
crime at regular intervals. The questionnaire contains questions regarding 21 forbidden or criminal acts. For each, the respondents are asked 
whether they have ever committed such an act in their lives, and if so, whether they have committed that act less than one year prior to the 
survey. 
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9 Drug-related crime, its prevention 
and drug use in prisons 
9.1 Drug-related crime 
Documented drug-related crime surged in the 1990s. Crime accompanying drug use, such as crime against 
property and driving under the influence of drugs, also increased in the 1990s. This growth levelled off after 
2000. The statistical increase in cases of driving while intoxicated was boosted by the zero tolerance 
approach with regard to drugs and driving, adopted in 2003. In the past few years, documented drug-related 
crime has again been on the increase. In 2011, more than 20,000 drug-related offences were recorded. The 
number of drug-related offences has increased each year. In 2008, the statistics only showed the offences 
reported to the police, but as of 2009 Statistics Finland changed its information base to include offences 
investigated by the Customs as well. This change may in fact explain part of the growth in the number of crimes, 
as it is observed later in the report that no corresponding growth in sanctions for drug-related crimes was found. 
(Kainulainen 2012a.) 
According to the police, Finnish professional crime has typically been loosely structured, but is now 
closing ranks and becoming more disciplined. Major drug-related crimes investigated in Finland clearly 
show that the drug trade is professional and largely handled by organised crime groups. Criminal 
motorcycle gangs in particular hold a strong position in the drug trade in Finland and have close and 
functioning relations to groups abroad, particularly organised crime in Estonia. The prominent role played 
by organised crime groups in Finnish drug crime can be seen, for instance, in the more frequent presence of 
weapons, particularly gas sprays, as well as in the larger amounts of cash seized in the context of narcotics 
offences. Organised criminal groups have extended their domain from the traditional drug trade and 
property crime to financial crime and fraud, as organised crime seeks to generate rapid profits and increase 
its influence in the legal economy and in society at large. (National Bureau of Investigation 2012.) 
In 2011, the number of seizures of cannabis products in Finland was, once more, higher than ever, 
according to statistics compiled by the police and Customs. The amount of hashish seized was the highest 
ever, and the amount of marijuana seized was the second highest per year on record. The number of 
cannabis plants seized (about 16,400) was also higher than ever in 2011. The number of seized cannabis 
plants doubled from 2007, which was probably due to the increased popularity of home growing and the 
fact that seeds are easy to buy over the Internet, and also due to the authorities becoming more effective at 
combating home growing. Home growing is still a minor activity in Finland, but the cases discovered have 
shown that cultivation is becoming more professional. A number of expertly set up cultivation facilities 
with more than 500 plants have been discovered in Finland. In Finland as elsewhere in Europe, criminal 
motorcycle gangs have taken up cultivation of cannabis. (National Bureau of Investigation 2012.) 
A worrying amount of new designer drugs continue to be found on the market. Designer drugs are a 
new threat that has joined the ranks of outlawed narcotics. Designer drugs may be lethal, as the substances 
used and their levels in new drugs vary greatly, and there is no past user experience to rely on. Users also 
order batches of designer drugs for their own use over the Internet, as is shown by the considerable increase 
in the number of parcels containing designer drugs sent by post. Designer drugs have cut into the market 
share of other drugs, including amphetamine, seizures of which in 2011 were considerably less than in 
previous years. The percentage of methamphetamine on the amphetamine market and in the seizure 
statistics of the authorities has clearly increased. The volumes of seizures of narcotic pharmaceuticals have 
also been on the increase in recent years. (National Bureau of Investigation 2012.) 
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Narcotics offences 
In 2011, some 12,100 cases of unlawful use of narcotics were recorded, about 59% of all documented drug-
related crime. There were about 7,200 cases of basic narcotics offences (35%). One of the factors explaining the 
increase in narcotics offences is that home growing of cannabis is becoming more popular. There were about 
1,000 cases of aggravated narcotics offences in 2011, about 5% of all narcotics offences and slightly fewer than 
in 2010. This was, however, the second largest annual total over the past ten years. Preparation or abetting of 
narcotics offences appears only rarely as a documented offence. (Statistics Finland 2012; National Bureau of 
Investigation 2012.) 
The police and the other PTR authorities71 have stepped up their combating of serious crime. The focus 
in investigating drug-related crime is on the recovery of criminal gains, which has resulted in a weakening 
of the operating potential of drug-related crime. 
Table 8.  Drug-related crime reported to the police in 2004 and 2007–2008, and drug-related 
 crime reported to the police, Customs and Border Guard in 2009–2011.* 
2004  2007  2008  2009  2010 2011 
Narcotics offences total 14,486 15,448 15,482 18,524 19,724 20,394 
Narcotics offence 4,672 4,206 4,835 6,274 6,444 7,226 
Unlawful use of narcotics 9,217 10,333 9,823 11,257 12,158 12,093 
Aggravated narcotics offence 582 883 789 922 1,083 1,036 
Preparation or abetment of 
narcotics offences 
15 26 35 71 39 39 
*The compilation of statistics changed as of 2009. The statistics for 2009–2011 include crimes reported to the Customs and 
Border Guard. This accounts for a 5% to 6% increase in the volume of drug-related crime. 
Source: Statistics Finland. 
 
In 2011, there were 20,394 suspects in narcotics offence cases. (Statistics Finland 2012.) Of course, the 
same persons may commit several narcotics offences in the course of a year. In 2011, the police suspected a 
total of 6,197 individual persons of narcotics offences. The number of individual persons suspected of 
aggravated narcotics offences was 687. Compared with 2007, the number of individual persons suspected 
of narcotics offences overall had increased by 42% by 2011, and the number of individual persons 
suspected of aggravated narcotics offences by 28%. (National Bureau of Investigation 2012.) 
Drug-related crime has robust international connections. The percentage of suspects of foreign origin in 
aggravated narcotics offences has increased remarkably in recent years. In 2011, no fewer than 24% of 
people suspected of committing aggravated narcotic offences were foreigners. This figure was 35% in 2010 
and 27% in 2009. The largest groups of suspects were Estonians and Russians/Russians living in Estonia. 
The number of Estonian suspects in particular increased notably in 2010. The nationality distribution of 
suspects has continued to diversify. The people suspected of aggravated narcotics offences in 2011 
included Nigerians but also a growing number of Iraqis, Moroccans, Dutch and Lithuanians. On the Finnish 
market, Finnish criminals generally manage the reception and distribution of drugs in Finland, while 
foreigners are engaged in import and smuggling. (National Bureau of Investigation 2012.) The 
                                                        
 
 
71 PTR is the Finnish acronym for police, Customs and the Border Guard. 
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internationalisation of drug-related crime has brought added challenges particularly to the uncovering and 
pre-trial investigation of aggravated narcotics offences, for instance because of interpreting requirements.  
In 2011, the authorities confiscated about EUR 1.2 million in cash (about EUR 1.1 million in 2010 and 
about EUR 990,000 in 2009) in connection with investigating narcotics and doping offences, which 
illustrates the volume of this area of crime. Other forms of payment such as stolen property are also used in 
the drug trade. (National Bureau of Investigation 2012.) 
Narcotics convictions 
Narcotics offenders are generally sentenced to a fine. In 2010, somewhat over 4,000 offenders were fined 
in summary penal proceedings, as compared with about 4,400 offenders fined in district courts. The total 
number of offenders fined for narcotics offences was about 8,400. Nearly 5,300 offenders were sentenced 
to imprisonment for narcotics offences, more than half of them (n=3,431) to unconditional imprisonment. 
Charges were waived by the prosecutor for about 500 persons, and 50 persons were acquitted by a district 
court. There have been no significant changes in sanction practices in recent years. (Kainulainen 2012b.) 
The usual consequence of unlawful use of narcotics (Penal Code, chapter 50 section 2a) is a summary 
fine, 15 day-fines on average. Between 2006 and 2010, in cases where the unlawful use of narcotics was 
the principal offence the sanction was a fine issued by summary penal order or imposed by a court in 95% 
of the cases. Alternatives to punishment remain a little-used option, but prison sentences are even more 
rare. In 2010, fines were issued by summary penal order in just over 4,000 cases and imposed by a court in 
almost 500 cases, while charges were waived in about 300 cases and punishment was waived in fewer than 
20 cases. (Kainulainen 2012b.) 
Between 2000 and 2010, the average number of day-fines in sanctions imposed for basic narcotics 
offences (Penal Code, chapter 50 section 1) was between 27 and 38. After the amendment regarding the 
unlawful use of narcotics, the average fine increased slightly, as in many cases minor narcotics offences are 
now handled in summary penal proceedings and never brought to court. In 2010, the average fine for a 
narcotics offence was 38 day-fines. (Kainulainen 2012b.) 
Sanctions for narcotics offences (Penal Code, chapter 50 section 1) include prison sentences. If the same 
person is sentenced for several offences at once, the average sanction is usually more severe. In cases 
where only one offence is cited in the sentence, the average sanction for both conditional and unconditional 
imprisonment has been about four months. In 2010, the average sentences for unconditional and 
conditional imprisonment were 3.8 months and 3.9 months, respectively. (Kainulainen 2012b.)  
For aggravated narcotics offences (Penal Code, chapter 50 section 2), the choice of punishment is in 
practice between unconditional and conditional imprisonment. An unconditional prison sentence is generally 
imposed for an aggravated narcotics offence; conditional imprisonment is considerably more rare. The 
average length of unconditional prison sentences has varied over the years; in 2010 it was about 2 years and 7 
months (31.5 months). The average for conditional prison sentences has remained at about 1 year and 3 
months for several years. Sometimes the sentences imposed for aggravated narcotics offences are quite long. 
(Kainulainen 2007; Kainulainen 2012b.) 
Sanction tables are often used for consistency of punishment for narcotics offences. There has been 
inconsistency in sentences imposed by courts for home growing of cannabis. In order to harmonise 
prosecution practices, the narcotics prosecution team has drafted a recommendation to estimate the volume of 
the harvest gained from cannabis plants. The average yield of one plant is estimated at 25 grammes. The 
recommendation notes that a prosecutor could demand imprisonment for growing more than 10 plants and a 
fine if there are fewer plants. (Hakkarainen et al. 2011; Prosecutor General’s Office 10 June 2010.) 
Driving while intoxicated 
In 2010, the total number of cases of driving while intoxicated decreased by 10% on the previous year. 
However, the number of cases involving drugs (3,125) and polydrug use (693) remained steady, and the 
percentage of cases involving alcohol thus decreased. In 2010, the cause of driving while intoxicated was 
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alcohol use in 82% of the cases, drug use in 15%, and polydrug use in 3%. (Statistics Finland 2012.) In 
2011, drugs and pharmaceuticals were tested for in 4,166 cases of driving while intoxicated. The most 
frequently detected substances were benzodiazepines (78%), amphetamines (59%) and cannabis (40%). 
(National Bureau of Investigation 2012.) 
A register study published in 200972 assessed the manifestation of, and trends in, driving under the 
influence of drugs or pharmaceuticals in Finland between 1977 and 2007. During this period, driving under 
the influence of drugs or pharmaceuticals increased by a factor of 18. Of all suspects during the monitoring 
period, a total of 89.6% were men, but the annual percentage of women increased slightly. Women 
accounted for 6.9% of suspects in 1977 and 10.3% in 2007. This trend has statistical significance. The most 
frequently detected substances were benzodiazepines (75.7%), amphetamines (46%), cannabis (27.7%) and 
opioids (13.8%). The most frequent narcotic substances, amphetamines and cannabis, began to appear 
during the late 1980s, and the number of drug use cases began to grow as Finland adopted a zero tolerance 
approach to drugs and driving in 2003. (Ojaniemi et al. 2009.) 
Most (77.1%) of those caught driving while under the influence of drugs tested positive for more than 
one substance. The most common findings in cases of polydrug use were benzodiazepines with alcohol 
(20%) and benzodiazepines with amphetamines (18%). Benzodiazepines were present in the five most 
frequently found combinations. The percentage of polydrug use cases where alcohol was involved have 
decreased during the monitoring period (one fifth of samples in 2007). (Karjalainen et al. 2010.) 
Other drug-related crime 
During recent years, the annual number of robberies involving a break-in in order to obtain narcotic 
pharmaceuticals has remained steady (106). Between 2005 and 2007, however, the number of such 
offences per year was a third lower. The increase in burglaries is probably due to the reduced availability of 
Subutex. (National Bureau of Investigation 2012.) 
In certain categories of crime the perpetrators are intoxicated in a large percentage of cases, but alcohol 
use is far more common than drug use or polydrug use. Out of all cases of all types of assault (assault, petty 
assault and aggravated assault), 56% were committed under the influence of alcohol but only 0.4% under 
the influence of other substances and 1% under the influence of both alcohol and other substances. The 
comparable figures are 31%, 3% and 4% for all robberies; 11%, 2% and 1% for theft offences (petty theft, 
theft, aggravated theft); and 22%, 9% and 3% for stealing a motor vehicle for temporary use. (Statistics 
Finland 2012.) 
Money laundering offences in Finland are mainly associated with drug-related or financial crime. In 
2011, the most common types of offence in data submitted for pre-trial investigation were dishonesty of a 
debtor, narcotics offence and fraud. Between 1994 and 2011, of all the cases where data on suspicious 
business actions were submitted for pre-trial investigation, about half involved financial crime, 9% 
involved narcotics offences and 8% involved money laundering. Money laundering based on corporate 
ownership structures, dealing in receipts and the grey economy undertaken by organised crime groups has 
become more common. In recent years, well above half of all reported cases of money laundering in 
Finland have involved the transborder movement of funds, usually from Finland to abroad. There are 
relatively few professional criminals in Finland specialising in money laundering, which is usually 
undertaken by persons in criminals’ immediate circle of acquaintances. (National Bureau of Investigation 
2012.) 
                                                        
 
 
72 The study was conducted as register-based research, including all cases of driving under the influence of drugs or pharmaceuticals 
(n=31,963) in Finland between 1977 and 2007. All toxicological analyses were conducted on blood and/or urine in the same laboratory 
(alcohol and drug laboratory of the National Institute for Health and Welfare, formerly under the National Public Health Institute). 
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The Financial Intelligence Unit of the National Bureau of Investigation has compiled a report73 on 
Finnish money laundering cases for the period 1994 to 2010. Of the 96 judgments issued, 46 involved a 
narcotics offence as a predicate offence. In the remaining cases, the predicate offence was a financial 
offence. With respect to the rest of the cases, other predicate offences included hormones trade, doping 
offences, alcohol smuggling, bank robbery, appropriation, means of payment fraud, fraud or usury. The 
most common sentence included in the study was conditional imprisonment. Of unconditional prison 
sentences, nearly all were joint sentences involving several offences – chiefly narcotics offences. (National 
Bureau of Investigation 2012.) 
Study on conceptions of habitual crime held by drug users and the police 
Tuula Kekki (2012) conducted a study on conceptions of habitual crime held by drug users and the police, 
exploring habitual crime from the perspective of a criminal lifestyle and identity on the one hand and from 
the perspective of law enforcement on the other. The domain of the study concerned drug users whose use 
is regular and who continuously engage in criminal activities.74 (Kekki 2012.) 
The study analyses the motives and feasibility of criminal offences and changes in the behaviour of 
criminals over time. The study indicates that drug users commit a wide variety of crimes. No specialisation 
or professionalisation as such was found in the history of criminal activities of drug users. Financial reasons 
were not the only motivation for committing crimes; unlawful means were also used to attain immaterial 
benefits such as thrills and peer acceptance. The study material strongly indicated that the persons studied 
considered the criminal culture an attractive way of life. They were not interested in a conventional 
lifestyle, and they also became estranged from such a lifestyle as they acquired a criminal identity. They 
were more interested in identifying with a criminal peer group and gaining the respect of that group. 
Habitual criminals who use drugs are typically willing to take risks and are unwilling or unable to 
comprehend the consequences of their actions. However, lifestyle preferences notwithstanding, living and 
acting according to the rules and customs of the chosen sub-culture did not always produce contentment. 
(Kekki 2012.) 
Secondly, the study examines ways in which the police see the significance of combating drug-related 
crime for the individual drug user on the one hand and for the social harm caused by criminal actions on the 
other. Because of the professional orientation of the police, there is a solid statutory foundation for their 
enforcement activities: all drug-related activities are criminal, so the police have the authority to intervene 
in them. The police also see drug-related crime as a harmful, immoral and undesirable pursuit, the 
discouraging of which is strongly supported by the majority of the population. Materials describing police 
operations show that enforcement was focused on known drug users, which is largely due to the fact that 
drug users often commit accompanying crimes too. In police rhetoric, controlling the use of drugs is largely 
about maintaining public order and safety. The police feel that they have very little potential in addressing 
individual offenders, whereas overall surveillance of drug users is significant for ‘keeping the peace’. 
(Kekki 2012.) 
                                                        
 
 
73 The study data included judgments issued by District Courts and Courts of Appeal. The collecting of cases began with the year 1994, when 
money laundering was criminalised in Finland. The dataset covers nearly all cases between 1994 and 2002 and contains some judgments 
from the years 2003 to 2010. A challenge in data collection lay in the fact that, until 2003, no essential elements required were specifically 
defined for money laundering crimes; instead, these were punished as receiving offences. 
74 The material for the study consists of interviews with police officers and drug users, a survey conducted at the Tampere Police 
Department and three different sets of pre-trial investigation records and notices of investigation. 
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9.2 Alternatives to prison 
Referral for treatment, and reprimand  
Alternative sanctions to prison have been developed for drug users: a reprimand procedure for young users 
and referral to treatment for problem users. The Prosecutor General has encouraged prosecutors to waive 
charges for drug users who have sought treatment. (Prosecutor General 2006:1.) The guidelines also note that 
breaking a drug addiction may be difficult and may require several treatment periods differing in content. 
Accordingly, it is possible to waive charges because of seeking treatment multiple times for the same individual. 
Seeking treatment must be demonstrated by written proof indicating that the drug user has sought treatment at a 
treatment institution or has booked a place or an appointment there. 
The amendment to the Penal Code concerning unlawful use of narcotics introduced the possibility of 
alternative penal sanctions. The focus was on two special groups: underage offenders should be 
reprimanded instead of imposing a fine on them, and problem drug users should be referred to treatment. A 
multi-professional reprimand is considered a more efficient sanction for young offenders than a fine. 
Treatment referral reduces the social exclusion of problem users as well as drug-related crime. According 
to studies and surveys, referral to treatment in particular has seldom been used. (Kainulainen 2009; 
Kainulainen 2012b.) 
According to data collected by the Prosecutor General’s office, in 2010 treatment was cited in 38 
decisions to waive charges. Half of these decisions were made in Lapland. According to a survey made in 
2009 of decisions to waive charges, of those seeking treatment 70% were men and 30% were women. One 
in five were underaged (n=6). In 43% of the cases, the offence only involved mild drugs. In 33% of the 
cases, a pharmaceutical classified as a drug was discovered. A further 10% of the cases cited only hard 
drugs (amphetamines). The remaining 13% involved combinations of various drugs. Subutex or Suboxene 
was mentioned in nearly one out of every three cases. (Kainulainen 2012b.) 
An offender who sought treatment and whose charges were waived might be indicted with only a petty 
narcotics offence such as one-off drug use. In some of the cases, the offender had been using drugs for 
some months; in some cases, for a few years. In nearly all cases, the type of offence was unlawful use of 
narcotics. In a handful of cases, the offender had also committed another offence such as forgery, petty 
firearms offence or unlawful possession of alcohol. The materials also included some cases of a narcotics 
offence involving the growing of cannabis or the transfer of drugs. (Kainulainen 2012b.) 
The Prosecutor General recommends that prosecutors arrange a reprimand session for 15–17-year-olds 
who have been arrested for unlawful use of narcotics for the first time. The young offender, his/her 
guardian, a representative of the social welfare authorities and the police participate in the session. 
(Prosecutor General 2006:1.) The young offender is informed of the criminal and reprehensible nature of 
drug use as comprehensively as possible, the offender’s life situation is examined and appropriate further 
measures are decided. After the session, the prosecutor may decide to waive charges. If the young offender 
does not attend, or if it is determined in some other way at the session that waiving charges is not a feasible 
option, this course of action may be abandoned. A fine may then be imposed on the young offender. 
(Kainulainen 2009.) 
According to data compiled by the Prosecutor General, 161 young offenders were reprimanded in 2010. 
The majority of these cases (61%) was in southwestern Finland. According to a survey conducted in 2009, 
in a typical case the reprimanded young offender was guilty of experimenting with cannabis on a small 
number of occasions. He/she was offered the substance personally or was reported to be responsible for 
acquiring it. Only a few cases involved a young offender with a longer history of cannabis use, and even 
then the longest period of use recorded was two years. Some cases involved not unlawful use of narcotics 
but a narcotics offence, because the young offender had distributed a small amount of drugs to another 
person or kept drugs in his possession with intent to distribute. (Kainulainen 2012b.) 
A reprimand session might be attended by the parents, a social worker, a foster home representative or a 
police officer in addition to the young offender. In some cases it was mentioned that an official had not 
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attended a session despite being invited. The prosecutor’s decision sometimes included a description of 
how the young offender behaved at the reprimand session. Support from the young offender’s family or 
child welfare services helped convince the prosecutor of the appropriateness of this approach. (Kainulainen 
2012b.) 
The Prosecutor General has also compiled data on reprimands and referrals to treatment in 2011. The 
number of reprimands in 2011 was 154, 7 fewer than in 2010. Similarly, there were 38 referrals to 
treatment in 2010 and only 23 in 2011. 
Table 9.  Reprimands and referrals to treatment by prosecution unit, 2010–2011. 
Prosecution unit Reprimand Referral to treatment 
  2010 2011 2010 2011 
Helsinki 4 22 2 - 
Länsi-Uusimaa  3 - - 
Itä-Uusimaa 13 15 - - 
Kanta-Häme 4 29 - - 
Salpausselkä 7 3 1 - 
Western Finland 98 48 13 13 
Pirkanmaa 2 7 3 - 
Pohjanmaa 4 10 - - 
Central Finland 2 2 - - 
Eastern Finland 19 8 - 5 
Oulu 7 7 - - 
Lapland 1 - 19 5 
Total  161 154 38 23 
 
Source: Office of the Prosecutor General (2012). 
 
In her doctoral dissertation, Heini Kainulainen (2009) examined the criminal control of drug users in 
Finland. The dissertation contains multiple sections, and its empirical section discusses alternative 
sanctions such as waiving measures and waiving prosecution, as well as referral to treatment and 
reprimands, which were added to alternative sanctions during the reform concerning the unlawful use of 
narcotics during the 2000s. The analysis indicates that proper consideration of sanctions has not been 
possible in the current processes. For instance, drug users have repeatedly been fined in summary penal 
proceedings. 
The data indicate that the waiving of measures has been used very seldom, although there is a particular 
need for it especially in relation to narcotics offences. For decades, the police have been reluctant to apply 
this procedure, since they consider it crucial to intervene in drug users’ actions. Prosecutors largely agreed 
with this view from the 1960s to the 1980s. Waiving punishment was common in the early 1970s, but 
within a few years practices became stricter. In the 1990s the procedure for waiving measures was 
reformed, after which waiving prosecution became more common. (Kainulainen 2009.) 
Alongside the reform concerning the unlawful use of narcotics in the early 2000s, sanctioning practices 
became stricter, since fining drug users in summary penal proceedings became more frequent and the 
number of cases where prosecution was waived declined. According to Kainulainen, the reform regarding 
the unlawful use of narcotics has not been successful, since waiving charges as a result of the offender 
seeking treatment is extremely rare. (Kainulainen 2009.) 
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9.3 Drug use and problem drug use in prisons  
The exact number of drug users in prisons is not known, but the drug market in prisons is small compared 
to the drug market on the outside. The important thing for monitoring the drug situation is to have a reliable 
statistical system for indicators relevant for substance abuse work, e.g. the number of substance abuse 
rehabilitation participants, the incidence of communicable diseases associated with substance abuse, the 
incidence of substance abuse during a prison sentence, the costs of outsourced services, and the attainment 
of substance abuse rehabilitation goals entered in the prison sentence plans. These data can be obtained 
from existing information systems. For a statistical system to support decision-making effectively, the 
contributing actors must be active and methodical in entering data into it. (Tanhua et al. 2011.) 
There are 28 prisons in Finland, all very different in their size, operating culture, structures and 
traditions. In some prisons there are scarcely any findings of indicators of drug use during prison sentences, 
while in others the results of surveys, seizures and drug tests indicate that drug use is fairly common. In a 
closed setting like a prison, drug use involves not only the usual adverse effects but also debt recovery and 
coercion to commit narcotics offences, which is why many prisoners wish to spend their time in prison 
completely isolated from other prisoners. Intoxicant monitoring will thus be paid more attention in the 
future. (Tanhua et al. 2011.) 
The results of intoxicant tests are documented comprehensively in the prisoner information system. 
Therefore drug tests may be regarded as the primary source for drug use by prisoners while in prison. In 
2010, more than 19,500 drug tests were performed on urine. Just under 1,500 of these were sent to a 
laboratory for confirmation and further tox screening; 727 findings were confirmed. The substances most 
commonly found were benzodiazepine, buprenorphine and amphetamine. (Tanhua et al. 2011.) 
According to Perälä (2011), benzodiazepine-based pharmaceuticals are a perennial favourite on the 
prison market. Buprenorphine is also popular, mainly because it can be packed into a small space and it is 
difficult for a drug detector dog to find if it is well packed. It also has the highest profit margin on the 
prison market, and it only shows up on a drug test for a short time after use. Amphetamines are the second 
most popular drug in prisons. Like buprenorphine, it can be packed economically, and it also only shows up 
on a drug test for a short time after use. However, its profit margin is not as good as that of buprenorphine, 
and a drug detector dog can find it more easily. (Perälä 2011.) 
Occasionally urine test results indicating cannabis use are found in prisons. This is usually the result of 
cannabis use outside prison, as the substance shows up in drug tests for a long time. Hashish, on the other 
hand, is used to some extent in prisons, even though its scent is such that it is easy not only for drug 
detector dogs but for personnel too to notice. It is bulky to smuggle in and does not carry much of a profit 
margin. (Perälä 2011.) 
According to Obstbaum, Tyni & Ryynänen (2009), offenders do not greatly differ from one another 
regarding positive drug test results except for sexual offenders. Most commonly positive test results are 
found in those guilty of narcotics offences, but on the other hand they tend to get tested more too. 
Benzodiazepine use is common in all groups, though most in the groups of violent crime and property 
crime offenders. 
Prisoners discovered to be dealing in intoxicants or otherwise committing narcotics offences while in 
prison are isolated from the rest of the prison population if necessary to prevent disruptions. For them too, 
the ultimate aim is to break the cycle of drug-related crime and to foster an intoxicant-free lifestyle. Local 
cooperation agreements between the prison and the police determine what the consequences of a drug 
discovery will be: a disciplinary matter within the prison or a referral to a police investigation. (Tanhua et 
al. 2011.) 
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Table 10.  Drugs discovered in prisons, 2008–2010. 
Chemical findings 2008 2009 2010 
Amphetamines 191 g 141 g 94 g 
Cannabis 85 g 133 g 95 g 
Subutex in powder form - - 19 g 
Subutex tablets 141 pcs 77 pcs 77 pcs 
Heroin 0.2 g 2 g 0 g 
Cocaine 0.98 g 20 g 1.3 g 
Hormones (liquid) - - 55 ml 
Hormone tablets 2,478 1,294 900 
Absorbed substances and powders (stamps, letters) 314 pcs 256 pcs 190 pcs 
Pharmaceuticals classified as drugs, in tablet form 1,549 1,766 1,089 
Other unidentified pharmaceuticals 3,740 pcs 4,165 pcs 4,046 pcs 
Drug syringe  176 pcs 97 pcs 
Needle  215 pcs 123 pcs 
Pipe  12 pcs 21 pcs 
Other drug use implements  10 pcs 8 pcs 
Source: Criminal Sanctions Agency 2011. 
 
In 2010, less drugs were seized in prisons than in previous years. The combined amount of cannabis, 
amphetamines and heroin seized in 2010 was under 200 grammes, compared with about 600 g per year in 
2003–2005. The decreasing trend may be ascribed to tighter security (including the use of drug detector 
dogs), intoxicant-free blocks and drug testing. These factors add up to an increased risk of being caught. 
Losing a place in an open prison is an effective deterrent to being caught in a drug-related offence. 
There are many unidentified tablets doing the rounds in prisons; imports of hormones may be one 
reason for this. Persons coming into possession of these substances may not know what it is that they 
contain. (Perälä 2011.) 
 
9.4 Prison health 
Finland has a comprehensive prisoner information system including data on risk assessments and needs 
assessments, drug tests conducted while in prison, participation in substance abuse rehabilitation and drug-
related disciplinary measures. Relatively few studies have been conducted in Finland focusing only on 
intoxicant use among prisoners, and even those that do exist do not always distinguish between drug use 
and alcohol use. (Tanhua et al. 2011.) 
There are not enough research data or statistics available on drug detoxifications performed or harm-
reducing measures undertaken during prison sentences. We do not know how many drug users overdose 
immediately after being released from prison. The drug test system is not foolproof, since prisoners may 
only be tested when intoxicant use is suspected or when certain permits are involved. Also, it is sometimes 
very difficult to detect intoxication clinically. The percentage of prisoners participating in group-form 
substance abuse rehabilitation programmes is quite small. (Tanhua et al. 2011.) 
Prisoner health 
The state of health of clients of the Finnish criminal sanctions system was studied in 2006. The sample 
consisted of some 600 prisoners and some 100 clients of community sanctions offices. The study methods 
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used were questionnaires, interviews conducted by nurses, psychiatric interviews, laboratory tests and a 
medical examination. Intoxicant addiction was ten times as prevalent among prison inmates as in the 
general population. The most commonly used intoxicant was alcohol, as is the case in the Finnish 
population in general. 
The study indicates that prisoners and other sanctioned offenders are more sick today than 20 years ago 
when the previous similar survey was conducted. Substance abuse problems among convicted offenders 
have mushroomed: 84% of all male prisoners and nearly all default prisoners have had an intoxicant 
addiction at some time in their lives. Two out of three had an alcohol addiction, and two out of five had an 
amphetamine addiction. Amphetamine addiction was common among all prison inmate groups. Nearly half 
(40%–48%) of the male prisoners, default prisoners and female prisoners had had an amphetamine 
addiction at some point in their lives; the figure was 29% for life prisoners. At the time of the examination, 
6% of the prisoners had an amphetamine addiction. Among male prisoners, 27% had had an opioid 
addiction at some point in their lives. (Joukamaa 2010.) 
The study by Kivimäki & Linderborg on short-term prisoners (2009) shows that prolific substance 
abuse is common among short-term prisoners. Nine out of ten prisoners said that intoxicant use had 
influenced their criminal actions. More than half had committed a crime in order to obtain intoxicants. The 
study also explored the availability of substance abuse treatment in prisons. Prisoners did not consider 
treatment and rehabilitation to be control measures violating their interests. The findings of the study 
support the present criminal policy aim to increase the supply of treatment and rehabilitation during periods 
of imprisonment. 
Nearly half (42%) of all prisoners75 had hepatitis C; 9% had hepatitis A and 8% had hepatitis B. An 
HIV infection was found in 1.0% of prisoners. (Joukamaa 2010.) The number of hepatitis and HIV tests 
conducted, as a percentage of the prisoner population, has remained stable, as has the number of positive 
results. 
Responses to drug-related health issues in prisons  
The Health Care Unit of the Criminal Sanctions Agency is responsible for the health care of remand 
prisoners and convicts during their time in prison. The administrative sector of the Ministry of Justice is 
currently exploring the transfer of prison health care to the general health care system. Nearly 200 health 
care professionals work at prisons and at the two prison hospitals. Health care personnel do not participate 
in the actual substance abuse rehabilitation undertaken during a period of imprisonment; this is managed by 
specially trained personnel at prisons such as substance abuse treatment instructors, psychologists and 
social workers. (Tanhua et al. 2011.) 
Under the Communicable Diseases Act, the central government is responsible for preventing the spread 
of communicable diseases in prisons. It is the duty of health care personnel to ensure that prisoners are 
instructed on how to protect themselves particularly against diseases transmitted by blood contact or sexual 
contact and to prevent their spreading. Communicable disease prevention is undertaken in prisons through 
health education and by ensuring opportunities for protection. The hygiene package issued to each prisoner 
contains instructions on condom use and on the cleaning and disposal of injection syringes and needles, and 
also a personal hygiene kit. (Tanhua et al. 2011.) 
According to a Decree of the Ministry of Social Affairs and Health (33/2008), substitution treatment for 
opioid addicts may be started on an opioid-dependent patient who has not been detoxified. According to the 
relevant Decree (33/2008), the need for treatment of an opioid addict may be assessed and treatment 
initiated at the Health Care Unit of the Criminal Sanctions Agency. To date, the Health Care Unit has not 
conducted assessments or begun treatment, but courses of substitution treatment begun by prisoners prior to 
                                                        
 
 
75 The prisoners were examined between 2005 and 2007. 
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prison admission have been continued. In 2010, there was an average of 50 prisoners each day receiving 
substitution treatment. (Tanhua et al. 2011.) 
Finnish prisons do not distribute or exchange needles for intravenous drug users. Disinfectant suitable 
for cleaning needles and syringes is available at the prison clinic, as are condoms. Disinfectant should also 
be anonymously available in the common facilities of a prison. In practice, prisoners do not use disinfectant 
dispensers in the common facilities to clean their syringes and needles because they believe that prison 
personnel are monitoring them (see e.g. Perälä 2011). Prisoners are recommended to take tests for hepatitis 
A, B and C and any vaccinations thought necessary. The communicable disease situation is monitored 
closely together with outside parties, and if a risk of infection through shared use of syringes and needles is 
detected, rapid preventive action is taken. (Tanhua et al. 2011.) 
The personnel of the Health Care Unit make an important contribution to substance abuse work in 
providing substance abuse treatment. This is particularly important when a prisoner is admitted. The need 
for detoxification and withdrawal treatment is assessed by surveying the prisoner’s substance abuse 
situation prior to being imprisoned. Substance abuse treatment provided by health care services consists of 
the treatment of substance-related illnesses and substance-related psychiatric treatment, and substitution 
treatment for opioid addicts. (Tanhua et al. 2011.) 
At the Assessment Centre, a prison sentence plan is drawn up for the prisoner listing the points that the 
prisoner should address during his/her imprisonment. In drawing up the plan, the Assessment Centre will 
take the prisoner’s substance abuse rehabilitation needs and the severity of his/her substance abuse problem 
into account, and this will influence prisoner placement. For about one prisoner in four, principally for 
those with a prison sentence of more than six months, the prison sentence plan is drawn up using a risk and 
needs assessment based on a face-to-face interview. (Tanhua et al. 2011.) 
Substance abuse rehabilitation in prison consists of a substance abuse rehabilitation needs assessment, 
substance abuse rehabilitation guidance, motivational instruction, relapse treatment, group-format 
rehabilitation programmes of varying intensity, personal therapy, the possibility of placement in an external 
substance abuse treatment facility, release training and networking services after release. Various forms of 
substance abuse rehabilitation are available in nearly all closed prisons. Some of the open prisons specialise 
in substance abuse rehabilitation. The rehabilitation is mainly undertaken by rehabilitative prison 
personnel: psychologists, instructors and social workers. There are some 50 instructors specifically engaged 
for substance abuse work in prisons. The Health Care Unit participates in substance abuse rehabilitation for 
prisoners only to a very limited extent due to a lack of human resources. (Tanhua et al. 2011.) 
The motivation and effectiveness programmes used in prisons must be approved through an 
accreditation procedure. The preference is for international programmes with research findings to back up 
their effectiveness. In addition to group sessions, one-on-one discussions are held with prisoners for whom 
group work is not suitable; they can discuss substance abuse issues in confidence by appointment. One-on-
one discussions are also often used as an extension of group sessions. Peer groups in prison (NA and AA 
groups) and KRIS-Finland are important contributors to abstinence from substance abuse. (Tanhua et al. 
2011.) 
According to data from the prisoner information system, 340 prisoners in 2010 entered a substance 
abuse rehabilitation programme that is accredited or accepted as a good practice. There are no substance 
abuse rehabilitation programmes in prisons specifically aimed only at drug users. (Tanhua et al. 2011.) 
Quality of services 
The Central Administration of the Criminal Sanctions Agency is responsible for monitoring attainment of 
the substance abuse work goals through performance management, inspections and external audits. Internal 
Inspection is a key actor in substance abuse work quality control, monitoring the implementation of 
substance abuse work as required by law, for instance concerning the goals entered in the prison sentence 
plans. In addition to monitoring through inspections, quality management and evaluation, special reports 
and research findings are used to support the steering of substance abuse work. (Tanhua et al. 2011.) 
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Under the Act on Welfare for Substance Abusers (41/1986), local authorities are responsible for 
providing substance abuse services. The Criminal Sanctions Agency is not a rehabilitation institution as 
referred to in the rehabilitation legislation, and the primary task of a prison is not to rehabilitate but to 
execute punishments. Finland’s prison legislation emphasises the preventing of recidivism and providing 
prisoners with the faculties they need to lead a crime-free lifestyle. Because a substance abuse problem is 
one of the key individual factors perpetuating a criminal lifestyle, a period in prison is a good time to stop 
and think about intoxicants. (Tanhua et al. 2011.) 
In co-operation with the relevant organisations, the Prison Service has prepared various alcohol and 
drug programmes for inmates in prisons and for drug users released from prisons. In the future, prisons will 
aim to focus on activities requiring special expertise in criminal behaviour. Substance abuse rehabilitation 
that requires no particular familiarity with the criminal sanctions client in question can be outsourced where 
the expertise is available, i.e. from substance abuse service providers outside the prison. The aim in 
substance abuse rehabilitation is to employ methods that are effective, of high quality and reasonably 
comprehensive. In particular, methods in use outside prisons are increasingly being taken into prisons, 
since in the current economic situation it makes no sense to maintain parallel systems. The quality of 
outsourced services will also be particularly addressed in the future. (Tanhua et al. 2011.) 
Special attention has been paid to the quality of the Criminal Sanctions Agency’s own substance abuse 
rehabilitation programmes. All motivation and effectiveness programmes to be deployed in the criminal 
sanctions sector must be approved in an accreditation procedure before widespread introduction. Also, the 
aim is to provide each programme with an individual quality standard. (Tanhua et al. 2011.) 
The structural decisions taken when the Health Care Unit was set up on 1 October 2006 have in some 
ways complicated cooperation between the unit and prison personnel. The administrative sector of the 
Ministry of Justice is currently exploring the transfer of prison health care to the general health care system. 
The Criminal Sanctions Agency is currently developing client assessment procedures and their tools. Client 
assessment will become a process lasting the duration of the sanction and including expert statements, 
initial evaluations by the convicts themselves, interim reports during the sanction and a final report as the 
sanction concludes. (Tanhua et al. 2011.) 
 
9.5 Reintegration of drug users after release from prison 
The various rehabilitation programmes in prisons involved 1,260 inmates in 2009 (1,835 in 2008). A total 
of 444 inmates participated in substance abuse rehabilitation programmes, 288 in programmes to minimise 
recidivism and 528 in other types of social rehabilitation. The purpose of the programme steering group set 
up in 2009 is to inspect the content of social rehabilitation in prisons. (Criminal Sanctions Agency 2010a.) 
A probationary freedom system was adopted at the end of 2006, with the aim of promoting an inmate's 
reintegration into society after release. The maximum length of probationary freedom is six months; it is a 
measure between imprisonment and parole. During probationary freedom, the inmate must participate in an 
activity, such as work, studying, rehabilitation or completing compulsory military service, and commit for 
instance to an intoxicant-free life and to respecting the obligation to remain in contact. In 2008, the daily 
number of inmates in probationary freedom averaged 50. Based on the experience gathered, probationary 
freedom appears to be an effective means of reducing the risk factors associated with release from prison, 
such as relapsing into substance abuse and subsequently returning to a vicious circle of crime. (Mohell 
2009.) The Act on electronic monitoring sentences (330/2011) entered into force on 1 November 2011. A 
person with an electronic monitoring sentence must comply with the daily programme and movement 
restrictions imposed on him/her. The convict is obliged to stay at home at all times when there is no 
predetermined reason for him/her to go outside. Absolute abstinence from intoxicating substances is also 
required, and this is monitored through tests. 
Osaava ohjaus (Skillful Guidance) 2010–2013 is a project run by the Probation Foundation with the 
aim of creating a multi-professional cooperation and expertise exchange model to reach out to adults at risk 
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of social exclusion. The project also offers training for professionals. The project has received ESF funding 
and is being run jointly with other actors. (Probation Foundation Finland 2012.) 
Since 1999, the Regional Prison of Southern Finland and City of Helsinki Social Services Department 
have been engaging in rehabilitation work for prisoners with substance abuse problems (Kuva); prisoners 
enter the system when they are transferred to open prison and continue with the same contact persons as 
during their imprisonment. Selected prisoners participate in work rehabilitation provided by the City and 
therapeutic outpatient rehabilitation provided by A Clinic substance abuse services. Financial matters and 
debts can be settled with the execution authorities and debt counselling. Prisoners also have peer support 
group meetings. The aim is for prisoners to become accustomed to working regularly while still in the open 
prison and to continue working in the same job immediately after their release. The majority of participants 
have no permanent place to live and are clients of the municipal social services for the homeless. By the 
end of 2010, 121 prisoners had entered rehabilitation, of whom seven have participated in work 
rehabilitation after their release. More than half of them were released under Kuva. (Probation Foundation 
Finland 2012.)  
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10 Drug markets 
Internationalisation has had an impact on drug-related crime. Major and aggravated narcotics offences 
investigated by the police indicate that, in general, the drug trade is professional and strongly dominated by 
organised crime groups. However, despite these international trends Finland is not a prime target in the 
worldwide drug trade due to its remote location and relatively small population. Also, there is a very low 
level of corruption in the police, and society at large is geared towards rooting out organised crime. (Perälä 
2011.) 
In drug supply in Finland, organised crime groups from Estonia have played an important role – at the 
beginning of the 21st century in terms of smuggling and importing drugs and later on as collaborators with 
Finnish crime groups, supplying drug consignments for distribution and delivery. Estonian criminals 
continue to be major players in cross-border drug-related crime in the Finnish context, but criminals from 
Finland and other countries have been increasing their activities. The group of foreign players importing 
drugs in Finland has become more diverse and the role of Lithuania in particular in the Finnish drug trade is 
clearly strengthening. (National Bureau of Investigation 2012.) 
On the one hand, the drug market appears organised and professional. On the other hand, the market is 
made up of several levels, where upper-level importers and wholesalers, mid-level distributors and low-
level street dealers operate in different ways. Research shows that drug dealing in Helsinki, whether we 
consider the very top or the very bottom of the pyramid, is a far from rational pursuit. The undertakings are 
not very systematic; they are more a reaction to intoxicant addiction(s) and other problems. (Perälä 2011.)76 
The drugs on the Finnish market are mostly cannabis products, particularly home-grown marijuana or 
hashish; amphetamines and ecstasy and other synthetic drugs; the substitution treatment preparation, 
Subutex; and many pharmaceuticals classified as narcotic substances, particularly benzodiazepines. The 
number of marijuana and cannabis plant seizures has grown in the 2000s, which indicates that the fairly 
small-scale cultivation of drugs partly intended for sale has become more common. Hashish is smuggled 
from central Europe via Finland to Russia, which explains the large volume of hashish seizures in 2011. 
Designer drugs are increasing in popularity in Finland, partly displacing substances such as MDMA and 
amphetamines, seizures of which decreased. Cocaine has grown slightly in popularity on the Finnish 
market in the past few years, but it remains rather a marginal drug. The volume of heroin on the market 
remains low. The intoxicant use of Subutex, by contrast, remains high. (National Bureau of Investigation 
2012.) 
 
10.1 Availability and supply of drugs 
No truly open drug market, such as those found in some major cities in Europe, exists in Finland; most of 
the sale and use of illegal drugs takes place in private homes. (Kinnunen 2008.) Home growing of cannabis 
has increased considerably in Finland, and this is reflected in the volume of seizures. The number of seized 
cannabis plants has doubled since 2007, which is probably due to the increased popularity of home growing 
and the fact that seeds are easy to buy over the Internet, and also due to the authorities becoming more 
effective at combating home growing. Although home growing mainly involves small-scale operations, it is 
becoming increasingly professional in nature. A number of expertly set up cultivation facilities with more 
                                                        
 
 
76 The study material was mostly collected through ethnographical field work, including observations and interviews. Interviews with 
officials and minutes of pre-trial investigations concerning aggravated drug crimes are also included. The study takes a constructionist 
viewpoint, according to which language shapes reality. Therefore people evince differing conceptions of reality in their speech. 
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than 500 plants have been discovered in Finland. In Finland as elsewhere in Europe, criminal motorcycle 
gangs have taken up cultivation of cannabis. (National Bureau of Investigation 2012.) 
Cases of home-grown cannabis in Finland usually involve cultivation for the grower’s own use, with 
cultures of no more than 20 plants. In the five most severe sentences imposed by a district court for home 
growing in 2002 and 2003, the average number of plants involved in the offence was 11, the median being 
6. The largest culture consisted of 130 plants. (Kainulainen 2006; Kainulainen 2011.) A study conducted 
among home growers of cannabis77 supported this, noting that the overwhelming majority of respondents 
were growing 1 to 5 plants at a time. These findings show that domestic production has increased in 
significance and that marijuana has surpassed hashish as the leading cannabis product. Using marijuana 
grown by the user himself/herself or obtained from a grower known to the user is now more common than 
buying marijuana on the market. (Hakkarainen et al. 2011a.) 
Most growers order their seeds (chemically treated seeds that produce pistillate plants) over the Internet, 
are given them by people they know, or obtain them from their own cultivation. Detailed growing 
instructions may also be found online. Also, the sale of equipment (which in itself is legal) required for 
home growing at certain shops favoured by home growers helps. The majority of home growing cases 
occur in major cities. The flower of a cannabis plant of a high-quality variant and grown under favourable 
circumstances can have a THC content of more than 10%. In the street trade, a cannabis flower is more 
valuable than low-grade hashish. (National Bureau of Investigation 2012.) 
No websites selling drug-like substances aimed specifically at the Finnish market have been detected. 
However, people are increasingly ordering cannabis seeds, designer drugs, medicines and GBL online from 
abroad in small quantities for their personal use. GBL or ‘lakka’78 in particular is ordered by mail and 
express cargo from the Netherlands, the UK and Poland, but also imported from Germany via Estonia. The 
foreign companies selling these substances clearly state on their websites that the stuff they are selling is 
100% GBL, which metabolises into GHB or ‘gamma’ in the body. The substance is sent to customers in 
plastic bottles whose labels indicate that they contain cleaning agents, for instance. Users also order batches 
of designer drugs for their own use over the Internet, as is shown by the considerable increase in the 
number of parcels containing designer drugs sent by post.  (National Bureau of Investigation 2012.) 
Import and the drug market 
Drug-related crime has robust international connections. In recent years, 24% to 35% of those suspected of 
aggravated narcotics offences in Finland have been foreigners. The largest groups of suspects were 
Estonians and Russians or Russians living in Estonia. On the Finnish market, Finnish criminals generally 
manage the reception and distribution of drugs in Finland, while foreigners are engaged in import and 
smuggling.  As in several earlier years, foreigners accounted for about 7% of suspects in all drug-related 
crimes in 2011. (National Bureau of Investigation 2012.) 
Drugs are imported to Finland by land concealed in cars, vans and trucks. Couriers carry drugs 
concealed in their clothes and luggage and, increasingly, within their bodies. Drugs are also imported by 
sea in cargo ships, fast ferries and private yachts. Drugs also arrive by air, although the number of large 
batches of drugs brought in with tourist traffic by air has decreased due to tighter security screening of both 
passengers and luggage. Instead, larger quantities are flown in by air cargo and through courier companies. 
In most cases, imported drugs are transferred via a cache, the seller hiding the stuff and then drawing a map 
or making a note of the GPS coordinates of the location. Cache maps are tradeable commodities on the 
criminal market. (National Bureau of Investigation 2012; Perälä 2011.) 
                                                        
 
 
77 For this study, 38 Finnish home growers of cannabis were interviewed in 2008, an anonymous online survey with 65 questions was 
targeted at Finnish home growers of cannabis (1,298 responses being received, of which 1,054 from growers) in 2009, and population survey 
materials analysed for hashish and marijuana use were examined. 
78 Gamma-butyrolactone (GBL), known in colloquial Finnish as ‘lakka’, is a substance governed by the Medicines Act and used as a cleaning 
agent and industrial chemical. 
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The majority of drugs are smuggled onto the Finnish market through various routes, particularly from 
the south and west. According to the police, most of the amphetamines on the Finnish market today come 
from western Europe, being smuggled in through Estonia or Lithuania. Currently, amphetamine and 
metamphetamine are also produced in Lithuania and trafficked to the Finnish markets by Estonian dealers. 
Today, amphetamine import is highly systematic and on a large scale. The usual scheme sees the Estonian 
dealers cache the amphetamine, with the Finns buying a map using which they retrieve the product. 
(National Bureau of Investigation 2012.) 
The drug culture in Russia is becoming more Western, and the use of amphetamine, ecstasy, hashish 
and cocaine in particular is increasing. Increased surveillance along heroin smuggling routes and overdose 
fatalities from 3-methylfentanyl have led to heroin being replaced by cheaper and more easily obtainable 
substances on the Russian market. Synthetic drugs have also eaten into the market share of heroin in 
Russia, and the sharp increase in the demand for amphetamines has led to a number of illegal amphetamine 
laboratories being set up in St Petersburg and the Leningrad Oblast. Amphetamine can be manufactured 
from a number of precursors that are freely available, and the quality of amphetamines on the drug market 
is highly variable. Amphetamine production growth in Russia is also of some relevance for the Finnish 
drug market. International amphetamine comparisons indicate that amphetamine originating on the Russian 
market has been found in both Estonia and Finland. (National Bureau of Investigation 2012.) 
Hashish, in turn, originates in Morocco, passing first through Spain, the Netherlands or Germany and 
then by sea, through Scandinavia or the Baltic countries. Hashish smuggling from central Europe via 
Finland to Russia has increased. Customs regularly seize major batches of hashish professionally concealed 
mainly in luxury cars. Hashish smuggling within the bodies of couriers has also become more common. 
Customs have found in criminal investigations that smuggling of khat is also an organised business 
involving large sums of money. Most khat seizures are made from airline passengers arriving from the UK, 
but the use of airmail and overnight courier services has increased in recent years. Khat is also smuggled 
into Finland concealed among legitimate cargo for instance in refrigerated transport. (National Bureau of 
Investigation 2012.) 
Russia has been a significant route, especially for smuggling heroin, but heroin also reaches Finland via 
other routes. The lack of treatment services and the decreased supply of Subutex on the illegal market may 
increase the demand for heroin. In addition, Finland is a potential route for the international smuggling of 
heroin from Russia to elsewhere in Europe. The threat of drug smuggling via the Nordic countries 
(including Finland) to Russia is also a point to consider, as drugs are being smuggled through the 
northeastern corner of the EU to Russia in particular, especially by Lithuanian criminal groups active in 
international cocaine trafficking. Potential smuggling of designer drugs via Finland to Russia should also 
be given special focus. (National Bureau of Investigation 2012.) 
A study on the drug market in Helsinki reveals that the operations are separated into distinct levels. The 
actors and modus operandi are different on each level, albeit there may be some overlap between them. The 
actors on the upper level may be described as the Brain, the Left Hand and the Wallet. The Brain has a 
Contact, who is the source of the supply. Bringing the drugs into the country commonly involves a Go-
Between, a Mule and a Tester. The actors on the upper level are better than other operators at avoiding 
being caught. (Perälä 2011.) 
There are considerably more mid-level actors than there are upper-level actors. A mid-level dealer 
usually operates with a small circle of mates, known as a ‘court’. A ‘court’ consists of a few trusted 
individuals, principally the Brains, the Help and the Muscle. They do not have as high a status and are not 
as technically proficient as the actors on the upper level. They use their own product in larger quantities and 
in a less controlled way than the upper-level actors. Nevertheless, both in Helsinki and abroad the mid-level 
dealers or Wholesalers are considered the most important people on the drug market, because it is through 
them that the upper-level actors gain their revenue. (Perälä 2011.) 
The lower level is made up of gramme dealers and users. A batch of drugs may be resold one gramme 
or one pill or one ‘fix’ at a time. All of the lower-level actors themselves use the drugs they sell, their sales 
are small in volume, and there are considerably more actors on the lower level than on the other levels. The 
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operations here are often quite brutal. Drug use brings a measure of uncertainty to the running of the system 
and erodes trust between actors. Everyday life becomes chaos as verbal agreements fail to be honoured. By 
contrast, the authorities have become very good at controlling this level with tactical means. (Perälä 2011.) 
Smuggling of pharmaceuticals classified as drugs 
Using intoxicating pharmaceuticals as drugs is very common among Finnish substance abusers. Acquiring 
intoxicating pharmaceuticals is done particularly by exploiting the lack of centralised monitoring of the 
dispensing of pharmaceuticals: prescriptions are obtained from several physicians, and the pharmaceuticals 
thus obtained are both sold on the illegal market and used by the users themselves. Pharmaceuticals are also 
obtained from abroad, typically by ordering them online from a variety of countries. More than 90% of the 
pharmaceuticals of foreign origin arrive by mail; the largest volumes of seizures have been made from 
postal deliveries originating in the UK, India, Thailand and Turkey. The Schengen enlargement has boosted 
the importance of smuggling on the illegal market in intoxicating pharmaceuticals, and smuggling 
particularly from the Baltic states to Finland has increased. With the end of ‘legal drug tourism’, smuggling 
drugs within the body has become more common in the traffic between Finland and Estonia. There is a 
lively tourist trade in pharmaceuticals in Estonia; substantial quantities of benzodiazepines are imported 
from Estonia to Finland, mainly by ship passengers. In autumn 2011, a batch of nearly 20,000 tablets of a 
clonazepam preparation (a benzodiazepine) was smuggled into Finland concealed in a car tyre. Drug 
tourism to the Far East is also becoming more common, and many airline passengers bring back 
intoxicating pharmaceuticals from Thailand, for instance. (National Bureau of Investigation 2012; Finnish 
Customs 2012.) 
The import routes for Subutex have been realigned after Estonia and Latvia joined the Schengen zone. 
Subutex is now often smuggled from France to Finland via the northern route, through Sweden. 
Buprenorphin has gained more ground in Sweden and Norway, and smuggling from these countries to 
Finland has increased, as is shown by the seizure of large batches of Subutex en route to Finland in Sweden. 
Northern Finland has become a significant market area for Subutex, which has now become a problem drug 
in the northern reaches of the country too. Another emerging area for sourcing Subutex is the UK, which 
lies outside the Schengen zone. Also, Subutex is available on prescription in Lithuania. The potential 
offshoring of Subutex production to the Far East will probably increase online sales, in particular. (National 
Bureau of Investigation 2012; Finnish Customs 2012.) 
Drug production facilities 
No synthetic drugs production facilities have been discovered in Finland. Overall, during recent years, only 
a handful of small facilities for the precipitation of amphetamine sulphate have been found. These have 
been procuring the necessary chemicals by ordering them from players in the chemistry field or by stealing 
them from research institutes or workplaces in the chemistry sector. Thus, combating illegal activities is 
also highly dependent on the alertness of the sector's players. Trade in the precursors required for drug 
production is often associated with legal business operations, but some legally transported chemicals may 
also end up in the production of drugs in Finland's neighbouring areas. In terms of the trade in precursors, 
Finland occupies a high-risk position: there are illegal drug production facilities in Russia and in all the 
Baltic states, and Finland engages in trade in chemicals or through transport of precursors with all these 
countries. No significant precursor seizures have been conducted in Finland. Precursor seizures are an 
effective means of preventing drug production and rendering it more difficult. (National Bureau of 
Investigation 2012.) In 2010, the Customs authorities seized ephedrine in tablet form. The users were 
fitness activists and had no intent of manufacturing drugs. (Finnish Customs 2011.) 
In May 2010, the police made a unique discovery in Helsinki, including nearly 60 kg of mCPP, a 
substantial number of Bromo-Dragonfly blotters and a tablet-making machine. Often marketed as a 
substitute for ecstasy, mCPP is a designer drug which was classified as a narcotic drug in Finland on 12 
March 2012. The police estimate that the quantity of mCPP seized would have been sufficient for about 
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800,000 tablets. A substantial number of Bromo-Dragonfly blotters, considered highly dangerous, was 
discovered in the same raid. Bromo-Dragonfly, which resembles LSD, was also classified a narcotic drug 
in Finland on 12 March 2012. (National Bureau of Investigation 2012.) Experts estimate that in the near 
future drug manufacturing may spread to Finland from countries that already have illegal drug production 
facilities. 
 
10.2 Narcotics seizures 
Data on drug seizures indicate that the situation prevailing on the Finnish drug market is fairly stable. 
Criminal cases concerning cannabis cultivation and narcotic pharmaceuticals have become more common 
in 2011. The number of designer drug discoveries, types of designer drug and types of intoxicating herbal 
product have all continued to increase, and the increasing popularity of ordering designer drugs online is 
apparent in the work of the Customs authorities in particular. In 2011, the Customs found 85 different kinds 
of designer drug, of which 42 had never been seen before. The number of intoxicating herbal products 
discovered was 13. In all, the Customs Laboratory discovered 10.4 kg of designer drugs. Those most 
common on the drug market are GBL or ‘lakka’, synthetic cannabinoids, methylone and methiopropamine. 
A new Act that entered into force on 12 March 2012 classified the following designer drugs as narcotic 
drugs: JWH-018, JWH-073, JWH-081, 2-DPMP, mCPP, methylone and Bromo Dragonfly. Last year, 
Customs seized more than 300 batches of the aforementioned seven designer drug types combined. 
(National Bureau of Investigation 2012; Finnish Customs 2012.) 
 
Table 11. Drugs recorded as seized by the police and Customs in 2004–2011 (kg). 
  2004 2005 2006 2007 2008 2009 2010 2011 
Hashish 467.4 430.6 282.7 360 47 440 250 860 
Marijuana 25.8 43.4 32.9 36 56 100 80 97 
Cannabis plants (pcs) 7,840 9,460 7,510 7,600 14,000 12,500 15,000 16,400 
Cannabis plants (kg)* 41.7 43.3 36.2 87 41 45 31 42 
Amphetamines +  
Methamphetamines** 108.6 116.6 129 152 130+17 110+5 113+39 71+28 
MDPV      4 9.5 2.4 
Cocaine 1.1 1.2 6.5 4 3 2.8 4.2 3.5 
Khat 2,118 2,562 3,283 3,300 2,250 3,300 4,700 5,800 
Heroin 0.2 52.4 0.2 0.4 0.2 2 0.4 1 
Subutex (tablets) 32,970 24,478 22,979 20,600 12,000 17,000 15,000 31,700 
Ecstasy (tablets) 23,243 52,210 39,185 83,000 34,000 15,100 27,000 17,800 
LSD (doses) 195 452 171 2,138 3,082 620 790 1260 
Bromo Dragonfly 
(pcs)      1,200 7,600 1,100 
GBL+GHB** (litres)   24 91 150+9 84+2 37+5 930+2.5  
* = In addition to the number of cannabis plants entered; mainly plant parts. 
** = Combined until 2007, separate from 2008. 
Source: National Bureau of Investigation 2012. 
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Table 12. Number of drug seizures recorded by the police and Customs in 2002–2011. 
  2002 2004 2006 2007 2008 2009 2010 2011 
Hashish 3,012 2,626 2,599 1,900 1,500 1,940 1,933 1,829 
Marijuana 1,275 2,067 2,269 2,400 3,000 3,700 4,018 4,281 
Cannabis 
plants 
923 1,406 1,378 1,900 2,100 2,650 2,716 3,187 
Amphetamines 
+ 
Methamphetam
ines 
3,399 3,392 3,101 2,990 2,900+120 2,910+125 3,154+199 3,157+90 
Cocaine 45 65 82 92 107 102 126 81 
Heroin 145 45 25 20 25 26 9 3 
Subutex 741 844 840 800 850 940 1,126 1,276 
Ecstasy 329 328 297 340 250 190 229 300 
LSD 10 21 15 50 73 52 73 92 
GBL+GHB   54 184 170+80 112+28 69+40 182+45 
Khat   180 199 130 220 227 237 
Source: National Bureau of Investigation 2012.  
 
In 2011, the number of seizures of cannabis products in Finland was, once more, higher than ever. The 
number of cannabis plants seized (about 16,400) was also higher than ever: the number of seized cannabis 
plants had more than doubled since 2007. The amount of marijuana seized was the second highest per 
year on record, about 97 kg. This figure has nearly tripled since 2007. The growth is explained by factors 
such as a small number of exceptionally large seizures from smuggling undertaken by foreign parties from 
the Netherlands to Finland. In 2011, the amount of hashish seized was a record-breaking 860 kg. Most of 
this was on its way to Russia; the hashish seized was discovered by Customs in caches professionally 
concealed mainly in luxury cars. Hashish smuggling within the bodies of couriers has also become more 
common. The volumes of seizures of the most popular imported drugs are crucially affected by the results 
of investigative operations focusing on large-scale smuggling. The largest individual seizures of hashish in 
2011 were an exceptionally large batch (about 210 kg) smuggled into Finland by ship concealed in two 
vehicles and two seizures of about 90 kg each made at the Vaalimaa border checkpoint in vehicles en route 
from Finland to Russia. (National Bureau of Investigation 2012.) 
In the category of synthetic drugs, seizures of amphetamines totalled about 71 kg in 2011, clearly less 
than in previous years. In the largest individual seizure of amphetamines, a 6 kg batch was discovered in a 
cache in the ground. The two next largest seizures both involved batches of about 2 kg, one discovered in 
the residence of a suspect and another in a cache in the ground near the residence of the suspect.  Shortages 
in amphetamine supply are continuing to be filled with metamphetamine, the percentage of which on the 
Finnish drug market and smuggling has continue to grow as is the case elsewhere in the Nordic countries 
and in the Baltic states. In 2011, the amount of confiscated metamphetamine was 28 kg. The largest single 
seizure was an outdoor cache of nearly 16 kg of methamphetamine. Another major outdoor cache with 8 kg 
of methamphetamine was discovered by Customs.  (National Bureau of Investigation 2012.) 
Alongside and among amphetamine on the market there are increasing amounts of 
methylenedioxypyrovalerone (MDPV), seizures of which in 2011 were lower than in previous years, 
totalling only 2.4 kg. The market share of MDPV has declined because of its poor reputation and because it 
was classified as a narcotic drug as of 28 June 2010. (National Bureau of Investigation 2012.) 
The quantity of ecstasy seized in Finland per year again decreased in 2011, to less than 20,000 tablets, 
which is considerably lower than the peak annual figures of more than 80,000 tablets in the 2000s. Seizures 
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of mCPP (chlorophenylpiperazine, classified as a narcotic drug in Finland as of 12 March 2012), marketed 
as an alternative to ecstasy, were also low, only 60 tablets. (National Bureau of Investigation 2012.) 
LSD seizures in 2011 increased slightly from the previous years to 1,260 blotters; seizures of Bromo 
Dragonfly (classified as a narcotic drug in Finland as of 12 March 2012) amounted to 1,100 blotters. 
(National Bureau of Investigation 2012.) 
Cocaine has grown slightly in popularity on the Finnish market in the past few years, but it remains 
rather a marginal drug: only about 3.5 kg of cocaine was seized in 2011, in fewer than 100 items. (National 
Bureau of Investigation 2012.) 
The amount of seized heroin in Finland plummeted at the beginning of the 21st century. The volume of 
heroin on the market remains low. Seizures in 2011 totalled about 1 kg. (National Bureau of Investigation 
2012.) 
Heroin has largely been replaced by the buprenorphine preparation Subutex, seizures of which 
increased considerably in 2011 to 31,700 tablets, the largest number in five years. The quantity seized of 
other pharmaceuticals classified as narcotic drugs (mainly benzodiazepines and some opiates) was 
double the annual average in recent years, some 243,000 tablets.  (National Bureau of Investigation 2012.)  
In 2011, Customs tracked down a large-scale and systematical operation for importing and distributing 
GBL in southwestern Finland. A Finnish man was suspected of ordering 1,000 litres of GBL from a 
Chinese pharmaceutical company. A total of 860 litres were seized, making this the largest single seizure of 
GBL in Finland to date. The substance was intended for the drug market in the Greater Helsinki area, and 
the batch would have been worth more than EUR 1 million on the street. The total volume of seizures of 
GBL in 2011 was a record-breaking 930 litres. (National Bureau of Investigation 2012.) 
The volume of seizures of khat, a drug favoured by Finnish residents of Somalian extraction, continued 
to rise to 5,800 kg in 2011, the highest figure recorded since the arrival of the substance in Finland. 
(National Bureau of Investigation 2012.) 
 
10.3 Price and purity of drugs 
Street prices of drugs remained fairly stable in 2011. Cannabis prices remained at previous year’s level, a 
gramme of cannabis costing EUR 13–20 on the street. The typical street price for hashish was EUR 6–15 
per gramme, slightly lower than in previous years. In Lapland, the price was higher, about EUR 20 per 
gramme. Amphetamines typically sold for just over EUR 20 per gramme on average, the range being from 
EUR 15–25 in the Greater Helsinki area to as much as EUR 40–50 in northern Finland. Methamphetamine 
prices were at about the same level. Heroin cost about EUR 120 per gramme and cocaine EUR 60–100 per 
gramme in 2011. An ecstasy tablet cost EUR 12–20 each and LSD blotters cost EUR 10–20 each for end 
users in 2011. (National Bureau of Investigation 2012.) 
A tablet of Subutex will cost the user EUR 25–40 in the Greater Helsinki area and as much as EUR 
100–160 in northern Finland. The price depends on the quantity bought. The street price of MDPV is 
reported to be around EUR 60–80 per gramme, although street prices as low as EUR 25–40 have been 
discovered in cases investigated by Airport Customs. A 0.5-litre bottle of GBL costs about EUR 60 when 
ordered online; the street price in Finland is EUR 1 to 20 per millilitre depending on the concentration. The 
price for intoxicating pharmaceuticals on the illegal market is EUR 1–3 per tablet nationwide, although 
benzodiazepines may sell for anything up to EUR 5 per tablet. (National Bureau of Investigation 2012.) A 
single dose of khat is 150 to 250 grammes and costs about EUR 25 when fresh. (Perälä 2011.) 
Finnish street prices for drugs vary greatly depending on the sales location: in Helsinki and the Greater 
Helsinki area, prices are clearly lower in general than in regional centres. A study conducted in the spring 
of 2011 suggests that, in regional centres, the price of amphetamines, popular among hard drug users, may 
be well be double that of Helsinki. Hashish and Subutex are also clearly more expensive outside the 
Helsinki area. Unlike the prices of smuggled drugs, cannabis prices do not show regional variation. Indeed, 
in regional centres cannabis may even be cheaper than in Helsinki. However, under special conditions, such 
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as when drugs are smuggled into a prison, prices may be very high on a case-by-case basis. (National 
Bureau of Investigation 2012.) 
Laboratory tests at the Forensic Laboratory of the National Bureau of Investigation or the Customs 
Laboratory are conducted to establish whether samples obtained in the course of an investigation or in a 
seizure contain substances or preparations classified as narcotic drugs, pharmaceutical substances or doping 
substances, or new unclassified intoxicating substances, i.e. designer drugs. The Forensic Laboratory also 
investigates the illegal manufacture of narcotic drugs. Drug batches are compared to establish whether two 
(or more) batches were manufactured at the same laboratory or come from the same original batch. Such 
comparisons are frequently performed between batches of amphetamines in particular. Routine analyses of 
concentrations of seized drugs are only conducted for amphetamine and methamphetamine if the seized 
quantity exceeds 10 grammes or, for heroin and cocaine, 2 grammes. On request, concentrations of 
cannabis plants and marijuana are analysed for consignments exceeding 150 grammes. In other respects, 
concentrations are not analysed. (National Bureau of Investigation 2012.) 
No significant changes were found in the average concentrations of drug samples during 2011. The 
average concentration of amphetamines has continued to decrease (2007: 29% by weight; 2011: 18% by 
weight). Average concentrations are about 30% by weight for cocaine and metamphetamine. What all 
drugs have in common is that there are huge variations in concentration. (National Bureau of Investigation 
2012.) 
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11 Institutional care for drug users in 
Finland 
The purpose of this chapter is to discuss trends and the current situation in institutional drug use treatment 
in Finland as illustrated by a variety of materials – treatment statistics, documents, strategies and previous 
studies on the treatment. Specialised drug use treatment in Finland dates back to the early 1970s, at which 
time the treatment of people with drug problems was transferred from psychiatric care to social services 
together with other substance abuse care. At the time, some of the care facilities specialising in substance 
abuse care took responsibility for drug user care too (Kuussaari 2006). In the following decades, trends in 
drug use treatment and also in the institutional care for drug users in Finland have followed shifts in 
treatment philosophies, drug policy, welfare policy and the funding and structures of services. Key 
determinants of treatment have included central and local government, which provide funding for services 
and also maintain care facilities of their own, and in particular the NGOs providing substance abuse 
services specialising in drug use treatment. Drug use treatment has also been determined from time to time 
by drug users’ family members, the drug users themselves, and certain individual persons and experts in the 
public eye. 
 
11.1 History of institutional care, and legislation and recommendations 
 on care 
The history of drug use treatment in Finland is an under-researched area. Also, there have not been very 
many clinical studies exploring drug use treatment methods in Finland (Selin 2011c; Kaukonen 2005). The 
paucity of research may be partly due to the fact that Finland did not really acquire a drug use treatment 
system separate from the treatment of alcohol problems until the 1990s; prior to that, drug use will have 
been subsumed in the broader history of substance abuse services (Kaukonen 2002). 
Generally, care provided for drug users in Finland has been analysed into various phases in previous 
studies, touching on trends in institutional care along the way. In their article Finland: Drug Treatment at 
the Margins (1998), Aarne Kinnunen and Juhani Lehto identify four phases in drug care from the early 
1960s to the mid-1990s: 1) the psychiatric care phase (late 1960s to early 1970s); 2) the social therapy 
phase (early 1970s); 3) the separate drug use treatment decline phase (1975 to 1986); and 4) the pluralist 
phase (1987 to 1996). Olavi Kaukonen (2002) later augmented Kinnunen and Lehto’s analysis by 
identifying a drug use treatment expansion phase from the mid-1990s onwards, influenced by significant 
changes in the drug use situation and drug policy in Finland towards the end of the decade. The following 
is a review of institutional care for drug users in light of the aforementioned phases. 
1970s to 1990s 
At the psychiatric phase of drug use treatment (late 1960s to early 1970s), drug problems were principally 
defined as medical problems, and responsibility for treatment for drug users rested with the health care 
system. Institutional care was provided primarily at psychiatric hospitals. No prior research exists 
concerning the contents and practices of drug use treatment applied during this phase, but it may be 
assumed that it involved psychiatric care practices typical for the era, such as various combinations of 
therapy and medication. In the mid-1970s, an experimental methadone treatment programme for people 
with chronic opiate addiction was begun in psychiatric medical care (Ahokas, Kajesalo & Holopainen 
1998). The use of coercive measures was more common during the psychiatric care phase than it is now. 
This was due not so much to principles of psychiatric care as to principles of social order. According to the 
then valid Act on the Care of Abusers of Intoxicating Substances and Vagrants Act, “abusers of 
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intoxicating substances” – not differentiated by the substance(s) used – could be committed to a sanatorium 
or an institution if this was considered necessary because the patient was dangerous, a burden to society or 
in need of social assistance. Also, persons suffering from psychosis and severe withdrawal symptoms could 
be put in psychiatric care pursuant to the Mental Illness Act. At the turn of the 1960s–1970s, psychiatric 
hospitals treated up to 900 drug users in inpatient care each year (Kinnunen & Lehto 1998). 
In the social therapy phase of drug use treatment (early 1970s), a move was made to shift drug use 
treatment away from psychiatric care, together with the treatment of problem users of alcohol. According to 
Kinnunen and Lehto (1998), the motivating force behind this was the deinstitutionalisation trend that had 
arrived in Finland through international influences in the late 1960s; one of the aims of this trend was to 
move certain groups of patients out of psychiatric hospitals who did not belong there, such as those with 
chronic substance abuse problems. As a result, the treatment of both drug problems and alcohol problems 
was transferred from general social services to the gradually emerging specialised substance abuse services, 
and social workers became a key professional group in drug use treatment and more generally in substance 
abuse services (Kinnunen & Lehto 1998). In terms of institutional care, responsibility for drug use 
treatment was transferred to two care facilities with a tradition of specialising in substance abuse problems: 
the Järvenpää Social Hospital and the A Home in Mikkeli (Kinnunen & Lehto 1998; see also Kuussaari 
2006). Both facilities received funding from the central government specifically earmarked for drug use 
treatment. 
What was remarkable in the social therapy phase compared with practices in the preceding decades was 
the emphasis on voluntary treatment and outpatient care for substance abusers, as outlined in two key 
reports on drug policy published in 1969 and 1971. These principles are still alive and well. The reports 
also stressed how similar alcohol problems and drug problems are; it was feared that creating special 
services just for drug users would enhance their sense of a separate identity and thereby the drug culture. 
(Kuussaari 2006; Hakkarainen 1999). This practice too can still be detected in the practices of care 
institutions, even though the treatment of patients with alcohol problems and those with drug problems 
have gradually become differentiated, particularly since the 1990s. 
In the separate drug use treatment decline phase (1975–1986), the professional identity and practices of 
drug use treatment declined, and dedicated drug use treatment wards began to lose clients. (Kuussaari 2006; 
Kinnunen & Lehto 1998). According to Kinnunen and Lehto (1998), there were three key factors behind 
this decline. Firstly, it was becoming increasingly rare to encounter clients who only had drug problems.  
For instance, many young people who sought treatment had experimented with drugs, but their main 
problem was with alcohol.  In other words, demand for specialised drug use treatment shrank. This strong 
downward trend can also be seen in the statistics on drug experimentation and use after the middle of the 
1970s (Kontula 1996). Secondly, the decline was facilitated by the principle of the essential similarity of 
alcohol and drug problems based on the aforementioned committee reports, which in turn influenced the 
ongoing reform of substance abuse legislation. There was a reluctance to single out drug use and related 
problems in this process, and it was therefore considered that substance abuse problems of whatever kind 
could be treated at the same locations. There was thus seen to be no need for separate drug use treatment 
units. The third change that significantly contributed to the reduction in drug us treatment capacity was in 
the funding of care facilities. With the major Finnish administrative reform known as VALTAVA in the 
1980s, local authorities were charged with added responsibilities in providing services, and the central 
government no longer provided funding ‘earmarked’ for drug use treatment; instead, local authorities were 
required to arrange their funding themselves. For NGOs, this reform involved a transfer to performance-
based funding, which meant that it was not worthwhile to maintain empty beds for drug users, who by that 
time were rarely encountered in treatment situations (e.g. Ahonen 1999). 
However, after the mid-1980s the number of beds for drug use treatment began to increase again. 
Kinnunen and Lehto (1998) describe the phase beginning at this time as the pluralist phase, referring 
particularly to the diversification that began to emerge in drug use treatment services in the 1980s. At that 
time, new players entered the field of drug use treatment, and new treatment ideologies emerged alongside 
the traditional social therapeutic approach (see also Kuussaari 2006; Kaukonen 2002). For instance, three 
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new institutional care facilities were founded that have been specialising in drug use treatment ever since: 
the Hietalinna Community, the Kisko Clinic and the Drug Detoxification Unit at Helsinki University 
Central Hospital (HUCS). 
This change, too, was enabled by several factors. Firstly, a new Act on Welfare for Substance Abusers 
entered into force in 1986; this Act emphasised the similarity of alcohol and drug problems. As a reaction 
to the new Act, parents of children suffering from drug problems began a public campaign to gain more 
beds for drug user treatment and particularly an enhancement to measures aimed at young drug users. They 
asserted that treating drug problems specifically required measures different from those used to address 
alcohol problems. Families’ organisations played an active role for instance in establishing the HUCS Drug 
Detoxification Unit. At the same time, a more general public debate was being conducted on drug policy 
and drug use treatment in Finland. Kinnunen and Lehto (1998) note that in the 1980s drug policy became a 
more important area in national politics because of international trends, and it was now considered essential 
for various authorities to allocate more resources to dealing with drug problems. Increasingly, a broader 
drug policy reform was called for in public, including a reform of drug use treatment. All of the above led, 
as Kinnunen and Lehto describe, to a paradoxical situation where the number of drug use treatment beds 
was being increased even though the newly minted Act on Welfare for Substance Abusers insisted that 
alcohol abuse treatment and drug use treatment should not be considered or provided for separately, and 
even though drug use and related problems had not grown by very much at all (Kinnunen & Lehto 1998; 
Hakkarainen & Kuussaari 1996). 
According to Kristiina Kuussaari (2006), the number of new drug use treatment units began to increase 
at this point due to yet another change in the central government’s funding practices. Because of a 1987 
amendment to the Decree on the Finnish Slot Machine Association, which has a monopoly on gaming 
machines in Finland, it was possible to allocate funds from the Association to NGOs. This enabled NGOs 
providing substance abuse services to improve their expertise in drug use treatment even if local authorities, 
which were otherwise responsible for funding these services, would not invest in it (see also Kaukonen 
2002). Indeed, international comparisons (Klingeman et al. 1992) show that at the end of the 1980s Finland 
had one of the world’s most comprehensive networks in specialist substance abuse services in the world 
relative to population and the level of drug use. Another key feature of Finnish substance abuse services at 
this time was the predominance of institutional care. 
Kinnunen and Lehto’s survey extends up to the year 1996. After that, major changes occurred in Finnish 
drug policy and drug use treatment, leading to a proliferation of the number of specialist drug use treatment 
units in the 2000s. The following is a discussion of trends in this period, described by Olavi Kaukonen 
(2002) as the expansive phase of drug use treatment, drawing on earlier analyses of changes in drug use 
treatment prompted by the second wave of drug use. 
2000s 
At the expansive phase of drug use treatment, specialist services increased in volume and diversity. At this 
time, the drug use treatment system was being developed as a consistent whole, and continuity of treatment 
was addressed through networking and training, with a view to increasing the capabilities of social welfare 
and health care professionals in particular in how to encounter and treat clients with drug problems. This 
trend was fuelled by a sharp increase in drug use with the arrival of the ‘second wave’ of drug use in 
Finland in the 1990s, particularly in the use of opiates. The harmful impacts of increasing drug use 
prompted a need for a reform of Finnish drug policy and drug use treatment, as can be seen in a substantial 
increase in the number of reports, documents, regulations and action plans produced between the 1990s and 
the 2000s (Hakkarainen & Tigerstedt 2002). In terminology, this change is reflected in the transition from 
general substance abuse services towards specialist drug use treatment (Kaukonen 2002; see also Weckroth 
2006). 
The central government allocated more than EUR 15 million to the development of drug use treatment 
in its budgets for 2002 and 2003; these funds were used both to augment the operations of existing 
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treatment facilities and to set up completely new units (Kaukonen 2005). Funds were allocated specifically 
to the development of opiate substitution treatment and low-threshold health counselling centres for 
intravenous drug users, the latter being intended to reach the most disadvantaged drug users (Kaukonen 
2005; see also Villikka 2004). 
Key documents governing drug use treatment in this period were the Report by the Finnish Drug Policy 
Committee (1997) and the related Government Resolution (1998), both of which highlighted the need for 
developing drug use treatment and a more diverse drug policy. Also, several memoranda on care for 
problem users were published, discussing issues related to the development of opiate substitution treatment 
in particular (Hakkarainen & Tigerstedt 2002). According to Pekka Hakkarainen and Christoffer Tigerstedt 
(op.cit), many of these documents show a ‘medical-liberal’ outlook focusing on pharmaceutical treatments. 
What is interesting from the perspective of institutional treatment is that the development of institutional 
drug use treatment was not separately discussed at this point. On the other hand, a ‘re-psychiatrisation’ of 
drug use treatment occurred in the 2000s, as witness the increasing number of clients at addiction 
psychiatry inpatient wards (Kaukonen 2005). 
Despite the proliferation of drug use treatment units, drug use treatment was the focus of critical 
discussion as well, even in this expansive phase. NGOs and treatment units subscribing to the social 
therapeutic approach, and also certain scientists researching substance abuse services, particularly criticised 
the dominance of substitution treatment in various drug use treatment strategies, as it was feared that this 
would eclipse discussion of the psychosocial issues related to drug use and lead to an unduly narrow 
definition and treatment of drug problems. Uncontrolled spreading of substitution treatment was also seen 
as a threat, leading in the long term to chronic drug use problems. 
In short, the development of drug use treatment in Finland may be described as a transition from generic 
control and treatment of substance abuse problems towards more specialised drug use treatment. Another 
major trend has been the transition from the social therapeutic approach originating in the 1970s to more 
medically oriented forms of drug use treatment (Selin 2011c; Tammi 2007; Kuussaari 2006). This can be 
considered to have influenced the development of institutional care too, as rehabilitative institutional care 
has had to yield to outpatient substitution treatment in the first decade of the present century. 
At the level of legislation and strategies, drug use treatment like all substance abuse services has 
become more client-oriented in terms of content; at the same time, the legislation has become broader, 
allowing more leeway for local negotiation and discretion as far as the providing of the services is 
concerned (Kaukonen 2005). 
 
11.2 Legislation, key strategies and recommendations underlying 
 institutional care 
In Finland, the responsibility for providing drug use treatment, as with all social and health services, rests 
with local authorities. The Act on Welfare for Substance Abusers (14/1986) requires municipalities to 
ensure that the provision of substance abuse services meets local needs as regards content and scope. The 
goal is to prevent and reduce problem use of intoxicants and related social and security issues. The Act is 
complemented by the Decree on Welfare for Substance Abusers (653/1986), which contains more detailed 
provisions for instance on providing substance abuse services, drawing up rehabilitation plans, official 
appointment procedures, treatment of clients under 18 years of age and isolation of clients. 
The Act on Welfare for Substance Abusers also allows for a client to be committed to involuntary 
treatment pursuant to the Mental Health Act, the Act on Welfare for Substance Abusers or the Child 
Welfare Act. Involuntary treatment is indicated when a substance abuser client is unable to make informed 
decisions because of his/her illness or intoxicant addiction. Traditionally, this provision has been invoked 
only very rarely in Finland.  However, there is currently a lively public debate on increasing the 
commitment to involuntary treatment of pregnant substance abusers, and a Government bill is being 
prepared to this effect. 
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Other principal legislation relevant for the providing of substance abuse services include the 
Communicable Diseases Act (583/1986), the Decree of the Ministry of Social Affairs and Health on the 
detoxification and substitution treatment of opioid addicts (33/2008) and the Act on the Rehabilitation 
Benefits and Rehabilitation Allowance Benefits of the Social Insurance Institution of Finland (566/2005). 
The implementation of substance abuse services is provided for in concrete terms in the Act on Health Care 
Professionals (559/1994) and the Decree on Qualification Requirements for Social Welfare Personnel 
(804/1992), both of which govern substance abuse services employees, and also in the Act on the Status 
and Rights of Social Welfare Clients (812/2000) and the Act on the Status and Rights of Patients 
(785/1992). In 2005, a treatment guarantee was introduced in Finland in amendments to the Public Health 
Act and the Act on Specialist Medical Care, specifying maximum waiting periods for access to non-urgent 
examinations and treatment. In the area of drug use treatment, the treatment guarantee covers opioid 
substitution treatment, to which a client must be provided access within six months of seeking treatment 
(for further information on acts and decrees, see also Kekki & Partanen 2008). 
Principal strategies and recommendations underlying the providing of drug use treatment include the 
‘Quality recommendations for substance abuse services’ published by the Ministry of Social Affairs and 
Health (2002) and the Current Care guidelines for drug abusers drawn up by Duodecim and the Finnish 
Society of Addiction Medicine (2006). The national plan for mental health and substance abuse work 
(MIELI), published in 2009, outlines the key principles and focus areas for mental health and substance 
abuse work up to 2015. What is interesting in the MIELI plan from the perspective of institutional care is 
an emphasis on outpatient care and the explicitly stated aim of reducing the need for institutional care in 
both mental health services and substance abuse services. These recommendations will be discussed below 
in section 3. 
11.2.1 Funding of institutional care and various means of funding 
In Finland, liability for funding institutional care rests with local government. Where a local authority does 
not provide statutory services itself, it may outsource them through competitive tendering, augment its own 
services by entering into strategic partnership agreements with the third sector, or set up a joint authority 
with other municipalities, a hospital district, third-sector NGOs and/or the private sector. At the moment, 
the most common means for funding institutional care is the purchaser-provider model, where a local 
authority buys the services it needs from a private service provider, an NGO or a private care enterprise. In 
2010, more than 60% of all substance abuse services were provided by NGOs or private service providers. 
Some local authorities still have care facilities of their own, and in some municipalities substance abuse 
services have been converted into foundations. For instance, there is a substance abuse service foundation 
in operation in the Jyväskylä area in central Finland and another in the Kuopio area in eastern Finland; 
local authorities sign annual purchase agreements with these foundations or issue guarantees of payment 
for their clients. The principal aim in setting up substance abuse service foundations is to bring together 
substance abuse service professionals in a single organisation for better coordination of services (see also 
Inkeroinen & Partanen 2006). 
In recent years, funding of substance abuse services in municipalities has been governed mainly by the 
Act on Public Contracts (348/2007), which requires local authorities to subject all outsourced services to 
competitive tendering. Some people feel that this has undermined the resources available for substance 
abuse services, as local authorities have only considered the financial aspects of tenders submitted. 
Increasing competitive tendering is also considered to erode the volume of institutional care, as local 
authorities seek to cut costs (for more on this debate, see Perälä 2010; Kekki & Partanen 2008). Indeed, 
local government politicians are considered to exercise a huge influence on the content of substance abuse 
services provided to citizens. (Ministry of Finance 2008; Kaukonen 2005.) 
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11.3 Organisation of drug use treatment and availability of institutional care  
Institutional care for drug users in Finland is largely a social service. Only addiction psychiatry wards and 
detoxification treatment beds at health centres fall within the domain of health care. Social welfare services 
on the one hand and health care services on the other are governed by different legislation, and the statistics 
on these operations are also compiled in differing ways. 
11.3.1 Recent developments in institutional care in the light of statistics: number of 
 treatment units, treatment days and clients treated 
In 2012, there are between 70 and 80 facilities providing 24h treatment for substance abusers.79 The 
number of rehabilitation institutions has somewhat decreased in recent years. (Forsell 2012b.) 
In 2010, there were an estimated80 2,000 to 3,000 individual clients in institutional care because of drug 
use: 1,000 to 2,400 clients in social welfare institutions and 700 to 1,700 clients at hospitals in the health 
care system (treatment periods longer than one week). The number of social welfare rehabilitation clients in 
particular has been decreasing since 2006 (by 10% to 25%). (Forsell 2012b.) At the same time, however, 
both the number of clients in residential substance abuse services and the number of treatment days have 
increased (by 10% to 25%). (Yearbook of Alcohol and Drug Statistics 2011, National Institute for Health 
and Welfare.) 
In the annual survey for collecting information from drug-related treatment conducted by the National 
Institute for Health and Welfare, 66% of clients in institutional care were men, about the same percentage 
as in outpatient care. The average age of clients was 30 years. Clients in institutional care are on the whole 
somewhat younger than those in outpatient care. No fewer than 17% of the clients in institutional care were 
homeless (vs. 8% in outpatient care), and only 4% of them had a job (11% ditto). Supported housing is not 
included in this survey. (Forsell 2012a.) 
According to the survey for collecting information from drug-related treatment, opiates were the reason 
for seeking treatment for half (49%) of the clients in institutional care. The percentages of problem users of 
stimulants (18%), tranquillisers (8%) and alcohol (17%) were somewhat higher in institutional care than in 
outpatient care, and 78% of the clients in institutional care had used intravenous drugs at some point in 
their life. Problem users of opiates and cannabis were more common among clients in inpatient care in 
health care services (treatment periods lasting more than one week), while problem users of stimulants 
were more common in institutional care in social welfare services81 (Forsell 2012a; 2012b). 
11.3.2 Forms of institutional rehabilitation 
Substance abuse service facilities in Finland offer detoxification, short-term care intervals and long-term 
rehabilitation. Drug users with severe mental health problems are treated in addiction psychiatry wards. 
Supported housing has become more common in recent years. It is a sort of combination of outpatient care 
and institutional care, with clients living in their own apartments or rooms but participating in day-centre 
activities integrated with the housing facility. 
                                                        
 
 
79 This estimate is based on TOPI, the Register of Institutions in Social Welfare and Health Care maintained by the National Institute for 
Health and Welfare. The majority of institutions in the TOPI register are in the social welfare sector, because health centres and hospitals are 
entered as single entities, not analysed by specialisation. Comparison over time is difficult because practices have changed. In actuality, the 
number of substance abuse rehabilitation institutions has decreased by a dozen since 2006.  
80 The estimate was obtained by comparing data on substance abuse clients in the statistics on ‘Finances and activities of municipalities and 
joint municipal boards’, in the Care Registers for Social Welfare and Health Care, and in the information from drug-related treatment 
compiled by the National Institute for Health and Welfare. The number of drug user clients was calculated by using a coefficient based on 
the census of intoxicant-related cases conducted by the National Institute for Health and Welfare.  
81 The estimate was obtained by comparing data in the Care Register for Health Care and in the information from drug-related treatment 
compiled by the National Institute for Health and Welfare.  Comparing the data from the former to data from the latter is rather difficult, 
because alcohol problems are not included in the health care statistics, and on the other hand the ‘combined use’ diagnosis, F 19, is rather 
common.  
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In most cases, rehabilitation for problem users of alcohol on the one hand and drugs on the other is not 
separated; services at rehabilitation facilities are aimed at both groups. Within these institutions, however, 
functions may be differentiated. Also, some rehabilitation facilities specialise in drug use treatment, while 
others do not accept drug users as clients at all. There are also beds and wards exclusively for men, women, 
families or adolescents. 
Treatment of drug addiction or drug problems begins with a course of detoxification. Detoxification 
treatment is provided at inpatient wards at municipal health centres, at detoxification centres specialising in 
withdrawal treatment, and at major rehabilitation facilities. The size of these units varies from a couple of 
beds to a couple of dozen beds. Especially at detoxification centres and rehabilitation facilities, the 
detoxification treatment includes rehabilitative elements in addition to the detoxification proper. In health 
care services there are addiction psychiatry wards at major central hospitals, where dual-diagnosis patients 
are often treated and assessments of treatment needs are conducted. 
After a course of detoxification, the client may seek entry to institutional rehabilitation by applying for a 
payment guarantee from the social services office of his/her home municipality. Having been through 
detoxification is often a requirement for being admitted to rehabilitation. Rehabilitation facilities in Finland 
vary in size from small institutions with a dozen beds to major hospitals with almost 100 beds. The larger 
facilities are sub-divided into wards. 
Rehabilitation is followed by post-rehabilitation, typically in outpatient care or supported housing. 
Typical forms of treatment 
Institutional withdrawal treatment almost always involves medication and 24h monitoring. Other methods 
used include rest, monitoring of physical condition, one-on-one and group therapy sessions, and planning 
of further treatment. Detoxification is based on a treatment plan, which is drawn up following an 
investigation of the severity of the intoxicant problem and an interview with the client. Many treatment 
facilities also employ a care agreement that determines the progress of detoxification: how long it will be, 
what medication will be administered and what examinations carried out, and what the rules of the 
treatment facility are concerning outdoor exercise, visitors, personal items and confiscation of intoxicating 
substances. 
No separate study has been conducted on detoxification treatment for drug users, although 
detoxification and withdrawal treatment have been discussed at a general level in some theses and reports 
(Lampela 2010; Mikkilä 2010; Makkonen 2005). Teija Makkonen’s report from 2005 also outlines a 
number of development proposals. One of the flaws and development needs highlighted is the lack of 
integration of detoxification with other substance abuse rehabilitation services, which according to 
Makkonen is a challenge due to the fragmented nature of the substance abuse service system. The quantity 
and quality of detoxification services varies from one municipality to another, and it is difficult to obtain a 
comprehensive overview of the state of detoxification in the country as a whole. 
Institutional rehabilitation is traditionally set up as a variety of therapeutic communities that often apply 
the 12-step programme and community treatment principles. The operations of the Kisko Clinic of the 
Kalliola Settlement Youth Association founded in 1986 and the Mikkeli Community founded in 1998, for 
instance, are based on these principles.  The operations of the Kisko Clinic have been registered as a brand; 
the concept combines the ideals of the Daytop therapeutic community model, the NA programme, social 
rehabilitation, and individual and group therapy according to the transactional analysis framework. The 
work of the Mikkeli Community is based on community treatment, combined with the NA programme and 
cognitive and creative methods. Both facilities have a non-medicinal approach. 
The work of the Kisko Clinic and the Mikkeli Community have been studied previously. (Selin 2010b; 
Heikkilä 2004; Kylmälä 2001; see also Hakkarainen & Kuussaari 1996.) Jani Selin (2010b) noted the ritual 
dimensions of community treatment in both these communities in his research, the purpose of the treatment 
being to ‘normalise’ the clients into becoming upstanding citizens and decent members of the community 
once again. Heikkilä highlights the “stressful” nature of the treatment at the Kisko Clinic, which he 
Institutional care for drug users in Finland 
 
THL - Report 76/2012 108 Finland – Drug Situation 2012 
describes as both an advantage and a disadvantage. The disadvantage is that many clients drop out of the 
treatment programme, but the advantage is that those who do go through with it generally achieve good 
results. Indeed, Heikkilä notes that the Kisko Clinic is suitable for drug users who are themselves motivated 
to make a change in their lives. 
There is also a number of small communities around Finland operating on the ‘halfway house’ principle, 
combining the 12-step programme with community treatment on a small scale. Many of these also rely on 
strong peer support, and some employees have a history of substance abuse themselves. 
Numerous rehabilitation facilities combine various models of psychosocial rehabilitation in their work. 
Therapeutic combinations are typical for instance of the services provided by the A Clinic Foundation, a 
national substance abuse service organisation. Rehabilitation facilities supervised by the A Clinic 
Foundation include: the Hietalinna Community, which relies on community therapy without medication; 
Järvenpää Social Hospital, which combines multi-professional treatment with medication and various 
forms of psychosocial rehabilitation; and the A Home in Kankaanpää, which relies on the ‘ASTA work’ 
concept, combining various forms of individual, pair and group therapy with recreation, manual skills and 
job assignments. These rehabilitation programmes often employ a client-oriented approach. 
Organisations with a Christian background have traditionally played a key role in Finnish substance 
abuse rehabilitation. Seukkala, a rehabilitation home owned by a private association, is a currently active 
facility with a Christian orientation. The work done at Seukkala combines the principles of community 
treatment with Christian ethics (see also Asikainen et al. 2004).  The Karismakoti facility operates on the 
same principle but is for men only. Clients usually have the option not to attend the spiritual functions at 
rehabilitation facilities with a Christian orientation. However, the Christian faith often has a strong 
presence at such facilities, and this is clearly indicated in their presentation. In recent years, the use of 
facilities with a Christian orientation in substance abuse rehabilitation has decreased. It has been suggested 
that this is due to a lack of trained personnel (see e.g. Perälä 2010). 
Rehabilitation facilities and programmes based on the cognitive framework have become more common 
in the 2000s. Some of them market themselves as an alternative to community treatment in particular. 
Another type of service that has increased in popularity is supported housing. This is a service typically 
intended for long-term substance abusers, combining accommodation with low-threshold psychosocial 
support services. Post-rehabilitation services may also be provided in the context of supported housing. 
Some treatment programmes and substance abuse service NGOs have their own sheltered housing, 
admission to which may be gained with a payment guarantee from the local authority. 
There are dedicated treatment facilities for women only and adolescents only in Finland. There are also 
separate rehabilitation services for pregnant women and for mothers and families with substance abuse 
problems. The latter are provided particularly by the nationwide Federation of Mother and Child Homes 
and Shelters. The treatment principles at rehabilitation facilities for women and adolescents usually follow 
the diverse approaches described above, but there is also a specific focus on womanhood or parenthood in 
the case of women and on regularity of lifestyle, healthy diet and self-care in the case of adolescents. 
Health care services have addiction psychiatry wards intended for drug users with severe mental health 
problems.  The Department of Addiction Psychiatry of the Hospital District of Helsinki and Uusimaa, for 
instance, provides psychosis treatment, detoxification in severe cases, evaluation periods, care intervals to 
support outpatient care, and initiation periods for substitution treatment. Treatment periods vary from a few 
weeks to a few months, depending on the client’s needs. 
Combinations of treatments and services 
Finnish institutional rehabilitation typically combines various forms of individual and group activities with 
the principles of community treatment. Group therapies often rely on the 12-step programme or 
occupational therapy, while individual therapies tend to involve various form of cognitive or social therapy. 
Facilities also offer opportunities for various leisure activities and in some cases also employment activities. 
In community treatment, clients are coached in responsible behaviour towards themselves and their 
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community and to commit to the rules of the community. In facilities with a Christian orientation, spiritual 
activities and pastoral therapy form an essential part of the treatment (cf. the previous section). 
Rehabilitation facilities typically offer health care services, for instance for controlling clients’ 
medication. Major facilities also have their own detoxification wards, from which clients are transferred to 
rehabilitation. The services of a social worker are often also available. Personnel often include 
professionals specialising in substance abuse services and mental health care, with training in social and 
behavioural sciences (e.g. social workers, psychologists, occupational therapists) or in health care (e.g. 
physicians, nurses, psychiatric nurses, physiotherapists). Smaller facilities often have personnel trained in 
substance abuse services and mental health care and a nurse, for instance. 
Substitution treatment in institutional rehabilitation 
Some facilities in Finland have integrated substitution treatment into their care programmes, particularly 
substitution treatment initiation periods. Sometimes substitution treatment clients are transferred to 
institutional care if they exhibit too much additional substance use in outpatient care. Substitution treatment 
at institutions is provided pursuant to the relevant Decree of the Ministry of Social Affairs and Health. 
Clients also participate in other activities at the institutions, such as community treatment as described 
above, individual or group therapy, or occupational therapy. 
There is one prior study on the providing of substitution treatment in institutional care (Weckroth 2006). 
An extensive study on the provision of substitution treatment in Finland was commissioned by the Ministry 
of Social Affairs and Health last year but has not yet been published. This study was intended to explore 
which parties currently provide substitution treatment in Finland and how many of them there are. At the 
moment, it is not known exactly who all the service providers are. 
Post-rehabilitation and care pathways 
Extended periods of rehabilitation always involve the drawing up of a treatment plan and visits to post-
rehabilitation facilities. Some institutions and some types of treatment have their own post-rehabilitation 
programmes or supported housing services. No comprehensive study has been conducted on post-
rehabilitation or its effectiveness in Finland. 
 
11.4 Quality control of institutional care 
The key recommendations underlying substance abuse services and drug use treatment were discussed in 
section 11.2. There is no current study on the quality of drug use treatment, nor indeed of substance abuse 
services in general. However, the current state and arrangements in substance abuse services have been 
touched upon in various articles and reports (Ministry of Social Affairs and Health 2012a; Kekki &   
Partanen 2008). Flaws identified in the providing of services include the fragmented nature of the service 
system and the resulting difficulty in coordinating and monitoring services; also, it has been considered that 
services rely too heavily on outpatient care. 
National and local recommendations 
The purpose of the quality recommendations for substance abuse services (2003) is to support the planning, 
providing and development of substance abuse services by local authorities. These recommendations are 
based on the key legislation governing substance abuse services, discussed in section 11.2. The quality 
recommendations cover both general principles in providing substance abuse services and more detailed 
recommendations for instance regarding the number of employees at treatment units or accommodation 
arrangements. The following is a brief discussion of the recommendations. 
Firstly, the quality recommendations require services to be provided in such a manner that the 
fundamental rights, human rights and legal protection of the client are safeguarded. The need for help, 
support and treatment by the client and by people close to him/her is considered the basic principle in 
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substance abuse treatment and services. The treatment itself is based on respect of self-determination, 
support for the client’s own initiative, and confidentiality. The client’s participation in the planning and 
content of his/her treatment and related decision must also be ensured, and the physical and mental health 
of the client, the social situation and the need for support must be taken into account. An individual 
rehabilitation plan must be drawn up for each client. 
There are concrete recommendations for substance abuse services for instance regarding institutional 
accommodation. In institutional, group or dormitory-type sheltered housing, the target standard is to 
provide clients with a private room with a floor area of at least 15 sq.m. The minimum floor area for a room 
with twin occupancy is 20 sq.m. The accommodation may be smaller in short-term institutional care such 
as detoxification. The client’s right to privacy must be taken into account when designing and building a 
treatment facility. 
The personnel numbers require 0.8 employees with social welfare or health care qualifications per client 
in 24h detoxification and withdrawal treatment. For some client groups, such as underage children, drug 
users and multidrug users, clients with mental problems or intoxicated clients, the requirement may be 1.5 
qualified employees per client. The personnel requirement for a rehabilitation facility is 0.5 employees with 
social welfare or health care qualifications per rehabilitation client. A sufficient number of personnel not 
involved with client work (administration, cleaning, catering, etc.) must also be present. 
Personnel qualifications must comply with the Decree on the Professional Qualifications of Social 
Welfare Personnel and the Act on Health Care Professionals. Also, in general social welfare and health care 
services and in specialist substance abuse services it must be ensured that employees have sufficient 
professional expertise acquired through basic, further and continuing education for the early identification 
of substance abuse problems, care needs assessment and high-quality professional treatment and 
rehabilitation of substance abuse clients. 
Quality assessment forms for substance abuse treatment units have been prepared on the basis of the 
recommendations; local authorities, for instance, can assess the quality of the substance abuse services they 
use with these forms. Quality assessment forms invite units to describe the basic features of their operations: 
what kind of treatment they provide, how clients are admitted to the unit, and how much care personnel the 
unit has and of what kind. 
No research has been done in Finland on how well the quality recommendations are followed. There are 
great differences between municipalities, and it is difficult to gain an overall impression of the situation. 
The purpose of the Current Care guideline on the treatment of drug abusers is to provide information to 
clarify treatment of drug problems, to improve cross-discipline co-operation, to promote networking and to 
influence attitudes. This guideline was drawn up by a working group appointed by the Finnish Medical 
Society Duodecim and the Finnish Society of Addiction Medicine, consisting mainly of physicians. The 
guideline notes among other things that various psychosocial methods are the foundation of drug use 
treatment but that there is no scientific evidence of their efficacy. For opioid addiction, medication is 
considered an effective treatment. 
In addition to national recommendations, there are also substance abuse strategies drawn up locally by 
local authorities themselves. Some of these may be found in the Neuvoa Antavat online service of the 
National Institute for Health and Welfare. According to the quality recommendations, each local authority 
must have a substance abuse strategy forming part of the municipal health and wellbeing strategy. The 
strategy must determine how the local authority intends to prevent the emergence of harmful impacts of 
substance abuse, how substance abuse services are provided and how the division of duties between social 
welfare and health care in substance abuse services is managed. A local authority may prepare its substance 
abuse strategy together with other local authorities. 
Some local authorities have only entered the title of their strategy in the online service, or a note to the 
effect that there is a strategy. Some strategies are regional, jointly drawn up by several municipalities. 
There are also some regional substance abuse service development centres, planning and monitoring 
substance abuse services and policy in a given region. 
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Monitoring and quality assessment of institutional care 
Finnish public services are highly fragmented, and it is very difficult to monitor how substance abuse 
services are provided in municipalities (Stenius et al. 2009). This applies to institutional care for drug users 
too. Service quality control is also diffuse. 
Principal responsibility for quality control and monitoring of services rests with the local authorities, 
which under the Act on Welfare for Substance Abusers have responsibility for organising these services. 
Quality control may be undertaken for instance by the social workers responsible for outsourcing the 
services, or any municipal officials or committees formed of same. Various regional government bodies 
also supervise the providing of services together with the National Supervisory Authority for Welfare and 
Health. 
Finland also has an Ombudsman for Substance Abusers, overseeing clients’ interests in issues related to 
substance abuse services and policy. Clients may file a complaint with the Ombudsman for instance if they 
have been poorly treated in the services or have had difficulty accessing the services. 
Today, the quality of substance abuse services is often monitored in the context of competitive 
tendering. In the tendering process, the quality level of services is often predetermined in the call for 
tenders, and only service providers fulfilling specific procurement criteria are invited to the tendering 
process. Service providers that do not fulfil the criteria listed in the call for tenders are excluded from 
tendering. In Finland, outsourced services are usually put to tender by local authorities, municipal 
federations or hospital districts. Service users generally do not make procurement decisions or engage in 
competitive tendering themselves. 
Some NGOs and local authorities still have traditional partnerships based on negotiation and involving a 
commitment for development of services according to mutually agreed goals. 
 
11.5 Conclusions and discussion 
The present chapter is a discussion of the current state of institutional care for drug users in Finland.  The 
discussion reveals that there is very little scientific information available on this. There is a clear need for a 
study of institutional care. Gaining new research findings would be important especially considering that 
the use of institutional care has been decreasing in recent years, as local authorities seek to cut costs in 
substance abuse services and invest in cost-effective and proven forms of treatment such as substitution 
treatment. 
Also, some quite critical public comments have been made about the state of drug use treatment in 
recent years, and there has been some civic activism demanding the upholding of institutional treatment. 
One of the issues is how favouring outpatient care has influenced the social status of drug users. One of the 
threats identified is that substance abuse problems may become chronic in the absence of sufficient 
psychosocial rehabilitation. 
Another often-mentioned flaw, which is referred to in this chapter too, is the fragmented nature of 
Finnish substance abuse services. This makes it difficult to gain an overall impression of the state of 
substance abuse services, to assess the quality of services or to ensure the equality of citizens in the system. 
For instance, municipal service policies have a great impact on the substance abuse services produced in 
their respective municipalities and the availability of those services. Secondly, substance abuse services are 
frequently outsourced to private service providers, which aggravates fragmentation and further complicates 
monitoring of the services. In a qualitative study on the providing of substance abuse services, 
representatives of both local authorities and NGOs considered it difficult to monitor and maintain quality in 
substance abuse services under current circumstances: municipal officials felt quality assessment to be 
difficult because of the large number of service providers and a lack of resources for monitoring, while 
NGOs felt that local authorities are pushing service providers’ revenues down by focusing only on what the 
services cost. (Perälä 2010.) 
On the other hand, the diversity of the Finnish substance abuse service system may be seen as a strength, 
as witness the client-oriented approach of rehabilitation facilities and the wide range of options available. 
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But because institutions largely operate according to their own principles, coordinating functions between 
institutions is often difficult. Because of their heterogeneous nature, it is also difficult to establish exactly 
what kind of treatment they provide on a day-to-day basis, and which types of rehabilitation work and 
which ones do not. 
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12 The drug situation in Helsinki 
12.1 Functions and responsibilities of large cities in drug policy 
Finnish local authorities have autonomy, and they are required by law to provide residents with certain 
statutory basic services, the most important of which involve social welfare and health care services, 
education and culture, and the environment and infrastructure. Local authorities are authorised to levy taxes; 
basic services are financed out of municipal taxes, central government transfers and service fees charged 
from clients. 
Finnish local government rests on the principles of publicity and transparency. The importance of direct 
influence and involvement by local residents is stressed in the Local Government Act, and local residents 
have the right to submit initiatives concerning matters in their municipality. Local authorities inform local 
residents about matters in progress, plans, decisions made and their impacts. 
The highest decision-making body in local government is the municipal council, elected in local 
elections with universal suffrage every four years. [Hereinafter, for ‘municipal’, read also ‘town’ or ‘city’.] 
The municipal council is responsible for the operations and finances of the municipality. The municipal 
council appoints the municipal board, whose job is to prepare decisions for the municipal council to make 
and to execute those decisions once made. The municipal manager and his/her deputy are subordinate to the 
municipal board. 
The municipal council also appoints the committees responsible for organising the services that the 
local authority is required to provide. It is not mandatory to have executive committees for these services, 
but in practice every municipality has committees consisting of elected officials managing social welfare 
and health care services, for instance. 
Under the Act on Welfare for Substance Abusers, local authorities are responsible for substance abuse 
services as part of social welfare and health care services. Specialist substance abuse services include 
outpatient care, short-term institutional care, long-term rehabilitation and support services. In addition to 
specialist substance abuse services, substance abusers are also treated under basic social welfare services 
and primary health care, and in specialist medical care. 
Under the Temperance Work Act, preventive substance abuse work is the responsibility of local 
authorities. Most local authorities have designated a coordinator for substance abuse prevention, and many 
major cities have a dedicated unit for this purpose. 
Municipal substance abuse strategies 
The purpose of municipal substance abuse strategies is to create a substance abuse policy aimed at reducing 
substance abuse and related harm. A municipal substance abuse strategy outlines the policies and focus 
areas of the local authority’s substance abuse work. One of the most important goals of these strategies is to 
improve cooperation and networking among authorities. Substance abuse strategies generally cover both 
alcohol and illegal drugs. The origin of municipal substance abuse strategies may be traced back to the 
publication Kunnallisen sosiaali- ja terveydenhuollon tavoitteet (Objectives of municipal social welfare and 
health care, Ministry of Social Affairs and Health 1998), where local authorities were encouraged to draw 
up substance abuse strategies. (Romppanen 2005). 
According to the database of municipal substance abuse strategies maintained by the National Institute 
for Health and Welfare, 82 out of the 336 municipalities in Finland in 2012 have a substance abuse strategy 
in place. (Neuvoa antavat website of the National Institute for Health and Welfare.) At the national level, 
efforts to reduce drug use and related harm are governed by a Government Resolution. 
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Substance abuse services in major cities in Finland 
Substance abuse services provided in Finland’s six largest cities (Helsinki, Espoo, Tampere, Vantaa, Oulu, 
Turku) and their costs are compared in the annual Kuusikko report. In addition to cost comparisons, the 
report discusses how these cities organise their substance abuse services and how they are prioritised. In 
2010, the cities’ substance abuse services included outpatient services such as A Clinics, youth stations, 
substitution treatment, health counselling, housing services and institutional care. Primary health care, 
substance abuse services in social welfare for adults and specialist medical care are excluded. (Korteniemi 
2011.) 
The six largest cities in Finland differ from one another in their organisation of substance abuse services 
and their definition of the various types of service. Generally, it may be noted that substantial structural 
changes have occurred and continue to occur in substance abuse services in all these cities. The aim in 
structural reform in all six cities is to shift the focus towards outpatient services. (Korteniemi 2011.) 
The overall costs of substance abuse services at the City of Helsinki Social Services Department in 2010 
were EUR 32.4 million under the narrow definition and EUR 50.7 million under the broad definition.82 
Costs under the broad definition break down as follows: institutional services 23.2%, housing services 
42.0%, substitution treatment in outpatient care 8.8%, outpatient care without substitution treatment 26.0%. 
(Korteniemi 2011.)83 
In Helsinki, the substance abuse prevention unit for children and adolescents, Klaari Helsinki, is 
subordinate to the Youth Department, while the substance abuse prevention unit for adults is subordinate to 
the Social Services Department. These units cooperate with other City departments, NGOs and substance 
abuse prevention units in other cities in the Greater Helsinki area. There are also various independent 
projects engaged in substance abuse prevention. 
 
12.2 Case study: Helsinki, the capital city 
The City of Helsinki prepared a drug strategy in 2000. According to this document, Helsinki applies a 
restrictive drug strategy aiming at reducing both drug use and related harm. Intoxication-oriented behaviour 
and easy access to drugs are considered particular threats for adolescents. General types of harm related to 
illegal drugs cited in the strategy include drug-related deaths, the spreading of serious communicable 
diseases, the proliferation of crime and insecurity, and problems related to social exclusion. Basically, the 
strategy follows on the same lines as Helsinki’s first ever drug strategy (1997), while focusing more closely 
on clarification of concrete practical goals and means. The strategy defines specific goals for various 
administrative sectors. (City of Helsinki 2000.) 
Particular goals named in the strategy include ensuring equal treatment of drug users as clients of social 
welfare and health care services, providing low-threshold treatment facilities, outreach work and a service 
framework with a variety of alternatives. 
The strategy also notes the special status of Helsinki as Finland’s largest city: generally, new services 
intended for problem users are introduced in Helsinki for the first time in Finland. The strategy stipulates 
that Helsinki must be actively engaged in research and development with neighbouring municipalities, with 
                                                        
 
 
82 Clients of substance abuse services often have multiple problems. A need for housing services may be seen as being caused variously by 
homelessness, a substance abuse problem or a mental health problem. The substance abuse service budget in Helsinki covers only part of the 
housing services most of whose clients have a substance abuse problem. Under the broad definition, the overall costs include services most 
of whose clients have a substance abuse problem. The Homeless Support Unit of the City of Helsinki Social Services Department is 
responsible for providing housing services for homeless adults. Forms of assisted housing include service centres, sheltered housing, 
communal supported housing or other types of supported housing. 
 
83 This figure does not include services outsourced by the Health Centre from other providers, such as the Helsinki Deaconess Institute HIV-
positive service centre, health counselling centres (Vinkki services and the mobile health counselling centre of the Helsinki Deaconess 
Institute), substitution treatment at health stations, or services outsourced from Helsinki University Hospital. 
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NGOs and with the central government while monitoring national and international agreements concerning 
drugs. (City of Helsinki 2000.) 
The Plan for Mental Health and Substance Abuse Work published by the Ministry of Social Affairs and 
Health in 2009 outlines mental health and substance abuse services at the national level, compiling 
proposals for improving these services by 2015. The plan focuses on strengthening the status of the client, 
promoting mental health and an intoxicant-free lifestyle, preventing problems and harm, and providing 
mental health and substance abuse services for all age groups with an emphasis on basic and outpatient 
services. Key points in the development of the service system include the low-threshold one-stop-shop 
principle and the setting up of combined mental health and substance abuse outpatient care units. (Ministry 
of Social Affairs and Health 2009b.) 
Pursuant to the Plan, the substance abuse services provided by the City of Helsinki focus on flexibly 
combining treatment for mental health and substance abuse problems, improving the status of the client and 
providing mental health and substance abuse services specifically for children and adolescents on the one 
hand and for the elderly on the other. In the overall plan for substance abuse services, the City provides 
service assessment and the basic service framework, augmented by outsourced services based on special 
needs and alternative treatment programmes. Clients are assisted as early as possible through a flexible and 
comprehensive network of outpatient services. (Fabritius 2011.) 
In practice, Helsinki pursues both a harm-reduction policy and a recovery policy in parallel. The 
purpose of this is to ensure sufficient and appropriate services for problem drug users at various stages of 
drug use or recovery. 
Extent of problem drug use 
Problem drug use in Finland has been assessed every few years since 1997 in statistical surveys; however, 
the first findings on problem drug use in the Greater Helsinki area date from 1995. The material for the 
study comes from drug-related data in the Hospital Discharge Register, the reported offences register, the 
intoxication register and the hepatitis C register. In the study, a ‘problem drug user’ is defined as a person 
whose use of opiates or amphetamines has led to action being taken by the authorities. (Partanen et al. 
2007.) 
In 2005, it was estimated that there were between 14,500 and 19,100 problem drug users in Finland, 
some 50% to 60% of them from Southern Finland and more than half of them from the Greater Helsinki 
area. 
In 2005, there were an estimated 5,100 to 8,200 problem users of amphetamines and opiates in the 
Greater Helsinki area, accounting for 0.9% to 1.4% of the population aged 15 to 54. Out of these, an 
estimated 4,000 to 6,000 (70% to 75% of all problem users) were amphetamine users, accounting for 0.7% 
to 1.0% of the population aged 15 to 54. The number of problem users of opiates was estimated at 1,300 to 
2,400, accounting for 0.2% to 0.4% of the population aged 15 to 54. (Partanen et al. 2007.) 
In terms of gender distribution, it was estimated that in 2005 men accounted for 75% to 85% of problem 
drug users in the Greater Helsinki area. Towards the end of the 1990s, about 40% of problem users of 
amphetamines and clearly more than 40% of problem users of opiates were aged 15 to 24. Thereafter, the 
percentage of users aged 15 to 24 has decreased markedly for both substance groups (to 20%–25% in 2007) 
while the percentage of users aged 25 to 34 has increased. There have been no major changes in the 
percentage of users aged 35 to 54. The aging trend among Finnish drug users is most evident in the Greater 
Helsinki area. (Partanen et al. 2007.) 
Only very limited quantitative data allowing for generalisation are available on which substances drug 
users in Helsinki use and in what ways. Problem drug use in the Greater Helsinki area was studied in a 
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survey where 100 drug users in Helsinki were interviewed.84 Out of the 100 people interviewed, 71 were 
men and 29 women. The age range was 19 to 47, the average age of the interviewees being 29.4 years 
(median 28.5 years). The survey revealed that the interviewees were disadvantaged in a number of ways 
and were living on the margins of society.85 Their educational attainment was low, and the majority of them 
(79 out of 100) were unemployed. More than half of the interviewees were not in a steady relationship at 
the time of the interview. More than half of the interviewees had a place to live, whether own or rented, but 
one out of four lived in a shelter or were completely homeless. Three out of four interviewees reported that 
their main source of income was social security. (Tammi et al. 2011.) 
The study material from interviews with 100 drug users indicates that buprenorphine and amphetamines 
were the most frequently used illegal drugs at the time, although the use of benzodiazepines and various 
pharmaceutical opioids was also common. Buprenorphine-naloxone combination (Suboxone) and pure 
buprenorphine (Subutex) were used almost exclusively intravenously when used for intoxication purposes. 
Intoxicant use of Suboxone appeared to be particularly popular among young users. Heroin and cocaine use 
were rare. (Tammi et al. 2011.) 
From the perspective of the care system, the assumed distinction between the groups of amphetamine 
users on the one hand and opioid users on the other is reinforced by the fact that there is a specific 
treatment available for opioid addiction, viz. medical opioid substitution treatment. In studies and surveys 
too, amphetamine and opioid users are typically described as two distinct groups. By contrast, the study 
discussed here indicates that although there are users who principally use amphetamines only or opioids 
only, the hard core of the drug sub-culture in Helsinki involves combined use featuring both polydrug use 
of opioid-based pharmaceuticals and benzodiazepines on the one hand and alcohol and cannabis on the 
other. The study also reinforces the findings that a substantial percentage of opioid addicts also have a 
benzodiazepine addiction and that  alcohol use is common among opioid addicts. (Tammi et al. 2011.) 
In 2010, clients who sought entry to the City of Helsinki substance abuse services reported their 
principal intoxicant as follows: alcohol 66.8%, buprenorphine 7.9%, tranquillisers 6.1%, cannabis 5.3%, 
amphetamines 5.5% (Korteniemi 2011.) 
 
12.3 The drug situation in Helsinki  
The size of the population in the area comprising Helsinki and its surrounding municipalities makes the 
area special in terms of drug use and the drug trade. Helsinki-Vantaa Airport and the Port of Helsinki 
handle a large volume of international traffic. Helsinki is the nexus of Finland’s drug trade, and the 
principal market is also in the Greater Helsinki area. Hence, the key players in the drug trade are in this 
area. No truly open drug market exists in Finland; most of the sale and use of illegal drugs takes place in 
private homes, although a minor trade in cannabis may sometimes be observed in public parks or in 
restaurants in Helsinki in the summer. The major items on the drug market in Helsinki are amphetamines, 
cannabis and the buprenorphine preparation Subutex. (Kinnunen 2008; Perälä 2011; National Bureau of 
Investigation 2012.) 
The street price of drugs is affected by many factors, one of them being the location where the particular 
batch of drugs is sold. In Finland, street prices of drugs are typically higher in the rest of the country than in 
                                                        
 
 
84 Drug users in the Greater Helsinki areas were studied in the context of the European Quaf2 project; 100 drug users in Helsinki were 
interviewed using a structured interview form. The interviewees were recruited through anonymous health counselling centres, their network 
of acquaintances or on entry into the service system. The study involved exploring the drug users’ life situation; analysing the frequency of 
use, mode of use and manner of procurement of drugs and psychoactive pharmaceuticals; and studying to what extent the groups of 
amphetamine and opioid users were distinguishable from each other. It was also considered whether users tended to combine opioid, 
benzodiazepine and alcohol use. 
 
85 Describing someone as ‘disadvantaged’ generally refers to various shortcomings in wellbeing such as unemployment, poverty, housing 
problems, family or other social problems, health issues, poor social skills and educational attainment, and marginalisation from participation 
and involvement in society at large. 
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the Greater Helsinki area. Amphetamines, hashish and Subutex are as a rule much more expensive outside 
the Greater Helsinki area. By contrast, unlike the prices of smuggled drugs, cannabis prices do not show 
regional variation because home growing has become more common. (Perälä 2011; National Bureau of 
Investigation 2012.) 
Jussi Perälä has made an ethnographic study of the drug market in Helsinki in the early 2000s. His study 
demonstrates that drug dealing in Helsinki is a far from rational pursuit; it is more a reaction to intoxicant 
addiction(s) and other problems. Operations also differ depending on whether the dealing involves just one 
drug or several. Selling and using Subutex is very different from using cannabis that the user grows himself. 
Dealing in Subutex yields the highest return on investment, while dealing in cannabis is the least profitable. 
(Perälä 2011.) 
Players on the drug market may be roughly analysed into upper, middle and lower level players. The 
upper level handles imports, the middle level handles wholesale dealing, and the lower level handles retail 
dealing. Typically, the players on the various levels also use the products they deal in. Several ethnic 
minorities are involved in the drug market in the Helsinki area in addition to native Finns. The largest 
group of foreign origin is Estonians, who are major players particularly in the import of amphetamines. 
Other prominent minorities include Russians and immigrants from Africa and Asia. (Perälä 2011.) 
An increase in the online ordering of designer drugs and intoxicating herbal products has been noted by 
the Customs authorities. There are no research findings on problem use of designer drugs in Helsinki in 
particular, but the entry to market of designer drugs has been noticed in practice in the work of health 
counselling centres and detoxification units. No designer drug production facilities have been discovered in 
Finland. (National Bureau of Investigation 2012.) Finland does not have ‘smart shop’ dealerships of the 
kind found in some other European countries. 
The police undertake home searches, street surveillance and traffic surveillance, and also engages in 
forensic investigation and screening at points of entry, for instance at major festivals. Efforts are made to 
influence the demand for drugs through substance abuse prevention, information distribution and public 
education. 
Low-threshold services for problem drug users 
Helsinki has four low-threshold health and social welfare counselling centres maintained on local 
government funds (Vinkki services, A Clinic Foundation) and a mobile health counselling centre (Helsinki 
Deaconess Centre), whose services are primarily intended for intravenous drug users. The purpose of the 
service is to reduce harm related to intoxicants and intoxicant use and to prevent the spread of infectious 
diseases. The health and social welfare counselling centres provide information on social welfare and 
health care services and offer needle and syringe exchange services, peer support and outreach field work. 
Clients are guaranteed anonymity at the health and social welfare counselling centres. The counselling 
centres also produce data on the local and regional drug situation. HIV-positive drug users have access to 
low-threshold substitution treatment, needle and syringe exchange and day centre services from the 
relevant NGO. 
Drug users may seek entry to the City outpatient care services without an appointment; clients may then 
be further referred to detoxification or rehabilitative institutional care. Case management is also available 
for drug addicts. 
Substitution treatment for opiate addicts is provided on a low-threshold principle. However, starting 
treatment requires undergoing an assessment period in outpatient services. 
Helsinki University Hospital has a special clinic for pregnant women with substance abuse problems 
where clients may go at their own initiative or on referral from a physician or a public health nurse. The 
clinic provides information on how alcohol and drugs affect the foetus and on the progress of pregnancy 
while encouraging an intoxicant-free lifestyle. When a client is admitted, a survey on intoxicant use is 
conducted and a tox screen taken. The goals of the clinic for pregnant women with substance abuse 
problems are: discontinued or decreased substance use (referral to substance rehabilitation); diagnosis and 
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treatment of diseases and nutritional disorders that may pose a threat to the pregnancy; detection of 
substance abuse related development and growth disorders in the foetus; evaluation of the mother’s 
capacity to take care of the baby, assessment of the need for child protection; evaluation of the possibilities 
for successful continuation of the pregnancy; and supporting the parents’ growth into parenthood. (HUS 
2008.) 
The Helsinki Deaconess Institute provides low-threshold services at day centres and in a mobile unit. 
The Institute also provides specialist services for HIV-positive drug users on the low-threshold principle 
together with the Clinic for Infectious Diseases at Helsinki University Hospital and the City of Helsinki 
Social Services Department. The service framework includes day centre services and home care services. 
The services are free of charge for clients, being financed by the City of Helsinki Health Centre and the 
Cities of Espoo and Vantaa. (Helsinki Deaconess Institute 2012.) 
 
12.4 Current issues in Helsinki 
Substance abuse services in Helsinki underwent a structural change throughout the 2000s, the strategic 
objective being to reduce the need for institutional care through a diverse range of outpatient services. The 
City of Helsinki Social Services Department and Health Department will be merged in 2013, and this 
change have an effect on substance abuse services. Psychiatric and substance abuse services will be 
combined into a single administrative entity. The purpose behind this is to improve parallel treatment of 
mental health and substance abuse problems and to reduce the risk of clients ‘falling between the cracks’. 
The change will involve the reorganisation of large service systems and is thus a demanding management 
task. 
The City of Helsinki has developed new service outsourcing models and engaged in closer cooperation 
with service providers and peer support providers. The substance abuse service system is being developed 
on a more networked and interactive basis. Efforts are being made to involve clients more closely in the 
development and implementation of the services. Support for clients will be built up of peer support, 
appropriately targeted treatment and care management. 
Although investments have been made in recent years to reduce long-term homelessness in Helsinki, the 
housing situation remains difficult, and this complicates the implementation of individual substance abuse 
rehabilitation programmes in many cases. 
Services will continue to be provided under both the harm-reduction and the recovery-promotion model. 
These two models are considered parallel, not mutually exclusive. 
Proactive prevention of social exclusion is a major challenge for all administrative sectors. 
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Several experts contributed to and provided helpful comments on the preparation of the report. We extend 
our warmest thanks to everyone involved in the preparation of the report. 
 
Immo Parviainen  Ministry of Education and Culture 
Helena Vorma   Ministry of Social Affairs and Health 
Veli-Matti Risku  Ministry of Social Affairs and Health 
Leena Metsäpelto  Finnish Prosecution Service 
Pentti Kangasniemi  National Police Board 
Sarianna Petrell  National Bureau for Investigation 
Ulla-Maija Laakkonen   National Bureau for Investigation 
Heini Kainulainen  National Research Institute of Legal Policy 
Jarmo Helin    Finnish Customs 
Erkki O. Vuori   Hjelt Institute, Department of Forensic Medicines 
Ilkka Ojanperä   Hjelt Institute, Department of Forensic Medicines 
Pekka Hakkarainen  National Institute for Health and Welfare 
Karoliina Karjalainen  National Institute for Health and Welfare 
Henrikki Brummer-Korvenkontio  National Institute for Health and Welfare 
Airi Partanen    National Institute for Health and Welfare 
Kristiina Kuussaari   National Institute for Health and Welfare 
Elina Kotovirta  National Institute for Health and Welfare 
Erja Ailio   National Institute for Health and Welfare 
Marke Jääskeläinen   National Institute for Health and Welfare 
Jarmo Kärki    National Institute for Health and Welfare 
Katja Pihlainen  Finnish Medicines Agency Fimea 
Jorma Kallio   Statistics Finland 
Mikko Tamminen  City of Helsinki, Social Services Department 
Kari Salovaara   City of Helsinki, Social Services Department 
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